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Abstract 
Orofacial clefts are among the most common congenital birth defects, occurring in as many 
as 1 in 800 births worldwide. Genetic and environmental factors contribute to the complex etiology 
of these anomalies. SPECC1L encodes a cytoskeletal protein with roles in adhesion, migration, 
and cytoskeletal organization. SPECC1L mutations have been identified in patients with atypical 
clefts, Opitz G/BBB syndrome, and Teebi hypertelorism syndrome. Our lab has previously shown 
that knockout of Specc1l in mice with gene trap alleles results in early embryonic lethality with 
defects in neural tube closure and neural crest cell delamination, as well as reduced PI3K-AKT 
signaling. However, the early lethality phenotype rendered these models incapable of 
recapitulating the human anomalies. To validate a role for SPECC1L in palatogenesis, we 
generated additional gene trap and truncation mutant Specc1l alleles. Specc1lgenetrap/truncation 
compound heterozygote embryos survive to the perinatal period, allowing analysis at later 
developmental stages. Examination of compound mutant palates revealed a delay in palate 
elevation, abnormal oral adhesions, and ectopic expression of adherens junction protein β-catenin 
at the apical surface of oral epithelial periderm cells, as well as a global increase in actin filament 
staining. We also establish that transcription factor IRF6, which has a causative role in many cases 
of orofacial clefting, is required for SPECC1L expression in the palate. After establishing a role 
for SPECC1L in the palatal epithelium, we asked if it also acted in the migration of palatal 
mesenchyme. Indeed, time-lapse imaging analysis of primary mouse embryonic palatal 
mesenchyme (MEPM) cells from Specc1lgenetrap/truncation mutant embryos show defects in 
migration. We also demonstrate that activation of the PI3K-AKT pathway with a small molecule 
activator improves mutant wound closure speed. Furthermore, random 2-D motility cultures 
revealed that MEPM cells have attributes of collective migration that are reduced in mutant cells. 
iv 
Lastly, we generated a mouse allele with the T397P point mutation, located in the second coiled-
coil domain (CCD2) of SPECC1L, that was previously identified in patients with Opitz G/BBB 
syndrome. Embryos with this allele displayed omphalocele and completely penetrant cleft palate 
defects that recapitulated the phenotype of patients with SPECC1L mutations. Together, these data 
identify roles for SPECC1L in palate epithelial integrity and mesenchymal remodeling, and thus 
firmly establish a requirement for SPECC1L in palatogenesis.  
v 
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1.1 Orofacial Clefting 
1.1.1 Early craniofacial development 
Craniofacial development of human embryos can be represented with morphologically 
distinct facial processes (Fig. 1.1) [Thomason, 2009; Dixon, 2011]. At four weeks post-
conception, these include the frontonasal prominence (FNP), two maxillary processes, and two 
mandibular processes. Over the next few weeks these primitive structures grow, move, and fuse in 
a coordinated fashion to build the early head and face. Two nasal placodes invaginate from the 
FNP ectoderm to form the nasal pits. These pits are bordered by the medial and lateral nasal 
processes, which eventually fuse to form the alae of the nose. At the same time, the upper lip and 
primary palate are created through the fusion of the medial nasal process and maxillary processes, 
the upper jaw and cheeks by the maxillary processes, and the lower jaw by the fusion of the 
mandibular prominences. 
Concurrent with the development of the other facial structures, the secondary palate is 
formed from the maxillary processes. Initial outgrowths from the maxillary processes, called the 
palatal shelves, grow vertically adjacent to the tongue. After this vertical outgrowth, the palatal 
shelves elevate to a horizontal position above the tongue and continue to grow medially until 
contact between the shelves is achieved. Lastly, the palatal shelves adhere and fuse along the 
midline to form the secondary palate, as well as anteriorly with the primary palate. 
 
1.1.2 Orofacial clefting in humans 
The complex organization of the facial processes allows the head and face to house some 
of the most intricate structures of the body. However, this complexity also renders craniofacial 
development particularly vulnerable to genetic and environmental insult [Dixon, 2011]. As a  
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Figure 1.1: Human craniofacial development. A-C) Depiction of craniofacial processes 
during the fourth (A), fifth (B), and end of the sixth week (C) of human embryogenesis. D-F) 
Oral view of palate development during the sixth week of human embryogenesis before 
elevation (D), after elevation (E), and after fusion (F). 
Dixon, M. J., Marazita, M. L., Beaty, T. H., & Murray, J. C. (2011). Cleft lip and palate: 
understanding genetic and environmental influences. Nat Rev Genet, 12(3), 167-178. 
doi:10.1038/nrg2933. Copyright 2011. Reprinted with permission from Springer Nature. 
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result, craniofacial anomalies are one of the most common types of birth defects, constituting over 
a third of congenital malformation cases. One of the most prominent craniofacial defects is an 
orofacial cleft (OFC), a defect resulting from the failed fusion between any of the various facial 
processes during embryogenesis. The severity of these defects is largely variable depending on the 
degree to which the development of the facial processes is disrupted. Some OFCs span large 
portions of the face and are often termed atypical clefts. These malformations were initially 
classified in a publication authored by Paul Tessier in 1976, where he grouped the clefts into 15 
different types [Tessier, 1976]. Repair of these clefts generally require multiple surgeries over the 
early life of the patient. While these defects are extreme, they are relatively rare, making up only 
a small percentage of all OFCs. 
Relatively milder OFCs such as cleft lip and cleft palate (CL/P) are much more common. 
These clefts can be found together or as isolated malformations [Dixon, 2011]. Many CL/P cases 
are associated with a syndrome that manifests with multiple malformations, of which more than 
275 are described [Leslie, 2013]. However, syndromic CL/P only accounts for approximately 30% 
of cases, while 70% of orofacial clefting patients have no other clear malformations [Stanier, 
2004]. Nonsyndromic CL/P (nsCL/P) can occur in as many as 1 in 800 live births [Rahimov, 2012; 
Mossey, 2012]. Surgical repair of CL/P is relatively simple compared to atypical clefts. However, 
any OFC can have a significant negative impact on the quality of life of the affected child, as well 
as a substantial financial burden on the patient’s family [Wehby, 2010]. Therefore, it is imperative 
that the biomedical community continue to improve our understanding of how these defects occur, 
both to help patients and doctors understand these disorders, as well as to treat any complications 
that happen after repair. 
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1.1.3 Investigating the genetic etiology of orofacial clefts 
OFC is a complex disorder with a multitude of genetic and environmental factors 
contributing to its etiology. One effective method of identifying genes implicated in CL/P is the 
genotyping and linkage analysis of affected families [Mangold, 2011; Dixon, 2011; Marazita, 
2012]. This is particularly useful in families with syndromic CL/P, as most syndromic CL/P 
follows a Mendelian inheritance pattern. Through these efforts, the cause of many clefting 
syndromes have been narrowed down to a small number of genes. However, nsCL/P often presents 
in families with incomplete penetrance, even in those with no history of OFC. While sequencing 
of individual patients may reveal causative variants, the heterogeneous nature of OFC often limits 
the effectiveness of these analyses. 
To account for the complex etiology of these disorders, scientists utilize genome-wide 
association studies (GWASs) to identify disease-associated variants that may not be discernable 
via linkage analysis. GWASs work by taking advantage of single nucleotide polymorphism (SNP) 
data and are largely possible because of recent advancements in microarray genotyping 
technologies [Witte, 2010, Mangold, 2011]. SNPs are natural variations in the human genome, and 
most have no impact on the health of individuals [W. Bush, 2012]. However, the collection of 
millions of SNPs from different populations allow large-scale statistical analyses that were 
previously impossible. By comparing the SNPs between healthy and affected populations, 
scientists can identify variations in genomic regions that correlate with an increased risk of many 
diseases [W. Bush, 2012]. This methodology has been used to great effect in the craniofacial field, 
resulting in the discovery of many genetic risk factors contributing to nsCL/P, including MAFB 
[Beaty, 2010], PAX7 [Leslie, 2015], IRF6 [Zucchero, 2004; Rahimov, 2008; Beaty; 2010; Leslie, 
2016], ARHGAP29 [Leslie, 2012], and many others [Reviewed in Dixon, 2011; Adeyemo, 2017]. 
6 
GWASs along with other methodologies including copy number variation and exome sequencing 
have provided a wealth of information on the genetics of these disorders. However, disease-
associated variations are not necessarily causal, so model systems must also be utilized to 
investigate the underlying mechanisms. 
 
1.1.4 Mouse models of orofacial clefting 
Alongside the various clinical discovery methods in human populations, animal model 
systems have been used to further our understanding of the mechanisms governing craniofacial 
development. The most common models include Mus musculus (mouse), Gallus gallus (chicken), 
Danio rerio (zebrafish), and Xenopus laevis/tropicalis (frog) [Van Otterloo, 2016]. The mouse is 
a particularly valuable model system. As mammals, mice are more closely related to humans than 
the other model organisms. Additionally, development of the murine palate is very similar to 
human palatogenesis, enhancing the clinical relevance of any data generated using this model (Fig. 
1.2) [Bush, 2012]. Between embryonic day 12.5 (E12.5) and E13.5, the palatal shelves grow 
vertically on either side of the tongue. By E14.5, palatal shelf elevation occurs, and by E15.5, the 
elevated palatal shelves fuse at the midline. 
This similarity in mammalian palatogenesis allows additional techniques to aid in the 
discovery of novel clefting genes. Genes important to craniofacial development can be identified 
through RNA expression profiling of the applicable tissues [Brunskill, 2014; Reviewed in Van 
Otterloo, 2016]. Novel genes can also be identified in an unbiased manner through mutagenesis 
screening with chemicals such as N-ethyl-N-nitrosourea (ENU) [Sandell, 2011; Caruana, 2013]. 
The embryos generated from these screens can be evaluated for relevant malformations and the 
isolated lines can be sequenced to find the mutated gene. However, perhaps the most important  
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Figure 1.2: Stages of mouse palatogenesis. A) Bar showing the different stages of mouse 
palatogenesis from E11.5 to E15.5. B-F) Scanning electron micrographs of the developing 
mouse palate. G-U) Coronal H&E histology sections of the anterior, middle, and posterior 
palates. MdbP, mandibular process; MNP, medial nasal process; MxP, maxillary process; NS, 
nasal septum; PP, primary palate; PS, palatal shelf; SP, secondary palate; T, tongue. 
Image (Palatogenesis in the mouse) from Bush, J. O., & Jiang, R. (2012). Palatogenesis: 
morphogenetic and molecular mechanisms of secondary palate development. Development, 
139(2), 231-243. doi:10.1242/dev.067082. Copyright 2012. Reprinted with permission from 
The Company of Biologists Ltd. 
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benefit of mouse models is that they allow examination of the underlying molecular and 
developmental mechanisms important for palatogenesis. For example, knockout (KO) mouse 
models were used to discover the integral role of Osr2 in the proliferation of the medial palatal 
shelf [Lan, 2004] and of TGFβ3 in palate fusion [Yang, 2007]. Additionally, they also provide a 
biological system to investigate whether a CL/P-associated gene identified in humans is causative. 
Despite the effectiveness of these models, interpreting these results for the context of the 
human system can be problematic. Many KO models result in early embryonic lethality, rendering 
the developmental role of a gene difficult to study [Papaioannou, 2012; Adams, 2013; Copp, 
1995]. This limitation can be partially overcome by utilizing drug-inducible and tissue-specific 
conditional KO’s [Friedel, 2011]. Additionally, knockout of a confirmed orofacial clefting gene in 
mice often does not result in clefting phenotypes [Gritli-Linde, 2008]. Cleft lip is also uncommon 
amongst OFC mouse models compared to cleft palate alone [Gritli-Linde, 2008]. These 
phenomena have several potential explanations, including the presence of genetic modifiers in 
different mouse strains, gene redundancy in the mouse genome, or simply morphological 
differences between human and mouse development [Dixon, 2004; Gritli-Linde, 2008; 
Doetschman, 2009]. Nonetheless, the value of mouse models to study the mechanisms of OFC is 
clear, and future studies will help delineate the relevant differences between the human and murine 
systems. 
 
1.2 Palate Development 
1.2.1 Neural crest cells 
The development of the mammalian palate is highly dynamic and requires the coordinated 
integration of multiple tissue types from various embryonic origins. Neural crest cells (NCCs) are 
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a population of migratory cells that contribute to many tissues throughout the developing embryo. 
To achieve this, NCCs must leave their origin at the dorsal neural tube and migrate to the various 
regions to which they will contribute. Once they arrive, they proliferate and differentiate to 
contribute to numerous neural, connective, and bony tissues. NCCs are particularly important for 
craniofacial development, as they are responsible for giving rise to a relatively large portion of 
bone and cartilage of the head and face. 
The exact timing of NCC specification in the early embryo is still under investigation. Two 
main hypotheses prevail in the current literature. The traditional model posits that specification 
occurs during neural tube closure as a result of integration of WNT, FGF, and BMP signaling at 
the junction between the neural plate and non-neural ectoderm [Reviewed in Trainor, 2005; 
Cordero, 2011]. Recent studies in avian embryos showed that induction of the NCC population 
requires PAX7 and begins at gastrulation [Basch, 2006]. PAX7 expression was also identified 
before neural plate formation in mouse embryos [Murdoch, 2012]. However, while PAX7 
expression overlaps with the NCC lineage, it only contributes to a portion of the NCC-derived 
tissues [Murdoch, 2012]. Pax7-null mice exhibit only minor craniofacial malformities, suggesting 
a role for PAX7 in some, but not all NCCs [Mansouri, 1996]. 
As a result of signals at the neural plate border, NCCs gain a migratory phenotype through 
epithelial to mesenchymal transition (EMT). This process is characterized by dramatic changes in 
morphology stemming from the disassembly of cell-cell adhesions and loss of apico-basal polarity. 
Adherens junctions are disassembled through the downregulation or proteolysis of junction 
components, such as N-cadherin [Wheelock, 2003; Shoval, 2007; Taneyhill, 2008]. Tight 
junctions, another cell adhesion contributing to cell polarity, are also disassembled through the 
downregulation of claudin and occludin. Removal of these adhesions allows the detachment of 
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NCCs from the neural tube epithelium. This loss of epithelial adhesions is accompanied by changes 
to the cytoskeleton of NCCs stimulated by RHOB [Liu, 1998; Strobl-Mazzulla, 2012]. These 
changes in protein regulation are largely driven by transcription factors, such as SNAIL and 
FOXD3, which suppress the expression of epithelial markers while enhancing the transcription of 
mesenchymal markers [Dottori, 2001; Taneyhill, 2007; Theveneau, 2012; Strobl-Mazzulla, 2012]. 
After delamination, the NCCs migrate along specified pathways in order to reach the early 
craniofacial regions. The pathway taken depends on the axial level of origin and defines the 
structures to which each cohort of NCCs will contribute. [Reviewed in Minoux, 2010; Kulesa, 
2010]. NCCs originating from the posterior mesencephalon and the first two rhombomeres will 
migrate to the first pharyngeal arch (PA1), a precursor to the maxillary and mandibular 
prominences [Lumsden, 1991; Serbedzija, 1992; Minoux, 2010]. These migrating populations rely 
on signals from the surrounding microenvironment to provide directional cues in order to arrive at 
the correct locations. NCCs migrating to PA1 express receptor Neuropilin 2, which stimulates a 
repulsive effect in the cells when bound to its Semaphorin 3f ligand, effectively creating a border 
that guides them down a particular route [Gammill, 2007; Schwarz, 2008]. These mechanisms 
along with others including Ephrin/Eph signaling shape the streams to prevent merging between 
them [Davy, 2004; Minoux, 2010]. The mechanisms responsible for NCC directionality have also 
been extensively studied [Reviewed in Shellard, 2016]. FGF8 and VEGF both have chemotactic 
effects on NCCs and are required for proper migration and survival of some NCC populations, but 
whether their endogenous role is chemotactic in nature has yet to be conclusively shown [Abu-
Issa, 2002; McLennan, 2010; Sato, 2011]. NCC streams also have an intrinsic ability to migrate in 
a directional manner. Through a phenomenon called contact inhibition of locomotion, wherein 
contact with a neighboring cell results in the generation of extensions in the opposite direction, the 
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NCCs establish a leading edge of polarized cells that provide directionality to the stream 
[Carmona-Fontaine, 2008]. Cumulatively, these mechanisms result in focused and directional 
migration that lead the NCCs to their targets. 
Patterning of the proliferation and differentiation of the NCCs upon arrival at the 
craniofacial primordia is dependent on a complex network of local growth factors, transcription 
factors, and signaling molecules. In PA1, the maxillary and mandibular processes are defined by 
different transcripts of distal-less homeobox (DLX) transcription factors. The maxillary process 
contains only DLX1/2, while endothelin signaling in the early mandibular process activates a 
signaling cascade that leads to the transcription of DLX5/6 and then DLX3/4 towards the end of 
the process [Qiu, 1997; Depew, 1999; Depew, 2002; Minoux, 2010]. These combinations of DLX 
proteins execute unique developmental programs that differentiate between the two processes as 
development proceeds. Other signaling molecules including Sonic hedgehog (SHH), bone 
morphogenic protein (BMP), and FGF also regulate the growth and patterning of the NCCs in a 
spatially and temporally controlled manner. 
NCCs contribute to a wide variety of different tissues in the craniofacial region and 
throughout the body, so it follows that defects in the delamination, migration, survival, 
proliferation, or differentiation may have substantial negative impacts on the development of the 
embryo. Pathologies resulting from NCC deficiency are collectively termed neurocristopathies, 
many of which result in craniofacial malformations [Bolande, 1974; Etchevers, 2006]. A 
prominent example is mandibulofacial dysostosis, more commonly known as Treacher Collins 
syndrome (TCS), a disorder clinically characterized by hypoplasia of the maxilla and mandible, 
lower eyelid colobomas, and downward slanting eyes [Reviewed in Kadakia, 2014; Achilleos, 
2015]. Many TCS patients also exhibit cleft palate. More cases of this disorder are associated with 
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mutations in TCOF1, POLR1C, and POLR1D, all of which are important in the transcription of 
ribosomal DNA [Reviewed in Achilleos, 2015; Noack Watt, 2016]. Experimental evidence in 
mouse models show that these defects stem from an increase in NCC apoptosis through p53 
pathway activation, resulting in reduced NCC contribution to the craniofacial structures [Dixon, 
2006]. CHARGE syndrome, another complex disorder, presents with a broad range of 
malformations including eye, ear, heart, and cranial nerve defects [Hsu, 2014]. Most diagnosed 
patients have mutations in the chromodomain helicase DNA-binding protein (CHD7) gene, which 
has been implicated in the regulation of migratory NCC genes Slug, Sox9, and Twist [Janssen, 
2012; Bajpai, 2010]. Neurocristopathies impact the development of other tissues as well. For 
example, Hirschsprung’s disease is due to incomplete trunk NCC contribution to the gut’s enteric 
nervous system, resulting in improper bowel motility and subsequent obstructions [Kenny, 2010]. 
 
1.2.2 Mammalian palatogenesis: Mechanisms of palatal shelf outgrowth 
Palatogenesis is a multistep process that requires the growth, elevation, and fusion of the 
palatal shelves (PS). These structures originate as a pair of outgrowths from the maxillary process 
and consist of two primary cell populations: the oral epithelium and NCC-derived mesenchyme. 
Proper palate development is directed through intersecting signaling pathways which dictate the 
growth and patterning of the PS. SHH signaling is a central pathway in initial PS outgrowth, with 
bone morphogenic protein (BMP) and Fibroblast growth factor (FGF) signaling also playing 
significant roles [Rice, 2006; Bush, 2012; Lan, 2015]. SHH signaling functions through binding 
to its receptor Patched 1 or 2 (PTCH). When not bound, the PTCH receptor inhibits the activation 
of the transmembrane signal transducer Smoothened (SMO). Upon SHH binding PTCH is 
internalized, allowing SMO to accumulate and initiate a signaling cascade through GLI 
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transcription factors [Carballo, 2018]. Activation of the SHH pathway in the developing palate 
upregulates several inducers of proliferation including Cyclin D1, Cyclin D2, FOXF1A, FOXF2, 
and OSR2 [Lan, 2009]. Indeed, conditional knockouts (cKO) of SHH signaling components in 
mice result in reduced PS growth, resulting in cleft palate [Rice, 2004; Lan, 2009]. 
Through these analyses, the dynamics of the epithelial-mesenchymal interactions driving 
PS outgrowth have been elucidated. For instance, cKO of SHH in the oral epithelium results in 
variable palate defects, but not knockout of SMO [Rice, 2004; Lan, 2009]. However, cKO of SMO 
in the palatal mesenchyme reduces proliferation in both tissues [Lan, 2009]. In addition, FGF and 
Bmp signaling were also shown to be required for the initiation and maintenance of SHH signaling 
during PS outgrowth [Zhang, 2002; Rice, 2004; Li, 2011]. Collectively, these studies reveal a 
reciprocal relationship between the mesenchyme and epithelium during PS outgrowth, wherein 
each population requires signaling from the other for proper palatogenesis. 
It is important to note that growth within the PS is not uniform, with differences seen along 
the anteroposterior and mediolateral axes. Following outgrowth, the PS must elevate and fuse, 
after which the anterior palate undergoes ossification to form the hard palate, while the posterior 
becomes the soft palate [Bush, 2012]. The dynamic changes during elevation and specialization of 
the tissues require distinct patterns of growth and differentiation, explaining the need for variability 
between PS regions. These regions are primarily characterized through differential expression of 
growth and transcription factors. Anteriorly, MSX1 maintains SHH signaling through a positive 
feedback loop with BMP4, while BMP4 and OSR2 in the posterior palate are regulated by PAX9 
[Zhang, 2002; Zhou, 2011; Zhou, 2013]. Similarly, DLX5 suppresses SHH signaling in the medial 
palate through FGF7 upregulation, while FGF10 and SHH drive each other’s expression in the 
lateral palate [Han, 2009; Lan, 2009]. Other region-specific transcriptional regulators have been 
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identified, such as SHOX2 in the anterior palate [Yu, 2005; Li, 2007]. The dynamics of these 
proteins in the development of the palate are an area of active research. 
 
1.2.3 Mammalian palatogenesis: Mechanisms of palatal shelf elevation 
After outgrowth, the PS undergo a process of elevation, where the shelves reorient 
themselves from a vertical position adjacent to the tongue, to a horizontal position above the 
tongue. In mice, this takes place between E14.0 and E14.5. After elevation, the reoriented palatal 
shelves make contact at the midline and fuse by E15.5 [Bush, 2012]. This short timeframe has 
rendered the elevation process difficult to observe, and so the mechanisms driving the process have 
yet to be completely elucidated. Many potential models for elevation have been proposed, 
including a mechanical “flip” of the shelves to a horizontal position, remodeling of the shelf, and 
changes in directional growth toward the midline [Reviewed in Bush, 2012]. A comprehensive 
histomorphological analysis of murine palate elevation was performed to investigate the validity 
of these different models [Yu, 2011]. In the study, coronal sections of E14.5 embryos were 
separated into five different planes based on anatomical landmarks. This was followed by 
morphological classification of the palatal shelves into one of six different stages. Systematic 
examination of palate elevation in this manner has provided insights into differences along the 
anteroposterior axis (Fig. 1.3). Elevation of the mid-palate resembled a “bulge” in the medial shelf 
wall, while the anterior palate exhibited a more rapid reorientation to the horizontal position. It 
was also noted that this remodeling of the mid-palate occurred before anterior elevation. This 
analysis corroborated previous findings that stated the mechanism of elevation differed along the 
anteroposterior axis, but contested conclusions that elevation began anteriorly and proceeded 
posteriorly or vice-versa [Walker, 1956; Coleman, 1965; Ferguson, 1978]. 
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Figure 1.3: Differences in palate elevation along anteroposterior axis. A-D) Depictions of 
palatal shelf elevation in the anterior (A,B) and posterior palates (C,D). The anterior palate is 
thought to go through a “flip-up” mechanism (B). In contrast, the posterior palate undergoes a 
remodeling process with a medial bulge (D). Mdb, mandible; NS, nasal septum; T, tongue. 
Image (Distinct mechanisms for palatal shelf elevation) from Bush, J. O., & Jiang, R. (2012). 
Palatogenesis: morphogenetic and molecular mechanisms of secondary palate development. 
Development, 139(2), 231-243. doi:10.1242/dev.067082. Copyright 2012. Reprinted with 
permission from The Company of Biologists Ltd. 
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Several mouse mutants exhibit defects or delays in palatal shelf elevation, allowing 
investigation into the causes for elevation failure as well as the molecular signals that govern the 
elevation process [Reviewed in Gritli-Linde, 2007; Gritli-Linde, 2008; Bush, 2012; Li, 2017]. 
Changes in shelf growth are a common reason for elevation failure. Mouse embryos null for 
transcription factor Mn1 show decreased proliferation in the middle and posterior palatal shelves, 
leading to drastically reduced shelf size [Liu, 2008]. The palatal shelves fail to elevate in these 
regions and eventually recede into the maxilla. Conditional KO of Foxf2 in the palatal 
mesenchyme also results in elevation failure due to reduced proliferation and hypoplastic shelves 
[Xu, 2016]. 
It is likely that some elevation defects in mutants with severe palatal shelf growth 
retardation are simply due to the significant decrease in palatal shelf size. However, smaller 
changes in region-specific proliferation can also result in elevation failure. KO of Cyp26b1, an 
enzyme responsible for degrading retinoic acid, causes elevation defects through decreased 
proliferation in the lateral half of the palatal shelves [Okano, 2012]. Further investigation revealed 
downregulation of Tbx1, Fgf10, and Bmp2, all of which are important in proliferation [Goudy, 
2010; Rice, 2004; Zhang, 2002]. Similar elevation defects and decreases in medial shelf 
proliferation were also seen in embryos null for transcription factor Osr2 [Lan, 2004]. 
Interestingly, proliferation in the medial half of the wildtype palate was greater than the lateral half 
[Lan, 2004]. This mediolateral asymmetry in proliferation toward the midline is likely a primary 
mechanism driving the “bulge” formation seen in the elevation of the middle palate, and alterations 
to this balance between medial and lateral proliferation could disrupt the process. Indeed, analysis 
of Sprouty2 mutants shows increased mesenchymal proliferation in conjunction with elevation 
defects [Matsumura, 2011]. 
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While changes in proliferation often result in palate defects, it is not the only requirement 
of elevation. The shelves must undergo extensive remodeling as they reorient and extend toward 
the midline. Therefore, it is reasonable to suggest that disruptions in the signals orchestrating this 
behavior could also result in palate defects. Evidence from several mouse models that exhibit cleft 
palate but do not exhibit changes in proliferation substantiate this claim. For example, KO mouse 
models of transcription factor Zfhx1a or growth factor BMP7 both show delays in elevation and 
subsequent cleft palate, but no detected differences in proliferation [Jin, 2008; Kouskoura, 2013]. 
While mediolateral proliferation ratios were not quantified in these studies, they indicate the likely 
requirement for instructive signals in palatal shelf remodeling during elevation. 
Another possible mechanism for palate elevation includes the generation of force through 
regulation of the extracellular matrix (ECM) [Brinkley, 1986; Ferguson, 1988; Morris-Wiman, 
1992; Meng, 2009]. The ECM is a dense network of structural molecules in which the cells of a 
tissue reside. Glycosaminoglycans (GAGs), a primary component of the ECM, are a group of polar 
polysaccharides that have been implicated in palatogenesis in several mouse models. Embryos 
homozygous for a targeted Fgfr2 point mutation show altered GAG composition, but whether the 
changes contribute to the defects remains to be determined. 
Lastly, elevation failure can occur due to factors extrinsic to the development of the palatal 
shelves [Reviewed in Bush, 2012; Okano, 2014]. cKO of TGFβ activated kinase 1 (Tak1) in the 
NCC lineage results in elevation defects, along with differences in tongue shape. [Song, 2013]. 
However, organ culture experiments with the lower jaw removed showed that mutant elevation 
occurred normally, indicating that obstruction by the tongue is a likely cause of cleft palate in these 
mutants. Deficits in mandibular growth can also result in micrognathia, a malformation strongly 
associated with cleft palate in many mouse mutants [Bjork, 2010; Lai, 2016]. These studies show 
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that coordinated growth of the surrounding craniofacial structures with the palatal shelves is 
required for proper palatogenesis. 
 
1.2.4 Mammalian palatogenesis: Mechanisms of palatal shelf fusion 
After elevation, the palatal shelves must make contact at the midline, adhere, and fuse to 
form the palate. The specialized section of the palate epithelium, called the medial edge epithelium 
(MEE), contacts the MEE of the opposing palatal shelf. Specification of the MEE is a temporally 
controlled process that does not require contact between the shelves, as evidenced by the presence 
of MEE markers in the unelevated palates of E14.5 Zfhx1a mutant embryos [Jin, 2008; Jin, 2010]. 
After adhesion, the MEE cells form a single layer called the medial epithelial seam (MES), 
which is selectively removed to allow proper fusion of the shelves [Bush, 2012]. Gene expression 
studies and mouse KO models have led to the identification of transforming growth factor beta 3 
(TGFβ3) as a primary regulator of this process [Reviewed in Bush, 2012; Lan, 2015; Li, 2017]. 
TGFβ3 is expressed in the MEE during palatogenesis, and loss of TGFβ3 in mice results in cleft 
palate due to palatal shelf fusion failure [Fitzpatrick, 1990; Proetzel, 1995; Brunet, 1995]. Manual 
contact between the palatal shelves in organ culture experiments revealed that this defect is due to 
the persistence of the MES [Kaartinen, 1997]. 
Molecular studies utilizing Tgfβ3-null mice and other lines have elucidated the downstream 
effectors regulating palatal shelf fusion. Activation of TGFβ receptors 1 and 2 through TGFβ3 
binding initiates a cascade of many transduction pathways within MEE cells to stimulate the fusion 
process [Reviewed in Li, 2017]. Canonical TGFβ signaling occurs through SMAD2 and/or 
SMAD3 which, upon phosphorylation, form a complex with SMAD4 that localizes to the nucleus 
to activate and suppress the transcription of target genes [Schmierer, 2007]. The requirement for 
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SMAD2 was demonstrated in palatal shelf culture experiments, where siRNA knockdown of 
SMAD2 prevented the dissolution of the MES [Shiomi, 2006]. However, cKO of Smad4 in the 
palatal epithelium has only a mild impact on palatal fusion, indicating the presence of other 
contributing pathways [Xu, 2008; Lane, 2015]. Indeed, analysis of other cKO lines revealed that 
both SMAD-independent p38 MAPK signaling through TAK1 activation and a chromatin reader 
TRIM33/SMAD2 complex independently contribute to palate fusion [Lane, 2015]. 
The exact cellular drivers of MES removal have been under investigation for decades. Until 
recently, MES dissolution by apoptosis, migration, or EMT were the three most popular 
hypotheses [Reviewed in Dudas, 2007; Nawshad, 2008; Bush, 2012; Kim, 2015]. Cell death of 
MEE cells can be readily seen during palate fusion, and blocking apoptosis pharmacologically was 
shown to be sufficient to prevent fusion in organ culture experiments [Cuervo, 2004]. However, 
observation of normal palate fusion in mice lacking a component of the apoptotic caspase-3 
pathway, Apaf-1, has led to the conclusion that apoptosis is not required for fusion to occur [Jin, 
2006]. The same study also showed static evidence of cell migration of the palatal shelf epithelium, 
but this mechanism has yet to be examined further [Jin, 2006]. Whether or not MEE cells can enter 
the mesenchyme through EMT is likely the most controversial proposal of the three. Early studies 
into EMT utilized fluorescent dyes that could be incorporated into the palate epithelium during 
organ culture experiments. This method provided conflicting results, as some groups identified the 
presence of the dye in the palatal mesenchyme after fusion, while others did not [Nawshad, 2008]. 
The advent of the Cre/lox system and lineage tracing studies did little to resolve these conflicts. 
Utilizing LacZ expression driven by an epithelial-specific Cre, two studies found that LacZ 
staining was restricted to the epithelium of the palate. [Vaziri Sani, 2005; Xu, 2006]. However, a 
different group using the same method found evidence for LacZ staining within the palatal 
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mesenchyme [Jin, 2006]. One possibility for these conflicting findings is that some MEE cells may 
end up trapped within the palate during fusion and undergo cell death, rather than being truly 
incorporated into the mesenchyme. 
Despite extensive investigation, these three proposals are still readily entertained as 
mechanisms of palate fusion in even recent reviews [Nakajima, 2018]. However, review of other 
recent studies has begun to form a clearer picture of MES dissolution, where the MEE cells take 
on some mesenchymal properties in order to be removed from the MES, rather than becoming 
incorporated into the mesenchyme through EMT [Reviewed in Li, 2017]. TGFβ3 signaling in the 
MEE cells activates SNAIL, thereby reducing E-cadherin expression and allowing the release of 
MEE cells from the underlying mesenchyme [Kitase, 2013; Li, 2017]. In addition, live-imaging 
studies of fusing palates have observed large actin cables formation of rosettes within the MES 
that actively extruded MEE cells. [Kim, 2015]. The regulation of E-cadherin and cell extrusion 
were shown to be dependent on the activity of the microtubule and actomyosin apparatuses, 
respectively, and their disruption through genetic or pharmacological means prevents proper palate 
fusion [Kitase, 2013; Kim, 2015]. Instead of intrinsic cell death or migration of MEE cells, these 
studies present a more comprehensive image of palate fusion that involves coordinated tissue 
morphology changes to drive MES dissolution. 
 
1.2.5 Mammalian palatogenesis: Mechanisms of palatal shelf ossification and patterning 
Although most investigations into palatogenesis concentrate on the outgrowth, elevation, 
or fusion of the palatal shelves, these alone do not result in a properly developed palate. After 
fusion is complete, the mesenchymal cells of the presumptive hard palate condense and 
differentiate into osteoblasts. This process, called intramembranous ossification, is controlled by 
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several molecular regulators, including those with roles in other steps of palatogenesis. For 
instance, BMP signaling is important for palatal shelf growth [Chapter 1.2.2; Zhang, 2002; Rice, 
2004; Li, 2011], but also plays a central role in palate bone formation. This was demonstrated 
through the conditional knockout of BMP receptor gene Bmpr1a in the palatal mesenchyme of 
mice, which resulted in reduced palatal shelf growth, palatine bone defects, and submucosal cleft 
palate [Baek, 2011]. Upstream regulators of BMP signaling also contribute to bone formation in 
the palate, including transcription factors HOX2A [Rijli, 1993; Gendron-Maguire, 1993; Iyyanar, 
2017] and PAX3 [Wu, 2008], as well as the Jagged1-Notch signaling pathway [Hill, 2014]. Given 
the broad functions of BMP signaling in palatogenesis, defects of palate ossification often coincide 
with other changes. This is seen in Hoxa2-null mice, which show increased osteogenesis and 
proliferation of the shelves, along with elevation failure [Iyyanar, 2017]. Conversely, conditional 
knockout of Jagged1 in NCCs led to decreased osteogenesis in the palate, but increased 
proliferation [Hill, 2014]. Together, these studies show that the molecular control of palatal shelf 
growth and bone formation partially overlap and underline the complexity of these mechanisms. 
The secondary palate consists of the bony hard palate at the front and the muscular soft 
palate at the rear. Though many regulators of palate ossification have been identified, how this 
bone formation is restricted to the hard palate is still under investigation. As mentioned in Chapter 
1.2.2, the specific expression patterns of transcription and growth factors along the anteroposterior 
axis provide a basis for these differences. It has been hypothesized that thickened epithelial ridges 
on the palatal shelves, called rugae, may help define the two regions [Peterkova, 1987; Pantalacci, 
2008; Welsh, 2009]. Rugae play a mechanical role in mastication, also contain many sensory 
structures that assist in eating [Peterkova, 1987; Nunzi, 2004; Ishizaki, 2006]. Detailed 
characterization of rugae development in mice revealed that the first three initially form around 
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E12.5 [Peterkova, 1987; Pantalacci, 2008]. Following this, additional rugae arise in a predictable 
manner until nine or ten have formed by E16.0 [Charles, 2007; Pantalacci, 2008]. In situ analysis 
revealed that the eighth ruga is located at the border between anterior Shox2 and posterior Meox2, 
two transcription factors with a mutually exclusive expression pattern along the anteroposterior 
axis [Zhang, 2005; Jin, 2006]. Importantly, this ruga is also located at the transition point between 
the hard and soft palate. These data indicate that the eighth ruga may serve as a boundary between 
anterior and posterior signaling during mouse palatogenesis, thereby inducing different tissue fates 
[Pantalacci, 2008]. Additional studies on rugae signaling will be needed to determine if this is the 
case. 
 
1.3 Broader roles of the epithelium: IRF6 network in periderm development and 
palatogenesis 
The epithelium plays several roles during development, but none so critical as defining the 
border between different tissues. During embryogenesis, all surface epithelia consist of an inner 
layer of cuboidal basal cells and an outer layer of flattened periderm cells [Richardson, 2009]. The 
basal layer serves multiple roles, including proliferating to accommodate the growth of palatal 
shelf, and undergoing differentiation to give rise to the periderm layer [Richardson, 2014]. While 
the periderm may have other functions, the best characterized role is the prevention of improper 
adhesions between epithelial layers [Lan, 2015]. This was demonstrated by direct ablation of 
periderm cells through Cre-mediated expression of diphtheria toxin fragment A, which resulted in 
ectopic oral adhesions and cleft palate [Richardson, 2014]. To achieve this non-adhesive property, 
the apico-basal polarity of the periderm cells is tightly regulated [Richardson, 2014]. Expression 
of adhesion markers such as E-cadherin are restricted to the basal membrane, thereby preventing 
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adhesions from forming on the apical surface [Richardson, 2014]. Establishment of the periderm 
layer occurs during the first stratification event of the epithelium and persists until shortly before 
birth [Richardson, 2014]. To maintain this population during development, a balance must be 
struck between the highly proliferative basal cells and terminally differentiated periderm 
[Richardson, 2006]. This balance is controlled through a complex network of regulatory factors 
[Richardson, 2014; Reviewed in Kousa, 2016]. Of these, interferon regulatory factor 6 (IRF6) 
plays a central role [Kousa, 2016]. 
Unlike other members of the IRF family which are important in the regulation of the 
immune system and metabolism, IRF6 acts mainly in the development of the epidermis [Yanai, 
2012; Zhao, 2015]. IRF6 is highly expressed in both epithelial layers during development and is 
responsible for mediating the switch that drives the basal cells towards differentiation [Richardson, 
2006]. While IRF6 acts through transcriptional regulation, it also has posttranslational roles 
[Kousa, 2016]. For example, ΔNp63, an isoform of p63 expressed in the basal layer, drives Irf6 
expression [Moretti, 2010]. In turn, IRF6 targets ΔNp63 to be degraded by the proteasome, thereby 
creating a negative feedback loop to control differentiation [Moretti, 2010]. In addition to ΔNp63, 
NOTCH/JAGGED2 and TGFβ signaling have also been shown to drive Irf6 expression [Jiang, 
1998; Restivo, 2011; Iwata, 2013]. Consistent with this role in epithelial development, loss of 
function or deletion of Irf6 in mice leads to a hyperproliferative basal layer that does not properly 
undergo differentiation [Ingraham, 2006; Richardson, 2006]. These epithelial abnormalities result 
in a broad range of defects including limb malformations and lack of a functional epidermal barrier 
[Ingraham, 2006; Richardson, 2006]. Irf6 mutants also exhibit cleft palate due to permanent 
ectopic oral adhesions [Ingraham, 2006; Richardson, 2006]. 
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Variants in IRF6 are the major cause of two orofacial clefting syndromes: Van der Woude 
syndrome (VWS; OMIM #119300) and popliteal pterygium syndrome (PPS; OMIM #119500) 
[Kondo, 2002; Leslie, 2013; Reviewed in Kousa, 2016]. The two syndromes share many 
similarities, including characteristic lip pits and orofacial clefting [Schutte, 2003]. VWS is 
currently the most common OFC syndrome and causes around 2% of all OFC malformations 
[Kousa, 2016]. However, PPS is much rarer and can include additional defects such as syndactyly, 
adhesions between the upper and lower eyelids, and genital abnormalities [Schutte, 2003]. The 
presentation of these syndromes is extremely variable, even within family cohorts [Burdick, 1985; 
Schutte, 2003; Martelli-Junior, 2007; Busche, 2016]. Given the epithelial defects seen in Irf6 null 
mice, disorders such as these are being given the relatively novel classification of 
“peridermopathies” [Richardson, 2014]. 
IRF6 mutations only account for approximately 68% of VWS cases [de Lima, 2009]. 
Therefore, there have been many efforts to identify new genes that contribute to the disorder. 
Sequencing of a Finnish VWS family revealed causative mutations in another transcription factor, 
Grainyhead-like 3 (GRHL3) [Peyrard-Janvid, 2014]. Mouse KO of Grhl3 resulted in phenotypes 
similar to those in Irf6 mutants, including loss of periderm cells, ectopic oral adhesions, and cleft 
palate [Peyrard-Janvid, 2014]. Surprisingly, cleft palate was only identified in a subset of the 
embryos, suggesting that the periderm was either abnormal or discontinuous, or that the loss of 
periderm is not solely responsible for the high penetrance of cleft palate in Irf6-null mice. In 
addition, analysis in zebrafish showed that Irf6 directly regulates Grhl3 expression [de la Garza, 
2013]. Together, these results broaden the known genetic etiology of VWS, and further implicate 
the role of the periderm in OFC. 
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A small percentage of VWS patients present with only isolated CL/P as their primary 
clinical phenotype [Kousa, 2016]. Indeed, variants in IRF6 have also been associated with nsCL/P, 
indicating that common mechanisms may be responsible for VWS and some nsCL/P cases 
[Zucchero, 2004; Rahimov, 2008; Beaty; 2010; Leslie, 2016]. Consistent with this, genes 
downstream of Irf6 have also been implicated in nsCL/P. A GWAS study searching for SNPs 
associated with nsCL/P identified statistically significant variants within ABCA4 [Beaty, 2010]. 
While the expression of ABCA4 was only identified in the retina, ARHGAP29, an adjacent gene 
coding for a Rho GTPase activating protein (GAP), was found to have broad craniofacial 
expression [Beaty, 2010; Leslie, 2012]. Consistent with these findings, multiple ARHGAP29 
coding variants, predicted to be detrimental to protein function, were identified in patients with 
nsCL/P [Leslie, 2012]. Furthermore, ChipSeq analysis identified an IRF6 binding site upstream of 
the region, and KO of Irf6 resulted in a reduction of ARHGAP29 expression in mice [Botti, 2011; 
Leslie, 2012]. Two recent studies have identified additional ARHGAP29 mutations in patients with 
isolated clefts, further solidifying ARHGAP29 as an OFC gene [Liu, 2017; Savastano, 2017]. 
Guanine-nucleotide-exchange factors (GEFs) and GAPs, such as ARHGAP29, are 
important for regulating the actin cytoskeleton through the activation and deactivation of Rho 
proteins, respectively [Sit, 2011]. Through these mechanisms, these proteins are integral in many 
cellular processes that require changes in cytoskeletal dynamics, such as cell migration [Sit, 2011]. 
Given that ARHGAP29 is reduced in Irf6 mutants, it follows that IRF6 may regulate this process. 
Consistent with this, live-imaging analysis of wound scratch assays showed that keratinocytes 
from Irf6-null mice failed to properly close the wound and had reduced speed and directionality 
compared to controls [Biggs, 2014]. The same study also identified increased actin stress fibers in 
Irf6-null keratinocytes, and found that pharmacological inhibition of ROCK, a downstream 
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effector of RHOA, was sufficient to rescue both the migration and stress fiber phenotypes [Biggs, 
2014]. Importantly, the study showed impaired wound healing in Irf6 mutant embryos and noted 
that this result was in agreement with previous reports of increased post-surgery complications in 
VWS patients [Jones, 2010; Biggs 2014]. ARHGAP29 has also been shown to regulate cell 
adhesion in the oral epithelium. Introduction of a point mutation in one copy of Arhgap29 in mice 
resulted in a delay in palate elevation and ectopic oral adhesions [Paul, 2017]. These adhesions 
were accompanied by disorganized basal and periderm layers, along with changes in cytokeratin 
expression [Paul, 2017]. Together, these studies show that IRF6 can regulate both cell movement 
and adhesion and implicate ARHGAP29 as a primary mechanism. 
Mouse models with disruptions in Irf6 and Irf6-related genes are steadily revealing the 
importance of periderm differentiation and function in palatogenesis. Absence of periderm in Irf6 
mutant homozygotes or through direct genetic ablation results in permanent oral adhesions and 
cleft palate [Ingraham, 2006; Richardson, 2006; Richardson, 2014]. These drastic epithelial defects 
are also phenocopied in other mouse mutants including mice null for Jagged2, ΔNp63, IκB kinase-
α (Ikkα), Stratifin, and receptor-interacting serine/threonine protein kinase 4 (Ripk4) [Jiang, 1998; 
Romano, 2012; Richardson, 2014; De Groote, 2015; Kousa, 2016]. While JAGGED2 and ΔNp63 
have established connections to Irf6, the function of the other proteins in epithelial development 
and whether or not they interact with IRF6 is under investigation [Reviewed in Kousa, 2016]. In 
contrast, Irf6 heterozygotes retain a stratified epithelium but still show transient oral adhesions 
[Richardson, 2006]. The periderm is still present in these embryos but is somehow abnormal, 
suggesting that Irf6 is required for periderm function as well as differentiation. [Richardson, 2006]. 
Transgenic overexpression of Irf6 in the basal layer of Irf6-null embryos resulted only in a partial 
rescue of the fusion defects, further reinforcing an autonomous role for IRF6 in the periderm 
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[Kousa, 2017]. Similar defects are seen in mice deficient for Grhl3 and Arhgap29, as well as 
Irf6/ΔNp63 and Irf6/Jagged2 double heterozygotes [Richardson, 2009; Thomason, 2010; Peyrard-
Janvid, 2014; Paul, 2017]. The ectopic oral adhesions in these mutants are not due to a total lack 
of epidermal differentiation, but rather a disorganized periderm layer or abnormalities in the 
function of the periderm itself [Richardson, 2006; Richardson, 2009; Thomason, 2010; Peyrard-
Janvid, 2014; Paul, 2017]. One possible mechanism for these adhesions is the misexpression of 
cell adhesions markers, as seen in Irf6/Jagged2 double heterozygotes [Richardson, 2009]. 
Furthermore, the delay in palate elevation identified in Arhgap29 heterozygotes shows that 
transient adhesions may be able to slow down palate development without causing a permanent 
defect [Paul, 2017]. This represents a possible mechanism for nsCL/P in humans, wherein 
mutations that impact periderm function result in a predisposition to palate defects, even if not 
completely penetrant. Collectively, these models show that regulation of both periderm 
differentiation and function is important in palatogenesis and demonstrate the need to identify 
additional genes that contribute to nsCL/P through peridermal abnormalities. 
 
1.4 Mesenchymal migration and remodeling in palatogenesis 
Tissue patterning during embryonic development involves drastic morphological changes. 
These processes can be seen readily in craniofacial development, wherein proper palatogenesis 
requires the outgrowth, elevation, and fusion of the palatal shelves coordinated with the growth 
and movement of the other craniofacial processes [Bush, 2012]. As previously discussed in 
Chapter 1.2, analyses of mutant mouse models have shown that many clefts are due to 
insufficiencies in proliferation of the palatal mesenchyme, ectopic adhesions, failure to remove the 
MES, or obstruction due to structures [Bush, 2012]. In contrast, other mutants that exhibit none of 
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these changes can still present with palate defects, such as Zfhx1a-null mice, which show delayed 
palatal shelf elevation [Jin, 2008]. While force generation through hydration of hyaluronan-rich 
ECM has been suggested as a mechanism for the rapid flipping motion of the anterior palate, it 
does not explain the bulge formation in the middle palate during elevation [Brinkley, 1986; 
Ferguson, 1988; Yu, 2011]. Additionally, it has been suggested that the speed at which this 
elevation occurs precludes proliferation from being the sole cellular mechanism driving this medial 
extension [Walker, 1956]. Tissue rearrangement through collective cell migration is a well-studied 
phenomenon in other systems [Reviewed in Scarpa, 2016]. Thus, it is possible that directed 
migration is also occurring during palatal shelf morphogenesis. 
The movement of the cranial neural crest cells (CNCC) is likely the most prominent 
example of collective migration in craniofacial development. Briefly, after delamination from the 
neural folds, CNCCs migrate through defined pathways toward the early craniofacial processes 
[Chapter 1.2.1; Minoux, 2010; Kindberg, 2018]. This migration pattern is characterized by an 
integration of contact inhibition of locomotion, co-attraction, and chemotaxis controlled through 
transient cell adhesions and cell polarity [Chapter 1.2.1; Scarpa, 2015; Barriga, 2015]. Despite 
extensive investigation into CNCC migration, relatively little is known about the behavior within 
the NCC-derived palatal mesenchyme. One of the first examples of mesenchymal migration was 
identified in a study of mice with deficiencies in WNT signaling, a pathway involved in a wide 
variety of developmental processes [Steinhart, 2018]. Mutants for ligand Wnt5a and/or its receptor 
Ror2 exhibit cleft palate, and a detailed examination showed increased proliferation and Sox9 
expression in the presumptive nasal half of the anterior palate [He, 2008]. Interestingly, chimeric 
palatal shelf explants with EGFP-expressing and non-fluorescent halves revealed directional 
movement of palatal mesenchyme from the posterior to the anterolateral regions [He, 2008]. This 
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directional migration was absent in Wnt5a mutants but was rescued when WNT5A beads were 
placed in the culture [He, 2008]. This study found that FGF10 beads had a similarly chemotactic 
effect [He, 2008]. Together, these results depict a novel mechanism of heterogeneity in the palatal 
shelves wherein posterior mesenchyme can be driven anteriorly by various chemotactic factors to 
impact gene expression and ensuing proliferative or morphological changes in the anterior palate. 
Given the difference in Sox9 distribution in Wnt5a mutants, mesenchymal movement may also 
serve to regulate the mediolateral asymmetry of gene expression in the palate. Additionally, these 
findings add a confounding factor to the interpretation of proliferation defects in mouse models 
with palate defects. If a deficit in mesenchymal migration results in proliferation changes, the 
proliferation may then be misconstrued as the primary cause of the malformations. Nevertheless, 
this study represents a novel perspective on the movement of palatal mesenchyme that had not 
been previously appreciated. 
The various mechanisms underlying tissue morphogenesis and the forces driving them 
have been well-characterized [Reviewed in Heisenberg, 2013]. Through regulation of cell 
junctions, cytoskeletal contractility, and the ECM, collections of cells can rapidly reorganize to 
modify the shape of a tissue [Heisenberg, 2013]. The drastic changes seen during palate elevation 
indicate that similar rearrangements are occurring in palatogenesis. Consistent with this, early 
studies found changes in regional cell density and ECM distribution during elevation [Brinkley, 
1986; Morris-Wiman, 1992]. These observations strongly suggested that remodeling plays a role, 
but it would be many years before follow-up experiments were performed. Recently, a 
computational analysis of serial sections has shed some light on the underlying dynamics of cleft 
palate in Tbx1-null embryos [Brock, 2016]. While some minor differences in palate dimensions, 
cell density, and proliferation were identified when compared to controls, the most striking change 
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was in the cell polarity [Brock, 2016]. Staining of Golgi bodies, serving as a proxy marker for the 
direction of cell movement, showed that orientation changes from ventral to medial immediately 
following elevation [Brock, 2016]. This change did not occur in Tbx1-null palates, suggesting that 
this change in cellular orientation may be important in palate elevation [Brock, 2016]. In a separate 
study, characterization of various palate-enriched ECM molecules found that Tenascin-C was 
expressed along the medial side of the middle palate before elevation but moved to the midline 
after elevation (Fig. 1.4) [Chiquet, 2016]. This shift in distribution is consistent with remodeling 
of the palatal shelf in the middle palate, as a static rotation of the shelf would result in a more 
dorsolateral distribution of Tenascin-C. Additionally, co-staining for F-actin with rhodamine-
phalloidin and Tenascin-C showed an alignment of these markers with the vertical palatal shelves 
that became more randomized after elevation, indicating a presence of a potential tensile force 
[Chiquet, 2016]. A comparable change in the alignment of elongated nuclei was also observed, 
serving as a possible explanation for the difference in orientation found in Brock et al. 2016 
[Brock, 2016; Chiquet, 2016]. Together, these studies highlight morphological changes in the 
palatal shelves during elevation and further implicate both ECM and cytoskeletal components in 
the remodeling of the mesenchyme. 
To date the only functional study of ECM in palate remodeling examined the role of RAC1 
[Tang, 2015]. As a member of the Rho GTPase family, RAC1 is integral for cytoskeletal 
organization but has also been shown to play a role in fibronectin ECM assembly [Dzamba, 2009; 
Sit, 2011; Payapilly, 2018]. Immunostaining of E13.5 shelves revealed fibrillar structure of 
fibronectin in the middle of the shelf with ring structures on either side, coinciding with lower and 
higher cell density, respectively. [Tang, 2015]. Electroporation of a constitutively active form of 
RAC1 resulted in an elevation failure and loss of this fibrillar arrangement [Tang, 2015]. Given  
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Figure 1.4: ECM protein distribution before and after palate elevation. Depictions of 
medial palatal shelves with superimposed gene expression patterns assessed by in situ 
hybridization and immunofluorescence experiments. Patterning before (top) and after (bottom) 
elevation is consistent with a remodeling process, rather than a “flip-up” mechanism. 
Image (Scheme of the combined expression patterns of ECM genes in palatal shelves before 
and after elevation) from Chiquet, M., Blumer, S., Angelini, M., Mitsiadis, T. A., & Katsaros, 
C. (2016). Mesenchymal Remodeling during Palatal Shelf Elevation Revealed by Extracellular 
Matrix and F-Actin Expression Patterns. Front Physiol, 7, 392. doi:10.3389/fphys.2016.00392. 
Copyright 2016 Chiquet, Blumer, Angelini, Mitsiadis and Katsaros. This open-access article is 
licensed under the Creative Commons Attribution License (CC BY 4.0). 
32 
the similarities to the F-actin pattern identified by Chiquet et al. 2016, it is possible that the 
fibronectin fibers may also exert a tensile force during elevation [Chiquet, 2016]. Tang et al. 2015, 
on the other hand, hypothesized that the differences in fibronectin arrangement facilitated different 
migration speeds, thereby changing regional cell density and driving palate elevation [Tang, 2015]. 
It is also possible that the constitutively active RAC1 impacted mesenchymal migration directly 
through disruption of cytoskeletal dynamics. Further experiments will be required to determine the 
precise mechanism. Nevertheless, these results represent one of the first functional studies into the 
role of ECM in palate development and provide additional evidence to support the claim that 
remodeling and/or migration of the palatal mesenchyme is a driving force in palatogenesis. 
 
1.5 SPECC1L in craniofacial development 
1.5.1 SPECC1L mutations in human patients with orofacial clefts 
The gene “Sperm Antigen With Calponin Homology And Coiled-Coil Domains 1-Like” 
(SPECC1L) encodes a cytoskeletal protein with roles in cytoskeletal organization, microtubule 
stability, cell migration, and cell adhesion [Saadi, 2011]. As the name suggests, SPECC1L contains 
eight coiled-coil domains (CCD) and a C-terminal calponin homology domain (CHD). Mutations 
in SPECC1L were originally detected in two patients with atypical facial clefts [Dasouki, 1988; 
Saadi, 2011]. The first patient exhibited severe bilateral oblique facial clefts, cleft palate, ocular 
hypoplasia, and calcaneovarus foot malformation, while the second had a unilateral oblique facial 
cleft, a lateral facial cleft, and cleft palate with no other defects [Dasouki, 1998; Saadi, 2011]. 
Genetic analysis of the first patient by karyotyping identified a balanced chromosomal 
translocation between chromosome 1 and 22 [Dasouki, 1988]. Further refinement through 
fluorescence in situ hybridization (FISH), southern blotting, and restriction digest experiments 
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pinpointed the breakpoint to intron 14 of SPECC1L, resulting in haploinsufficiency of the gene 
[Saadi, 2011]. Sequencing of the second patient identified the heterozygous point mutation 
p.Gln415Pro (Q415P; NM_015330.2) in the second CCD of the protein [Saadi, 2011]. These 
results were the first to associate SPECC1L with craniofacial development and OFC. 
Additional sequencing led to the discovery of SPECC1L (NM_015330.3) mutations in 
Opitz G/BBB syndrome patients [Kruszka, 2015]. Opitz G/BBB syndrome can be either autosomal 
dominant or X-linked and most commonly presents with hypertelorism, abnormalities of the 
laryngotracheoesophageal region (larynx/trachea/esophagus), and cleft palate [Kruszka, 2015]. 
The Opitz G/BBB mutations p.Thr397Pro (Family A; T397P) and p.Gly1083Ser (Family B; 
G1083S) were identified in two multigenerational families [Kruszka, 2015]. Each family had 
multiple affected members, and each instance segregated with the respective mutation [Kruszka, 
2015]. SPECC1L (NM_015330.3) mutations were also identified in two patients with Teebi 
hypertelorism syndrome [Bhoj, 2015]. As the name suggests, Teebi hypertelorism syndrome also 
presents with an abnormally large interocular distance, but also includes malformations such as 
interdigital webbing, shawl scrotum, and upslanting palpebral fissures [Bhoj, 2015]. The first 
Teebi mutation p.Glu420Asp (E420D) was identified in a family with both mother and child 
affected [Bhoj, 2015]. Lastly, a de novo deletion identified in the second Teebi patient resulted in 
an in-frame deletion of two amino acids (p.I400_H401del) [Bhoj, 2015]. Only Opitz G/BBB 
syndrome has a strong association with cleft palate. However, the phenotypes of both disorders 
partially overlap, and both show distinctive facial features such as a prominent forehead and broad 
nasal bridge, suggesting that they may have related etiologies [Kruszka, 2015; Bhoj, 2015]. 
Recently, a comprehensive report of the previous patients along with 16 additional 
individuals from 8 families with SPECC1L (NM_015330.4) variants has suggested the 
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classification of “SPECC1L-related syndrome” for the subset of patients originally identified with 
Opitz G/BBB or Teebi syndromes [Bhoj, 2018]. Compilation of the reported clinical anomalies in 
this group totaling 31 individuals revealed a wide variety of phenotypes [Bhoj, 2018]. These 
encompassed craniofacial defects such as CL/P and micrognathia, but also included malformations 
of the larynx, heart, diaphragm, reproductive organs, central nervous system, and ears [Bhoj, 
2018]. A learning or intellectual disability was also present in a percentage of the patients [Bhoj, 
2018]. Interestingly, all the mutations reside within or immediately adjacent to the second CCD or 
C-terminal CHD, suggesting that these domains are important in SPECC1L function. The study 
also compared these phenotypes to those seen in patients with mutations in MID1, the gene 
responsible for X-linked Opitz G/BBB syndrome [Taylor, 2010; Winter, 2016]. Like SPECC1L, 
the MID1 protein is involved in microtubule-stabilization [Winter, 2016; Bhoj, 2018]. The 
anomalies between both groups overlapped significantly, likely owing to the similar cellular 
function, but the study argued that the clinical presentation was distinct enough to separate the two 
[Bhoj, 2018]. Patients with SPECC1L mutations had an increased incidence of abdominal wall 
(omphalocele), diaphragm, and uterine anomalies, while patients with MID1 mutations had a 
higher incidence of laryngeal clefts [Bhoj, 2018]. Interestingly, the urogenital defect hypospadias 
was exclusively identified in patients with MID1 mutations, despite it being a common Opitz 
G/BBB syndrome phenotype [Bhoj, 2018]. Collectively, these results define these conditions 
resulting from SPECC1L and MID1 mutations as two distinct syndromes, which further elucidates 




1.5.2 Diverse functions of coiled-coil and calponin homology domain-containing cytoskeletal 
proteins 
The cytoskeleton is a complex network of filamentous proteins involved in virtually every 
cellular process including migration, vesicular trafficking, cell division, and adhesion [Tang, 2017; 
Bezanilla, 2015]. In mammalian cells, this network is composed of actin, microtubules, and 
intermediate filaments [Fletcher, 2010]. Integral to this system is a myriad of regulatory proteins 
that serve to control cytoskeletal dynamics [Fletcher, 2010]. Many cytoskeletal proteins act as 
molecular scaffolds that serve to mediate signal transduction or the assembly and stability of 
proteins complexes [Fletcher, 2010]. For example, microtubule and actin crosslinking factor 1 
(MACF1) of the Spectraplakin family is required for the targeting of microtubules to focal 
adhesions [Wu, 2008; Reviewed in Zhang, 2017]. Another cytoskeletal crosslinker, IQGAP1, 
regulates the stability of endosome-associated networks, but also plays roles in cell adhesion and 
migration [Samson, 2017; Noritake, 2007]. 
Scaffold proteins often regulate cytoskeletal dynamics by directly binding to cytoskeletal 
components. Many of these proteins contain calponin homology domains (CHD), which allow 
binding to filamentous actin (F-actin) [Korenbaum, 2002]. Named after the muscle contraction 
protein calponin, CHDs are highly structurally conserved motifs consisting of four large, 
sandwiched α-helices connected by three smaller α-helices [Gimona, 2002]. CHD-containing 
proteins identified to date contain one, two, or four CHD repeats, and two CHDs in tandem form 
an actin binding domain (ABD) [Korenbaum, 2002; Gimona, 2002]. While ABDs have a high 
affinity for F-actin, proteins containing only a single CHD, such as IQGAP1, have also been shown 
to interact with the actin cytoskeleton [Gimona, 2002; Mateer, 2004]. 
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Coiled-coil domains (CCD) are another motif common in cytoskeletal proteins [Burkhard, 
2001; Truebestein, 2016]. Like CHDs, the structure of CCDs is highly conserved, comprising two 
supercoiled α-helices [Truebestein, 2016]. CCDs are found in proteins with a wide variety of 
functions [Truebestein, 2016]. For instance, the family of CCD-containing Golgin proteins act to 
tether vesicles to the Golgi body during vesicle transport [Witkos, 2015]. CCDs span most of the 
length of these proteins and serve as molecular spacers between each structure [Truebestein, 2016]. 
This function as a molecular spacer can also be seen in CCD-containing proteins involved in 
chromosome segregation and centriole architecture [Truebestein, 2016]. The highly standardized 
structure of CCDs allows them to be used as molecular rulers to measure distances in proteins with 
enzymatic or transcriptional roles, as well as maintain precise distances between components of a 
cytoskeletal complex [Truebestein, 2016]. Conformational changes of CCDs can also propagate 
down the length of the domain to other regions of the protein, allowing force to be propagated 
longer distances, such as in molecular motors [Truebestein, 2016]. In many cases, the length and 
structure of the coil is more critical than the amino acid sequence, leading to examples where the 
former, but not the latter, are conserved across species [Truebestein, 2016]. 
 
1.5.3 Cellular analysis of SPECC1L expression 
SPECC1L contains eight CCDs along the length of the protein with a CHD at the C-
terminal end. Endogenous SPECC1L has a punctate expression pattern distributed throughout the 
cell, with some nuclear expression [Saadi, 2011; Mattison, 2011]. Consistent with SPECC1L 
containing a CHD, much of SPECC1L expression aligns with F-actin, and reorganization of the 
actin cytoskeleton using ionomycin treatment results in concomitant reorganization of SPECC1L 
expression [Saadi, 2011]. SPECC1L also highly co-localizes with acetylated-α-tubulin in the 
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mitotic spindles and during mitosis [Saadi, 2011; Mattison, 2011]. Furthermore, SPECC1L also 
concentrates along cell adhesions and adherens junction markers, especially at high cell density 
[Wilson, 2016]. These expression studies indicate that SPECC1L is a cytoskeletal protein involved 
in the regulation of cell adhesions and division through association with F-actin and microtubules. 
The function of SPECC1L domains has been analyzed using green fluorescent protein 
(GFP) tagged SPECC1L constructs [Saadi, 2011]. When a SPECC1L-GFP overexpression 
construct is transfected into cells, it results in a filamentous pattern very different from normal 
expression [Saadi, 2011]. This pattern associates largely with acetylated-α-tubulin [Saadi, 2011]. 
However, addition of syndromic human mutations in either CCD2 or the CHD disrupts this 
association [Saadi, 2011; Kruszka, 2015]. Likewise, truncation of the CHD ablates this expression 
pattern [Saadi, 2011]. In a different study, the authors evaluated the expression pattern of 
SPECC1L fragments (1-351, 351-851, and 851-1117) with respect to F-actin [Mattison, 2011]. 
They found that the C-terminal and middle fragments showed a strong and weak F-actin 
association, respectively [Mattison, 2011]. In contrast, the N-terminal fragment showed no co-
localization with F-actin [Mattison, 2011]. These studies show that the C-terminal section of 
SPECC1L mediates F-actin association, while both the CCD2 and CHD are important for 
association with stabilized microtubules. 
 
1.5.4 Cellular analysis of SPECC1L function 
Knockdown of SPECC1L has been utilized to evaluate how loss of the protein impacts cell 
function [Saadi, 2011; Mattison, 2011; Wilson, 2016]. For example, when grown at low density, 
control and SPECC1L-kd U2OS cells exhibit similar morphology. However, at high density, 
SPECC1L-kd U2OS cells display an elongated phenotype compared to the cuboidal shape of 
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control cells [Wilson, 2016]. Similarly, SPECC1L-kd 293T cells cultured at high density lose 
adherence to the substrate and lift off in clumps [Saadi, 2011]. Although the consequence between 
cell types is different, both are examples of impaired regulation of cell-substrate and cell-cell 
contacts. In agreement with this, immunostaining of adherens junction markers β-catenin and E-
cadherin in SPECC1L-kd U2OS cells reveals abnormally widened cell junctions compared to 
controls. These cells also have defects in cytoskeletal organization, as shown by staining for F-
actin and non-muscle Myosin II-B (NM-IIB) [Saadi, 2011; Wilson, 2016]. This cytoskeletal defect 
is made even more apparent upon treatment with compounds that induce cytoskeletal 
reorganization, such as ionomycin or WNT5A [Saadi, 2011]. SPECC1L-kd U2OS cells also 
exhibit impaired migration during wound-repair assays [Saadi, 2011]. Lastly, knockdown of 
SPECC1L in HeLa using siRNA results in spindle rocking and defects in chromosomal distribution 
during mitosis [Mattison, 2011]. Collectively, these studies demonstrate a role for SPECC1L in a 
variety of cellular processes including adhesion, cytoskeletal organization, migration, and division. 
Loss of SPECC1L has been linked with reduced PI3K-AKT signaling in vivo and in vitro 
[Wilson, 2016]. Canonical phosphatidylinositol 3-kinase (PI3K)-AKT signaling is mediated by 
receptor tyrosine kinases, such as Platelet-derived growth factor receptor α (PDGFRα) 
[Vasudevan, 2010]. After recruitment to the membrane by receptor tyrosine kinases, PI3K converts 
the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) into PIP3 [Vasudevan, 2010; 
Manning, 2017]. In turn, PIP3 recruits protein kinase B (AKT) to be phosphorylated, after which 
AKT proceeds to modulate downstream effectors to promote cellular survival, proliferation, 
migration, and a variety of other functions [Vasudevan, 2010; Xue, 2013; Manning, 2017]. 
Embryos containing a knock-in PdgfraPI3K allele that prevents PI3K recruitment exhibit midline 
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blebbing and cleft palate, demonstrating the importance of PI3K-AKT signaling in craniofacial 
development [Fantauzzo, 2014]. 
Western blotting showed reduced pan-AKT levels in SPECC1L-kd U2OS cells [Wilson, 
2016]. Upregulation of PI3K-AKT signaling with AKT activator SC79 partially rescued the cell 
shape and adherens junction defects in SPECC1L-kd U2OS cells [Jo, 2012; Wilson, 2016]. 
Likewise, PI3K inhibition by wortmannin was sufficient to induce SPECC1L-deficient phenotypes 
in control cells [Ui, 1995; Wilson, 2016]. These results suggest that SPECC1L regulates adherens 
junctions in part through the stabilization of AKT [Wilson, 2016]. 
 
1.5.5 Animal models of SPECC1L deficiency 
The developmental consequences of SPECC1L-deficiency have been investigated in fruit 
fly, zebrafish, and murine model systems [Saadi, 2011; Gfrerer, 2014; Wilson, 2016]. In 
Drosophila, knockdown is achieved through conditional RNAi targeting of SPECC1L-orotholog 
CG13366 [Saadi, 2011]. Ubiquitous knockdown using the daughterless-GAL4 driver results in 
crumbled or inflated wings, a cleft proboscis, and eventual death attributed to feeding difficulties 
[Saadi, 2011]. Crumpled or blistered wings, along with a dorsum fusion defect are also seen upon 
knockdown in the wing-imaginal-disc using the A9-GAL4 driver [Saadi, 2011]. The authors state 
that the wing phenotypes are reminiscent of those seen in knockdown models of integrins and 
integrin-associated proteins [Saadi, 2011; Narasimha, 2013]. Integrins are adhesive molecules 
with close ties to the actin cytoskeleton, and the similar phenotypes are consistent with a role for 
SPECC1L in cell adhesions [Delon, 2007]. 
The genetic utility combined with optically accessible development has allowed for the 
extensive study of craniofacial genetics in the zebrafish model [Van Otterloo, 2016; Machado, 
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2017; Duncan, 2017]. While the craniofacial skeleton may differ from mammals, parallels can be 
made for specific craniofacial structures, such as between the ethmoid plate and secondary palate 
in fish and mammals, respectively [Duncan, 2017]. Furthermore, the high degree of conservation 
between fish and mammalian genomes allows identification of functionally relevant homologs 
[Duncan, 2017; Machado, 2017]. The zebrafish genome contains two SPECC1L homologs on 
chromosomes 8 (specc1la) and 21 (specc1lb) [Saadi, 2011]. An initial study using morpholino 
(MO)-based knockdown of these homologs found no apparent phenotype [Saadi, 2011]. However, 
knockdown of a SPECC1 homolog, a gene related to SPECC1L, did result in a dose-dependent 
“faceless” phenotype [Saadi, 2011]. In contrast to these previous findings, a second study 
described multiple defects after specc1lb knockdown, including clefts of the ethmoid plate and 
absent lower jaw [Gfrerer, 2014]. Why knockdown of specc1lb resulted in different consequences 
between the two studies is unclear, but may have been due to differences in morpholino design. 
These defects were partially rescued when embryos were treated with specc1lb mRNA, reinforcing 
the causal role of the initial knockdown [Gfrerer, 2014]. Furthermore, lineage tracing of NCC cells 
using a sox10-driven photoconvertible marker found that MO-treated embryos exhibited reduced 
NCC contribution to craniofacial structures, in addition to reduced proliferation in those regions 
[Gfrerer, 2014]. These studies showed the first example of craniofacial malformations in a 
vertebrate model of SPECC1L-deficiency, as well as established a role for SPECC1L in NCC 
function. 
Murine palate development shares many similarities with the human process, making mice 
one of the most relevant model systems for studying orofacial clefting [Otterloo, 2016]. A 
relatively quick method of generating mouse knockout models is through the insertion of gene trap 
vectors into the genome, which disrupt a gene at the point of insertion [Friedel, 2010]. Recently, 
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our group generated two mouse models of SPECC1L deficiency using existing gene trap 
embryonic stem cell lines [Wilson, 2016]. These vectors, termed DTM096 and RRH048, reside 
within intron 1 and 15, respectively, and each consists of a splice acceptor, β-galactosidase 
reporter, and polyA tail [Wilson, 2016]. As DTM096 is inserted before the start of protein 
translation, only β-galactosidase is expressed, while the RRH048 allele results in a SPECC1L-βgal 
fusion protein [Wilson, 2016]. Embryos heterozygous for either allele displayed craniofacial 
phenotypes very rarely, along with a slightly reduced Mendelian ratio than expected [Wilson, 
2016]. LacZ staining of these embryos revealed a pattern of SPECC1L expression that aligned 
closely with the NCC lineage, and immunofluorescence confirmed the overlap between SPECC1L 
and both SOX10 and AP2α, two widely-used NCC markers [Wilson, 2016]. 
In contrast to the relatively mild heterozygote phenotype, the homozygotes exhibited 
embryonic lethality between E9.5 and E10.5 with a cranial neural tube closure defect [Wilson, 
2016]. Evaluation of the NCCs by immunostaining with SOX10 showed NCCs still present within 
the open neural folds of the homozygote, while NCCs within control embryos had already begun 
to enter the facial primordia [Wilson, 2016]. The delamination defect is consistent with the reduced 
NCC contribution to craniofacial structures in the specc1lb MO knockdown zebrafish model 
[Gfrerer, 2014]. 
Molecular analysis of Specc1l gene trap homozygotes recapitulated several of the in vitro 
findings from SPECC1L-kd U2OS cells [Wilson, 2016]. Staining for adherens junction and 
cytoskeletal markers showed increased intensity, and the levels of both phosphorylated and non-
phosphorylated AKT were reduced [Wilson, 2016]. Consistent with the role of PI3K-AKT 
signaling in cell survival, a marked increase in apoptosis was also observed [Wilson, 2016]. 
Collectively, these results provide a possible mechanism for the NCC delamination defects in 
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homozygotes, wherein reduced AKT signaling leads to abnormal cell adhesions, which in turn 
prevent proper exit from the epithelial layer. 
 
1.6 Study Significance 
Orofacial clefts have a multitude of genetic and environmental causes. While the causes of 
these malformations have been identified in numerous patients, there remain many cases for which 
the basis is still unknown. This complex etiology necessitates continuous genetic screening of 
affected individuals to identify novel genes associated with these birth defects. Subsequent 
analyses into the molecular, cellular, and developmental function of these novel genes are essential 
for understanding how they contribute to orofacial clefts. Variants in SPECC1L have been 
identified in multiple patients with craniofacial anomalies, including cleft palate. This dissertation 
investigates the role of this cytoskeletal protein using both deficiency and gain-of-function models. 
Chapter 2 describes the generation and characterization of a compound heterozygous 
mouse model containing one null and one truncation Specc1l allele. The data show that moderate 
Specc1l deficiency can cause a delay in palate elevation and establish a role for SPECC1L in the 
oral epithelium downstream of IRF6. In Chapter 3, we explore a role for SPECC1L in cell 
migration using both SPECC1L-kd U2OS cells and primary mouse embryonic palatal 
mesenchyme cells from compound heterozygotes. Thorough analyses of time-lapse imaging 
movies show that SPECC1L-deficiency in both cell types leads to reduced speed and poor 
collective movement during wound closure. We also show that activation of PI3K-AKT signaling 
can rescue the defects in wound closure speed. Lastly, Chapter 4 investigates the developmental 
impact of the p.Thr397Pro SPECC1L Opitz G/BBB syndrome mutation using a CRISPR Cas9-
generated knock-in mouse model. This disruption to the second coiled-coil domain of SPECC1L 
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results in embryos with ventral body wall defects and fully penetrant cleft palate. Additionally, we 
show that SPECC1L localization is altered in mutant palates, consistent with a gain-of-function 
mutation. Taken together, these studies establish a direct role for SPECC1L in palatogenesis and 
connects it with a well-known orofacial clefting pathway. They also specify distinct functions for 
SPECC1L in the palatal mesenchyme and epithelium. Furthermore, the phenotypic differences 
between embryos with truncation and point mutation alleles demonstrate that each has a distinct 
impact on protein function. Future inquiries comparing the cellular and molecular consequences 
of different Specc1l alleles will be critical to understanding how mutations in this gene contribute 
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2.1 Abstract 
SPECC1L mutations have been identified in patients with rare atypical orofacial clefts and 
with syndromic cleft lip and/or palate (CL/P). These mutations cluster in the second coiled-coil 
and calponin homology domains of SPECC1L and severely affect the ability of SPECC1L to 
associate with microtubules. We previously showed that gene trap knockout of Specc1l in mouse 
results in early embryonic lethality. We now present a truncation mutant mouse allele, 
Specc1lΔC510, that results in perinatal lethality. Specc1lΔC510/ΔC510 homozygotes did not show cleft 
palate, however, when crossed with a gene trap allele, Specc1lcGT/ΔC510 compound heterozygotes 
showed a palate elevation delay with incompletely penetrant cleft palate. Specc1lcGT/ΔC510 embryos 
exhibit transient oral epithelial adhesions at E13.5, which may delay shelf elevation. Consistent 
with oral adhesions, we show periderm layer abnormalities, including ectopic apical expression of 
adherens junction markers, similar to Irf6 hypomorphic mutants and Arhgap29 heterozygotes. 
Indeed, SPECC1L expression is drastically reduced in Irf6 mutant palatal shelves. Lastly, we 
wanted to determine if SPECC1L deficiency also contributed to non-syndromic (ns) CL/P. We 
sequenced 62 Caucasian, 89 Filipino, 90 Ethiopian, 90 Nigerian and 95 Japanese patients with 
nsCL/P and identified three rare coding variants (p.Ala86Thr, p.Met91Iso, p.Arg546Gln) in six 
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individuals. These variants reside outside of SPECC1L coiled-coil domains and result in milder 
functional defects than variants associated with syndromic clefting. Together, our data indicate 
that palate elevation is sensitive to deficiency of SPECC1L dosage and function, and that 
SPECC1L cytoskeletal protein functions downstream of IRF6 in palatogenesis. 
 
2.2 Introduction 
Orofacial clefting is the most common craniofacial congenital malformation, with an 
incidence of approximately 1 in 800 live-births [Rahimov, 2012; Mossey, 2012]. Among orofacial 
clefts, approximately 70% of cases manifest as isolated or non-syndromic cleft lip with or without 
cleft palate (nsCL/P) [Stanier, 2004], while the remaining 30% consists of more than 275 different 
syndromic forms of clefting [Leslie, 2013a]. 
The underlying pathology of many syndromic CL/P cases can be narrowed down to a single 
causative gene and shows a Mendelian inheritance pattern in affected families. In contrast, nsCL/P 
often presents in families with incomplete penetrance and represents a complex disorder with a 
heterogeneous genetic component [Murray, 1995; Jugessur, 2009; Rahimov, 2012; Pengelly, 
2016]. Genome-wide association studies in conjunction with traditional candidate gene and 
linkage analyses have contributed to the identification of several nsCL/P-associated genes [Dixon, 
2011; Marazita, 2012; Adeyemo, 2017]. One method of conceptualizing the effect of these many 
genes is by organizing them into regulatory networks. For instance, both IRF6 and GRHL3 
mutations have been identified in patients with Van der Woude syndrome (VWS) [Kondo, 2002; 
Leslie, 2013b; Peyrard-Janvid, 2014; Kousa, 2016], as well as patients with isolated CL/P 
[Zucchero, 2004; Rahimov, 2008; Beaty, 2010; Leslie, 2016a; Leslie, 2016b; Gowans, 2017]. 
Previous studies have shown that IRF6 regulates GRHL3 expression [Botti, 2011; de la Garza, 
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2013], and mouse mutants for the two genes show similar phenotypes [Ingraham, 2006; 
Richardson, 2006; Peyrard-Janvid, 2014]. Together, these studies implicate functional deficiency 
of an IRF6-GRHL3 network in nsCL/P [Kousa, 2016; Leslie, 2016a; Leslie, 2016b]. This network 
has been expanded to include ARHGAP29 [Leslie, 2012; Letra, 2014; Savastano, 2017; Liu, 
2017]. 
The IRF6-GRHL3 network is required for specification and proper differentiation of the 
periderm [Richardson, 2009; de la Garza, 2013; Peyrard-Janvid, 2014], a single layer of 
specialized epithelial cells that prevents abnormal epithelial adhesions during embryonic 
development [Richardson, 2014]. The periderm achieves this non-adhesive property by localizing 
adhesion molecules away from its apical surface, preventing cell-cell adhesion [Richardson, 2009; 
Richardson, 2014]. During palatogenesis, the periderm is selectively removed at the medial edge 
epithelium to allow palatal shelves to adhere at E14.5 [Reviewed in Lan, 2015]. Deficiencies in 
the IRF6-GRHL3 network result in an absent or abnormal periderm layer. Irf6 mutants lack 
periderm and result in ectopic permanent adhesions all over the body, including the oral cavity, 
which causes cleft palate [Ingraham, 2006; Richardson, 2006]. Heterozygotes for Irf6R84C and Irf6gt 
alleles, as well as heterozygotes for an Arhgap29 null allele, show transient oral adhesions 
[Richardson, 2006; Ingraham, 2006; Paul, 2017]. These transient oral adhesions frequently 
accompany a delay in palatal shelf elevation at E14.5 [Paul, 2017]. Considering that rare and 
common variants in IRF6 have been associated with nsCL/P [Zucchero, 2004; Rahimov, 2008; 
Beaty, 2010], IRF6 regulation of the periderm represents a critical pathway in palatogenesis. 
Identification of additional members of this pathway is necessary to further elucidate nsCL/P 
etiology. 
48 
We first identified SPECC1L mutations in two patients with atypical clefts [Saadi, 2011]. 
At the time, we posited that atypical clefts are a severe manifestation of more common cleft lip 
and palate phenotype. Thus, we proposed that pathogenetic mechanisms underlying SPECC1L 
deficiency would also result in more common syndromic and nsCL/P. Consistent with our 
proposition, ten additional SPECC1L mutations were identified in a total of 31 patients originally 
diagnosed with clefting-associated autosomal dominant Opitz G/BBB (OMIM #145410) and 
Teebi Hypertelorism syndromes (OMIM #145420) [Kruszka, 2015; Bhoj, 2015; Bhoj, 2018]. Bhoj 
et al. 2018 compiled a relatively distinct phenotypic profile of patients with SPECC1L mutations 
that includes hypertelorism, orofacial clefting, wide short nose with large tip, and ventral body 
wall closure defects (omphalocele). This range of malformations led them to propose an 
independent autosomal dominant SPECC1L mutation syndrome. Interestingly, these syndromic 
mutations cluster in either the 2nd coiled coil or the calponin homology domains of SPECC1L. 
To validate that a decrease in SPECC1L dosage or function can affect midface 
development, we generated gene trap and truncation Specc1l mutant mouse alleles. Indeed, 
compound heterozygotes with a gene trap and a truncation allele exhibit a delay in palate elevation. 
Furthermore, we identify defects in the periderm of Specc1l compound heterozygous embryos and 
show that SPECC1L expression in the palate requires IRF6. We also sequenced 426 individuals 
with nsCL/P from five different populations and identified three rare SPECC1L variants. A total 
of six individuals (1.4%) were heterozygous for one of these three variants. Functional analyses 
indicate that these variants result in partial loss of function. These studies show that deficiency of 
SPECC1L is sufficient to disrupt palate development and implicate SPECC1L in the expanding 
IRF6-GRHL3 orofacial clefting gene network. 
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2.3 Materials and Methods 
2.3.1 Patient information 
The study was approved by the ethical committee or by the Institutional Review Boards at 
all the participating sites in Ethiopia, Iowa, Nigeria and Philippines in accordance with the relevant 
guidelines and regulations. Study participants gave written informed consent for participation in 
this study in accordance with the Declaration of Helsinki and for the publication of this study. We 
also have adhered to standard biosecurity and institutional safety procedures in this study. 
 
2.3.2 Generation of Specc1lΔC510 truncation allele  
A zinc-finger nuclease (ZFN) was targeted to exon 4 of mSpecc1l near the exon 4/intron 4 
boundary. 0.25 ng of targeting primer (Table 2.1) was co-injected with the ZFN expression 
construct into FVB/C57BL6/J hybrid blastocysts at the University of Kansas Medical Center 
Transgenic Facility. The injected embryos were transplanted into pseudo-pregnant females. The 
resulting progeny were analyzed by PCR for genomic deletions. A founder animal carrying one or 
more deletions was outbred with wildtype C57BL6/J females to establish a line. Specc1lΔC510 
was identified in such a manner. The deletion is 154bp in length and spans the mSpecc1l exon 
4/intron 4 boundary (NM_153406.3:c.1825_1941+37del). RT-PCR and western blot analyses 
were performed to determine the functional consequences of this genomic deletion. 
 
2.3.3 Generation of Specc1lcGT gene trap allele 
This strategy for generating a multifunctional gene trap targeting construct has been 
described previously (Appendix A; Table 2.2) [Nagy, 2003; Strassman, 2017]. In brief, 5’ and 3’ 




Primer Name Sequence 
ZFN Targeting Forward GTCTGAGCAGAAGGGCAAAG 
ZFN Targeting Reverse AAGAACGTGTTTACGTGGGC 
Δ154 Genomic Forward AGTGAGAACGAAAGGCTGGG 
Δ154 Genomic Reverse GAAGAGGAGCGGCTGACAAT 
Δ154 RT-PCR Forward AGAGCAGCGCTACATGGATT 
Δ154 RT-PCR Reverse CTTCTTGGCCTCTTCCTGGA 




1112 mPrdm16in2cGT-3'TargetPCR_F GGGAGGATTGGGAAGACAAT 
1115 mPrdm16in2cGT-5'TargetPCR_R ACTGGAAAGACCGCGAAGAG 













1712 Specc1l-HomA-5R GGATGTCTTGATCCCTGGAA 
1713 Specc1l-HomA-3F AACTCTCAAGCCCTCCACAG 









1754 Specc1lx2_F (w/ oBB1125) ACCAAGAGGCAGCCCAGAAT 
- pUC_F CTAGTCCACTGGCACAGCCTAC 
- Hsvtk_R ACACTCCAGAGAGGGCAGAG 
Table 2.1: Specc1lΔC510 primer sequences. 
Table 2.2: Specc1lcGT primer sequences. 
51 
genomic DNA isolated from EDJ#22 (ATCC SCRC-1021) mouse 129S5/SvEvTac embryonic 
stem cells and cloned into pENTR-5’HR and pENTR-3’HR Entry clones. The three Entry clones, 
pENTR-5’HR, pENTR-3’HR, and prsFlipROSAβgeo* TT0-ENTR11, and the pPNT-DEST-R4-
R3 Destination vector described previously [Strassman, 2017] were combined to create the final 
~20 kb targeted trapping vector, prsFlipROSAβgeo*-Specc1lin2, via the in vitro Multisite 
GATEWAY recombination system using LR Recombinase II Plus enzyme following 
manufacturer’s protocols (Thermo Fisher Scientific). Linearized plasmid DNA was electroporated 
into EDJ#22 ES cells. Positive ES colonies were selected first by Neomycin resistance using G418 
(250 ug/ml) and then by RT-PCR for Specc1l-βgeo* fusion gene trap transcript. Correctly targeted 
ES cells were microinjected into C57BL6/J blastocysts (KUMC Transgenic and Gene-Targeting 
Institutional Facility, Kansas City, KS). Chimeras were crossed to C57BL6/J mice for germline 
transmission. Heterozygous progeny was confirmed by PCR genotyping to identify the Specc1lcGT 
allele. All animal studies were performed consistent with protocols approved by the KUMC 
Institutional Animal Care and Use Committees. 
 
2.3.4 Histological analysis 
Mating pairs were set up in timed matings and then checked for plugs on the following 
morning. Noon on the day the plug was identified is classified as embryonic day 0.5 (E0.5). At the 
given embryonic time-point, females were euthanized using a primary and a secondary method as 
approved by the institutional IACUC. Embryos were then harvested, washed in 1x PBS, and fixed 
overnight in 4% paraformaldehyde at 4°C. For paraffin sectioning, embryos were then gradually 
dehydrated in increasing concentrations of ethanol and processed for paraffin embedding using the 
Leica ASP300 tissue processor. For cryosectioning, embryos were submerged in 30% sucrose until 
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the tissue sank, embedded in OCT solution, and stored at -80°C until use. Sections were obtained 
between 8-10 µm. 
 
2.3.5 Immunostaining analysis 
For the U2OS transfection experiments, coverslips were fixed with ice cold 4% 
paraformaldehyde for 10 minutes, permeabilized with 0.5% Trixon X-100 in 1x PBS for 10 
minutes, washed, and then blocked in 10% normal goat serum (Thermo Fisher Scientific, 50062Z) 
for one hour at room temperature. The primary antibody was incubated overnight at 4°C, washed 
in 1x PBS, then incubated in secondary antibody for one hour at room temperature covered from 
light. Lastly, the coverslips were washed again in 1x PBS and mounted on slides with Prolong 
Gold with DAPI (Invitrogen, P36930). 
For immunostaining on embryo sections, conditions varied depending on the antibody 
used. Briefly, antigen retrieval was performed by heating the slides in sodium citrate buffer (10mM 
Sodium Citrate, 0.05% Tween 20, pH 6.0) at 96°C for 10 minutes. The slides were then washed in 
H2O, permeabilized with 0.5% Triton X-100 in 1x PBS for 30 minutes, washed in PBS, then 
blocked in 10% normal goat serum. Primary and secondary antibodies were incubated as described 
above. For phalloidin staining, antigen retrieval was not used and the stain was included during 
secondary antibody incubation. 
Primary antibodies: SPECC1L C-terminus [Saadi, 2011], SPECC1L N-terminus 
(Proteintech, 25390-1-AP), Acetylated-α-tubulin (Sigma, T6793), ΔNp63 (Biolegend, 619001), β-
Catenin (Cell Signaling Technology; 2677), KI-67 (Cell Signaling Technology; 12202). 
Secondary antibodies and stains: Goat anti-Rabbit IgG (H+L) Alexa 488 and 594 
(Invitrogen; A-11008, A-11012), Goat anti-Mouse IgG1 Alexa 488 (Invitrogen, A-21121), Goat 
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anti-Mouse IgG2a Alexa 594 (Invitrogen, A-21135), Goat anti-Mouse IgG3 Alexa 594 
(Invitrogen; A-21155), Acti-stain 555 phalloidin (Cytoskeleton, PHDH1-A). 
 
2.3.6 Western blot analysis 
Protein extraction was performed by sonicating flash-frozen embryonic tissue in 
radioimmunoprecipitation assay (RIPA) buffer with HALT protease inhibitor Cocktail (Thermo 
Scientific, 78440). Samples were then spun down for 10 minutes at 13,000 rcf and the supernatant 
collected. Lysates were then electrophoresed in 4-15% gradient Mini-Protean TGX Stain-Free 
precast gels (Bio-RAD, #4568084) and transferred onto Immobilon PVDF membranes (EMD 
Millipore, IPVH00010). PVDF membranes were then blocked in Odyssey Blocking Buffer (Li-
Cor, 927-5000) either overnight at 4°C or at room temperature for 1 hour. Primary antibodies used 
were anti-N-SPECC1L (1:2000; Proteintech, 25390-1-AP) and anti-IRF6 (1:2000; Sigma, 
SAB2102995). The secondary antibody used was HRP-linked goat anti-rabbit IgG (1:10,000; Cell 
Signaling Technologies). Femto SuperSignal West ECL reagent (Thermo Scientific, 34095) was 
used to develop the signal. Image Lab software (Bio-Rad) was used for quantitative analysis of the 
western blots. 
 
2.3.7 Cell culture and transfection analysis 
Human U2OS osteosarcoma cells (ATCC, HTB-96) were cultured in DMEM media with 
high glucose and pyruvate, supplemented with 10% fetal bovine serum and 
penicillin/streptomycin. U2OS cells were transfected with either wildtype SPECC1L-expressing 
construct (33) or with constructs carrying the Q415P [Saadi, 2011], A86T, M91I, T299A and 
R546Q variants (present study). The GFP tag from previous studies [Saadi, 2011] was removed in 
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favor of visualizing the overexpressed protein by immunofluorescence. Transfected cells were 
analyzed for qualitative differences in the ability of SPECC1L to associate with microtubules and 
the extent of acetylation of associated microtubules [Saadi, 2011; Kruszka, 2015]. 
 
2.4 Results  
2.4.1 Moderate reduction of Specc1l in mouse results in palate elevation defect 
We previously reported that severe deficiency of Specc1l using gene trap constructs results 
in early embryonic lethality by embryonic day E9.5 [Wilson, 2016]. These mutants exhibited an 
open neural tube and defects in cranial neural crest cell delamination from the anterior neural folds. 
While a deficiency in neural crest cell function is a plausible cause of a craniofacial defect [Trainor, 
2010; Snider, 2014], early embryonic lethality prevented confirmation of a direct role for 
SPECC1L in midface or palate development. Therefore, we sought to generate alternative Specc1l-
deficient alleles that would allow embryos to survive longer in gestation to study these perinatal 
phenotypes. We utilized zinc-finger nuclease-based genomic deletions to target the 3’ end of exon 
4, which yielded a 154bp deletion (Fig. 2.1A). RT-PCR sequencing analysis revealed that the 
deletion abolished the exon 4 splice donor site (Fig. 2.1A), resulting in the use of a cryptic splice 
site within intron 4 and the subsequent introduction of a novel coding sequence (Fig. 2.1B). This 
novel sequence coded for 9 amino acids followed by a stop codon, leading to premature truncation 
of the protein (Fig. 2.1C). For clarity, we have termed this allele Specc1lΔC510, as it results in the 
loss of the 510 amino acids at the C-terminal end of the protein (Fig. 2.1C). To validate this 
truncation, we performed western blot analysis with an antibody targeting the N-terminal end of 
SPECC1L. Indeed, a band can be seen at ~100kDa in the mutant, compared to wildtype SPECC1L 





Figure 2.1: Generation of truncation Specc1l allele. A) Schematic of Specc1l introns and 
exons depicting the locations of the cGT construct (red) and zinc-finger nuclease deletion Δ154 
(orange). B) Δ154 ZFN deletion removes the canonical splice donor of exon 4, resulting in the 
usage of cryptic splice donor within intron 4 (RT-PCR; underlined green sequence) and 
subsequent truncation of the protein due to the introduction of a stop codon (RT-PCR; red 
highlighting). Genotyping by PCR amplification of genomic DNA and RT-PCR reveals a size 
difference between WT and Δ154 bands. C) Diagram of WT and ΔC510 SPECC1L protein. 
Orange section represents the 9 novel amino acids. D) Specc1lΔC510/ΔC510 embryos are smaller 
compared to littermate control and die shortly after birth. Western blotting shows a ~50kDa 
size decrease in ΔC510 homozygotes compared to WT control lysates. E) Specc1lcGT/cGT 
embryos exhibit embryonic lethality with open neural folds (arrows) at E9.5, compared to 
littermate control. Western blotting shows a loss of SPECC1L protein in cGT homozygotes 
compared to WT control lysates. 
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homozygotes, Specc1lΔC510/ΔC510 mutants showed perinatal lethality (Fig. 2.1D). Specc1lΔC510/ΔC510 
homozygotes showed no gross malformations, apart from occasional size differences and curly tail 
phenotypes (Fig. 2.1D; arrow). Additionally, we did not detect instances of cleft palate on the 
C57BL6/J background (N=6). 
We hypothesized that a further reduction in Specc1l dosage by crossing gene trap and 
truncation alleles would result in palate defects. To achieve this, we utilized a newly generated 
gene trap allele, termed Specc1lcGT-ko (abbreviated Specc1lcGT from here on) using a 
multifunctional gene trap cassette adapted for targeted trapping (Fig. 2.1A) [Schnutgen, 2005; 
Strassman, 2017]. Homozygous Specc1lcGT/cGT mutants undergo embryonic lethality at E9.5 (Fig. 
2.1E), consistent with our previous gene trap alleles, Specc1lRRH048 and Specc1lDTM096 [Wilson, 
2016]. Interestingly, Specc1lcGT/cGT homozygotes often show complete neural tube closure failure 
(Fig. 2.1E; arrows), while Specc1lRRH048 and Specc1lDTM096 mutants only show closure defects in 
the cranial neural tube [Wilson, 2016]. This is indicative of an increased trapping efficiency of the 
Specc1lcGT allele. 
To evaluate the impact of Specc1lcGT/ΔC510 compound heterozygosity on palate 
development, we harvested embryos at E13.5-E15.5. Compared to control embryos (Fig. 
2.2A,C,E), Specc1lcGT/ΔC510 mutants (Fig. 2.2B,D,F,G) appeared smaller and manifested 
subepidermal blebbing at E13.5 (Fig. 2.2B; arrowheads), and at E14.5 (Fig. 2.2D; arrowheads). 
This blebbing resolved by E15.5, except in occasional cases of hemorrhaging (Fig. 2.2F,G; 
arrowheads). Importantly, approximately 66% (n=9) of Specc1lcGT/ΔC510 mutants showed 
vertically oriented (unelevated) palatal shelves when compared to littermate controls at E14.5 (Fig. 




Figure 2.2: Specc1lcGT/ΔC510 compound mutants exhibit palatal shelf elevation delay. A-G) 
Representative whole mount images (top row) and coronal H&E palate sections (bottom three 
rows) of control and Specc1lcGT/ΔC510 embryos from E13.5-E15.5. Compound mutants show 
edema, midline subepidermal blebbing (B,D; arrowheads), and occasional hemorrhaging (F,G; 
arrowheads) compared to control embryos. At E14.5, approximately 66% of mutant embryos 
had palatal shelves that had not elevated (D; arrows) compared to littermate controls (C; 
arrows). By E15.5, most mutants had closed palates (F), indicating that these mutants 
experience a delay in palatal shelf elevation. However, cleft palate can occur in mutant embryos 
with severe phenotypes (G; arrows). 
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later (n=12), resulting in cleft palate (Fig. 2.2G; arrows). These results confirmed our assertion 
that palate development is sensitive to functional Specc1l dosage. 
 
2.4.2 Specc1lcGT/ΔC510 mutants show ectopic oral adhesions and abnormal periderm 
A delay in palatal shelf elevation is also found in other mouse models [Reviewed in Gritli-
Linde, 2007; Gritli-Linde, 2008; Bush, 2012]. Most notably, Arhgap29 heterozygotes showed a 
palate elevation delay accompanied by ectopic transient oral adhesions [Paul, 2017]. Therefore, 
we histologically scanned the oral cavity of our mutants. Indeed, our Specc1l compound mutants 
showed several occurrences of ectopic adhesions (Fig. 2.3). Evidence of oral adhesions was found 
in the anterior nasal cavity (Fig. 2.3, A vs. B), the palate hinge region (Fig. 2.3, C vs. D), and 
between palatal shelf and buccal or lingual epithelia (Fig. 2.3, E vs. F). These oral adhesions 
almost always accompanied a dissociation of epithelia from the underlying mesenchyme in 
paraffin sections (Fig. 2.3, A’ vs. B’, C’ vs. D’, E’ vs. F’). 
 
2.4.3 Specc1lcGT/ΔC510 mutants show abnormal adherens junction staining in the periderm 
To investigate how SPECC1L deficiency in our compound mutants could cause both a 
delay in palatal shelf elevation and transient oral adhesions, we first evaluated SPECC1L 
expression in the palate by co-staining cranial E13.5 and E14.5 sections for SPECC1L and ΔNp63, 
a marker for the basal epithelium (Fig. 2.4A-C, A’-C’). Indeed, we found that SPECC1L is 
expressed in the CNCC-derived palatal mesenchyme (Fig. 2.4A-C, A’-C’), as well as both the 
ΔNp63-positive basal cells (Fig. 2.4A’) and ΔNp63-negative periderm cells of the palatal shelf 




Figure 2.3: Specc1lcGT/ΔC510 compound mutants show transient oral adhesions. A-F) 
Coronal H&E palate sections of WT and Specc1lcGT/ΔC510 mutant embryos at E13.5. Compound 
mutants show evidence of adhesions between the oral and nasal cavity epithelia (A vs. B; 
arrows) and between the oral and tongue epithelia (C vs. D; arrows). Adhesions were also 
identified at the junction between the tongue and palatal shelf (E vs. F; arrows), which resulted 






Figure 2.4. Periderm of Specc1lcGT/ΔC510 embryos show changes in F-actin and adherens 
junction markers consistent with abnormal adhesion. A-C) Immunostaining for SPECC1L 
(red) and ΔNp63 (green; basal epithelial marker) on coronal sections between E13.5 and E14.5. 
SPECC1L expression is present in the periderm and basal layers of the epithelium (A’; arrow), 
as well as the underlying mesenchyme. D-K) Coronal sections of E13.5 WT and 
Specc1lcGT/ΔC510 palatal shelve epithelia co-immunostained for cell junction marker β-catenin 
(D,H) and basal epithelium marker ΔNp63 (E,I). Both wildtype and mutant sections contain 
flattened, ΔNp63-negative periderm cells (G,K; arrows). However, the mutant sections have 
abnormal apical β-catenin staining on some periderm cells (G vs. K; arrows). L-S) Sections 
stained with phalloidin (L,P) show increased F-actin staining in the mutants compared to 
controls (O vs. S). Scale bars are 2mm for A-C, 50μm for A’-C’, and 10μm for D-S. p=palatal 
shelf; mx=maxillary process; mn=mandibular process; t=tongue; ns=nasal septum. 
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Previous studies have shown that ectopic oral adhesions involve abnormalities of the 
periderm [Casey, 2006]. Irf6 mouse mutants exhibit a complete absence of periderm cells 
[Richardson, 2009], resulting in severe oral adhesions and permanent cleft palate [Richardson, 
2006; Ingraham, 2006].However, partial loss of IRF6 function has been shown to result in the 
mislocalization of adherens junction markers to the apical surface of the periderm, which is 
normally devoid of cell adhesion molecules [Richardson, 2009; Richardson 2014]. IRF6 
deficiency also results in increased actin stress fiber formation [Biggs, 2014]. Similarly, we 
previously showed increased actin filament and adherens junction marker staining upon SPECC1L 
deficiency [Saadi, 2011; Wilson, 2016]. Therefore, we examined these markers in the oral 
periderm of our compound mutants. Co-staining for ΔNp63 and β-catenin (Fig. 2.4D-K) revealed 
abnormal apical expression of membrane-associated β-catenin in mutant periderm (Fig. 2.4, G vs. 
K; arrows). These instances of apical expression were present at the buccal and lingual palatal 
shelf interfaces, consistent with the occurrence of ectopic adhesions. We also stained for 
filamentous actin (F-actin) using phalloidin and found a generally increased staining in mutant 
palate epithelium and mesenchyme with regions of disorganized filaments (Fig. 2.4L-S; arrows). 
Together, these results indicate that the transient oral adhesions seen in our Specc1l mutants may 
be due to ectopic apical expression of cell adhesion markers. 
 
2.4.4 SPECC1L expression in the palate is dependent upon IRF6 transcription factor 
The similar adhesions and molecular changes in Irf6 and Arhgap29 heterozygotes and our 
Specc1l mutants suggest that SPECC1L regulation of the periderm may functionally overlap with 
the IRF6 pathway. To test if SPECC1L could be connected to the IRF6 regulatory pathway, we 
looked at SPECC1L expression in the palate of Irf6 knockout embryos (Irf6-/-) [Ingraham, 2006]. 
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Indeed, SPECC1L expression was reduced in the epithelium of the Irf6-/- palatal shelves (Fig. 2.5, 
A vs. B). It was previously shown that K14 promoter-based transgenic expression of Irf6 in the 
oral epithelia (TgK14-Irf6/+) partially rescued the oral adhesion phenotype in Irf6 knockout mice 
[Kousa, 2017]. Consistent with this rescue, SPECC1L expression was restored in the oral 
epithelium of Irf6-/-; TgK14-Irf6/+ embryos (Fig. 2.5, B vs. C). Furthermore, IRF6 expression was not 
altered in our Specc1lcGT/ΔC510 mutants (Fig. 2.5D,E). Together, these results show that SPECC1L 
expression in the palatal shelves requires IRF6 function. 
 
2.4.5 Identification of nonsynonymous SPECC1L coding variants in nsCL/P patients 
Given that SPECC1L mutations were identified in patients with atypical and syndromic 
CL/P [Saadi, 2011; Kruszka, 2015; Bhoj, 2015; Bhoj, 2018], we posited that variants would also 
contribute to nsCL/P. To test this, we sequenced the coding region of SPECC1L (NM_015330.5; 
NP_056145.4) in 426 nsCL/P patient samples. These included 62 samples from Iowa Caucasians, 
89 from the Philippines, 90 from Ethiopia, 90 from Nigeria, and 95 samples from Japan (Fig. 2.6). 
One novel (c.273G>A, p.Met91Iso), two rare (c.256G>A, p.Ala86Thr; c.1637G>A, 
p.Arg546Gln), and one population specific (895A>G, p.Thr299Ala) variant were identified. The 
variants p.Met91Iso, p.Arg546Gln and p.Thr299Ala were identified once each in the Filipino, 
Iowa Caucasian, and Japanese samples, respectively. The p.Met91Iso variant was not present in 
either ExAC or gnomAD databases (n=372576) [Lek, 2016]. The p.Ala86Thr novel variant was 
identified in four different Japanese individuals with nsCL/P (n=95; Allele Frequency = 0.042) 
compared to 0/8654 and 1/18394 occurrence in East Asian samples in ExAC and gnomAD 
databases (n=27048; Allele Frequency = 0.000037), indicating a strong enrichment. The 
p.Arg546Gln variant was not present in the ExAC database (n=121096), but was present in six  
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Figure 2.5: IRF6 is required for SPECC1L expression in the palate. Immunostaining of 
coronal embryonic palate sections at E15.5. A) SPECC1L is expressed widely (red) in the palate 
in wildtype mice. B) Irf6-null mice exhibit abnormal oral adhesions throughout the oral cavity 
and loss of SPECC1L expression. C) These phenotypes are rescued with transgenic expression 
of Irf6 in the oral ectoderm using a Keratin 14 promoter. Grayscale insets are of red channel. 
Scale bar is 100μm. D) Representative images from IRF6 western blots of wildtype and 
Specc1lcGT/ΔC510 mutant craniofacial lysate. E) Bar graph showing relative expression 
normalized by total protein. There is no significant difference in IRF6 protein levels between 





Figure 2.6: SPECC1L variants in patients with non-syndromic orofacial clefting. A) 
Schematic representation of SPECC1L protein showing positions of the eight coiled-coil 
domains (CCD; blue), calponin homology domain (CHD; red), as well as the heterozygous 
mutations identified in patients with non-syndromic cleft lip/palate (A86T, M91I, T299A, 
R546Q; green text). Also shown are the previously identified mutations found in a patient with 
Oblique Facial Clefts (Q415P; purple asterisk), two multigenerational families with autosomal 
dominant Opitz G/BBB syndrome (T397P, G1083S; orange asterisks), patients with Teebi 
Hypertelorism Syndrome (400-401del, E420D; red asterisks), and the additional syndromic 
patients identified in Bhoj et al. 2018 (black asterisks). B) Chart describing the source of the 
patient samples that were sequenced in this analysis including the patient population, the 
incidence of each variant within that population, Polyphen2 and SIFT substitution predictions, 
and occurrence in ExAC and gnomAD databases [Adzhubei, 2010; Sim, 2012; Lek, 2016]. 
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individuals in the gnomAD samples (n=282708; Allele Frequency = 0.0000025). The p.Thr299Ala 
variant (rs146907080) was encountered a combined 88 times only in East Asian samples of the 
ExAC and gnomAD databases (n=28606; Allele Frequency = 0.00308), indicating that it is an East 
Asian population specific variant. 
The identification of one novel, one enriched and one very rare variant suggested that they 
may affect SPECC1L function. None of these variants lie in any of the coiled-coil domains of 
SPECC1L protein, in contrast with previously identified SPECC1L mutations in patients with 
atypical facial clefts [Saadi, 2011], autosomal-dominant Opitz G/BBB syndrome [Kruszka, 2015], 
and Teebi Hypertelorism syndrome [Bhoj, 2015; Bhoj, 2018]. Thus, we hypothesized that these 
variants from nsCL/P patients will affect SPECC1L function to a different or lesser degree than 
those identified in syndromic patients. 
 
2.4.6 Expression analysis of SPECC1L variants shows reduced acetylation of SPECC1L-
associated microtubules 
We previously analyzed pathogenic SPECC1L variants identified in syndromic patients in 
a qualitative assay using a SPECC1L-GFP fusion construct [Saadi, 2011; Kruszka, 2015], where 
wildtype (WT) SPECC1L-GFP expression in U2OS osteosarcoma cells, 24-hours post-
transfection, resulted in strong association with a subset of microtubules. We further showed that 
this subset of microtubules is heavily acetylated [Saadi, 2011]. Compared to WT SPECC1L-GFP, 
none of the four variants showed any demonstrable differences in the ability to associate with 
microtubules after 24-hours of transfection (not shown). To sensitize the assay, we first removed 
the C-terminal GFP tag to prevent any ectopic microtubule association or aggregation that may be 
mediated by the tag itself, and used anti-SPECC1L antibody to detect transfected cells (Fig. 2.7). 





Figure 2.7: SPECC1L variants from non-syndromic patients result in reduced association 
with acetylated microtubules. A-C) Representative images of U2OS cells transfected with 
wildtype (A,B) and Q415P (C) SPECC1L in U2OS cells. SPECC1L (green) was visualized by 
immunofluorescence and counterstained with DAPI (blue). D) Transfected cells were scored 
for elaborate (A) or incomplete/abnormal microtubule patterning (B,C). The four variants 
identified in syndromic patients showed no changes, while the Q415P syndromic mutation 
resulted in a markedly reduced proportion of elaborate patterning. E-G) Transfected cells were 
co-stained with SPECC1L (green) and acetylated-α-tubulin (red) and binned into high (E), 
moderate (F), or low (G) groups based on the extent of SPECC1L-associated acetylated tubulin 
staining. H) Compared to wildtype, cells transfected with the A86T- and R546Q-SPECC1L 
constructs exhibited a significantly increased proportion of cells in the low group, and a 
significantly decreased proportion in the high (A86T, R546Q) and moderate (A86T) correlation 
groups. I-J) Representative images of transfected cells taken at 10ms and 300ms exposure to 
demonstrate the difference in the level of overexpressed SPECC1L compared to endogenous 
(J). Scale bars are 20μm. 
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microtubules. We found that even without the GFP tag, wildtype SPECC1L associated with a 
subset of microtubules that formed an elaborate cytoplasmic pattern within almost 80 percent of 
transfected cells (Fig. 2.7A,D). Only a small fraction of cells showed an incomplete microtubule 
pattern, which may represent cells where the elaborate pattern is not yet developed. As expected, 
a syndromic mutation (Q415P) failed to generate this elaborate pattern in ~90% of the transfected 
cells (Fig. 2.7C,D). Instead, cells transfected with the Q415P construct transfected cells showed 
fine, punctate, incongruent pattern, which we described previously for pathogenic syndromic 
variants [Saadi, 2011; Kruszka, 2015]. However, all four nsCL/P variants were able to form this 
elaborate pattern to near-WT levels, between 70-80% of transfected cells (Fig. 2.7D). Thus, we 
concluded that the kinetics of microtubule association is not affected by these nsCL/P variants. 
Next, we evaluated the levels of acetylation among these SPECC1L-associated microtubules (Fig. 
2.7E-G). To minimize variability, we only assayed cells with elaborate microtubule pattern in WT 
and all four variants. Interestingly, we found that ~95% of WT transfected cells showed strong or 
moderate microtubule acetylation just 8 hours after transfection, while ~5% showed low 
acetylation (Fig. 2.7H). These results suggest that this phenomenon is a two-step process, wherein 
SPECC1L first associates with a subset of microtubules, and then facilitates microtubule 
acetylation. We next analyzed acetylation of microtubules in cells expressing the nsCL/P variants 
8 hours after transfection. We found a statistically significant reduction in the number of highly 
acetylated microtubules, and a statistically significant increase in microtubules with low 
acetylation for the A86T and R546Q variants (Fig. 2.7H). The M91I and T299A variants did not 
show statistically significant differences from WT (Fig. 2.7H). It is possible that no significant 
change was identified in M91I samples because either the functional consequence on SPECC1L 
was too mild to be detected in our assay, or it impacted SPECC1L function in a manner that did 
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not alter microtubule acetylation. Compared to syndromic variants (Q415P) [Saadi, 2011; 
Kruszka, 2015], which fail to form the elaborate pattern, the two nsCL/P variants (A86T and 
R546Q) show a moderate reduction in SPECC1L function where they are able to associate with 




Pathogenic SPECC1L variants were found in patients with atypical [Saadi, 2011], 
syndromic [Kruszka, 2015; Bhoj, 2015], and now non-syndromic orofacial clefting. Interestingly, 
even with a small number of mutations identified, SPECC1L variants from atypical and syndromic 
orofacial clefting patients cluster in the second coiled coil and calponin homology domains. In 
contrast, the present variants from nsCL/P patients reside outside of these SPECC1L domains (Fig. 
2.6). Functional analysis also indicates that the nsCL/P mutations are less severe than their 
syndromic counterparts (Fig. 2.7). As we better understand SPECC1L function at the molecular 
level, especially of the second coiled coil domain, the functional differences between variants will 
become clearer. 
We utilized a mouse model with a novel Specc1l truncation allele to confirm a role for 
SPECC1L in the regulation of palate development, consistent with the cleft palate phenotype 
observed in some patients with SPECC1L mutations [Saadi, 2011; Kruszka, 2015; Bhoj, 2018]. 
Our results show that palatal shelf elevation is particularly sensitive to Specc1l deficiency. While 
most Specc1lcGT/ΔC510 mutants eventually completed palatal shelf fusion, they frequently showed 
mild abnormalities in shape and rugae pattern (not shown). Considering that we did not observe 
any differences in the extent of vertical growth (Fig. 2.2) or cell proliferation of palatal shelves at 
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E13.5 (Fig. 2.8), it is unlikely that the delay in palatal shelf elevation in Specc1lcGT/ΔC510 mutants 
is due to an overall underdevelopment of the embryos. It is important to note that a delay in palatal 
shelf elevation presents a potential model both for incomplete cleft palate penetrance that is 
frequently observed in syndromic CL/P [Jugessur, 2009; Dixon, 2011], and for the complex 
etiology of nsCL/P where this delay may predispose the developing embryo to cleft palate pending 
additional genetic or environmental insult. 
We have shown previously that SPECC1L affects cell adhesion [Saadi, 2011; Wilson, 
2016] and cell migration [Saadi, 2011]. Adherens junction markers E-cadherin and β-catenin, as 
well as F-actin, show increased expression upon SPECC1L deficiency in vitro and in vivo [Wilson, 
2016]. Consistently, E-cadherin expression is decreased upon ectopic IRF6 expression [Ke, 2015]. 
In the Specc1lcGT/ΔC510 mutants, we again see a general increase in F-actin staining. Importantly, β-
catenin is mislocalized to the apical surface of the periderm cells in regions where the palatal shelf 
epithelium interfaces with both the tongue and buccal region. Such ectopic localization of adherens 
junction molecules has previously been shown in the periderm of Irf6 mutants [Richardson, 2009], 
suggesting that transient oral adhesions can slow palatal shelf elevation due to increased “friction”. 
IRF6 mutations result in Van der Woude (1/35,000) and Popliteal Pterygium (1/300,000) 
syndromes. Importantly, approximately 10-15% of IRF6 mutations manifest as nsCL/P. Several 
studies have also associated common IRF6 variants with nsCL/P at large [Zucchero, 2004; 
Rahimov, 2008; Beaty, 2010]. One of these variants is located in an upstream enhancer element of 
IRF6 [Rahimov, 2008] and affects IRF6 expression levels [Fakhouri, 2012], and it is also 
associated with the severity of nsCL/P [Kerameddin, 2015]. We now show that SPECC1L 
expression in the palate epithelium and mesenchyme is dependent upon IRF6, thereby expanding 
the IRF6 network. In the future, it would be interesting to explore expression levels of SPECC1L  
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Figure 2.8: Palates of Specc1lcGT/ΔC510 E13.5 embryos show no changes in cell proliferation. 
A-B) Representative images of palatal shelves from E13.5 wildtype and Specc1lcGT/ΔC510 mutant 
coronal sections immunostained for Ki67 (red) and counterstained with DAPI (blue). Scale bars 
are 50μm. C) The proliferation index was determined by measuring the proportion of Ki67+ 
nuclei in the mesenchyme and epithelium of the palatal shelves of three embryo pairs. The 
index is not significantly different between wildtype and mutant samples. Error bars show 
SEM. 
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in mouse mutants for other genes known to interact with Irf6, including Grhl3 [Peyrard-Janvid, 
2014], Tfap2a [Kousa, 2017; Kousa, 2019] and Spry4 [Kousa, 2017]. In conclusion, our data 
suggest SPECC1L is a downstream cytoskeletal effector molecule in the palate, regulated by IRF6 
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3.1 Abstract 
Clefts of the lip and/or palate (CL/P) are common anomalies that occur in 1/800 live births. 
Pathogenic SPECC1L variants identified in patients with rare atypical clefts and syndromic CL/P 
suggest the gene plays a primary role in face and palate development. Palatogenesis requires 
extensive mesenchymal remodeling, especially during palatal shelf elevation. We posit that this 
remodeling involves collective migration of neural crest-derived palatal mesenchyme cells. Live 
time-lapse microscopy was performed to visualize in vitro wound-repair assays with SPECC1L-
deficient U2OS osteosarcoma and primary mouse embryonic palatal mesenchyme (MEPM) cells. 
SPECC1L-deficient cells consistently showed delayed closure in wound-repair assays. To evaluate 
which features of cellular movement were responsible, we performed automated particle image 
velocimetry (PIV) and manual cell tracking. The analyses revealed that both cell speed and 
directionality are disrupted in SPECC1L-deficient cells compared to controls. Stream formation is 
a hallmark of collective migration. Indeed, MEPM cultures displayed correlated movement of 
neighboring cells. Consistent with a role in collective migration, correlation length was reduced in 
SPECC1L-deficient cultures. Furthermore, we previously demonstrated SPECC1L to be a novel 
regulator of PI3K-AKT signaling, with SPECC1L-deficiency leading to reduced pan-AKT levels. 
We show that activation of this pathway with the 740 Y-P small molecule can rescue the wound 
closure delay in both SPECC1L-deficient U2OS and MEPM cells. Cell tracking analyses show 
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that this rescue is in part due to increased speed and improved directionality. Altogether, our data 




The development of the secondary palate involves the coordinated growth and movement 
of the palatal shelves in conjunction with surrounding craniofacial structures [Reviewed in Bush, 
2012; Lan, 2015; Li, 2017]. In mice, the palatal shelves originate as a pair of vertical outgrowths 
from the maxillary processes at embryonic day 11.5 (E11.5) and extend downward adjacent to the 
tongue until E13.5 [Bush, 2012]. Over the next 24-hour period, the palatal shelves elevate to 
position themselves horizontally above the tongue and extend toward the midline by E14.5. By 
E15.5 the shelves have adhered and fused at the midline to form the secondary palate. Defects in 
palatal shelf outgrowth, elevation, or fusion can lead to cleft palate, one of the most common 
human birth defects [Mossey, 2009; Bush, 2012]. Of these steps, elevation is the most poorly 
understood. During this process, the palatal shelves display drastic morphological changes. 
Histological studies of palate elevation have shown that the mechanism differs along the 
anteroposterior axis [Jin, 2010; Yu, 2011; Reviewed in Bush, 2012]. The anterior palate exhibits 
a “flipping up” motion where the distal ends of the shelves turn up toward the midline. In contrast, 
the middle and posterior sections of the palate undergo more extensive remodeling, wherein the 
medial wall of the shelves extends medially as the distal ends of the shelves retract [Walker, 1956; 
Jin, 2010; Yu, 2011]. This latter process can be referred to as mesenchymal remodeling [Jin, 2010]. 
Interestingly, the “bulging” appears to occur first, indicating it may be the driving event during 
elevation [Yu, 2011]. 
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Several cellular mechanisms for mesenchymal remodeling during palate elevation have 
been proposed [Reviewed in Gritli-Linde, 2007; Bush, 2012; Lan, 2015; Li, 2017]. The 
concurrence of elevation defects with changes in proliferation in numerous mouse mutants has led 
to proliferation as a commonly discussed model [Lan, 2004; Okano, 2012; Matsumura, 2011]. 
Previous studies have shown increased proliferation in the medial half of palatal shelves at E13.5, 
suggesting that a mediolateral asymmetry of growth could promote formation of the bulge at the 
medial edge [Lan, 2004]. Nevertheless, elevation defects in other mutants without apparent 
changes in proliferation show that proliferation is required, but not sufficient, for elevation to occur 
[Jin, 2008; Kouskoura, 2013; Lan, 2016]. Regional accumulation of glycosaminoglycans (GAG), 
such as hyaluronic acid (HA), are also hypothesized to drive elevation [Brinkley, 1986; Brinkley, 
1987; Ferguson, 1988]. The high affinity for water of GAGs is proposed to result in osmotic 
swelling of specific regions of the palate. Identification of altered GAG composition in mouse 
mutants with elevation defects lends credibility to this idea [Snyder-Warwick, 2010; Lan, 2016]. 
However, whether these differences contribute to the failed elevation in these models is still 
unclear. 
Mesenchymal remodeling and migration represent a third possibility for palate elevation. 
Tissue reorganization through collective cell movement has been described in several model 
systems [Scarpa, 2016]. This phenomenon has been extensively studied in cranial neural crest cells 
(CNCC), a migratory cell population that contributes to many craniofacial tissues, including the 
mesenchyme of the palatal shelves. Organ culture of chimeric palatal shelf explants have shown 
that palatal mesenchyme also has migratory properties [He, 2008]. Additionally, WNT5A and 
FGF10 have both been found to have chemotactic effects on palatal mesenchyme cells [He, 2008]. 
A different study showed that regional differences in fibronectin organization within the palatal 
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shelf were partially regulated by RAC1 and demonstrated that introduction of a constitutively 
active RAC1 construct could induce elevation [Tang, 2015]. Since fibronectin organization was 
shown to impact migration speed in vitro, it was suggested that changes in regional fibronectin 
organization may facilitate different migration speeds during palate remodeling [Tang, 2015]. 
Together, these studies show evidence that migration may contribute to palatal remodeling, but 
whether palate mesenchymal cells can migrate collectively has not been shown. 
SPECC1L is a cytoskeletal protein that associates with both filamentous actin and 
microtubules [Saadi, 2011; Mattison, 2011]. Mutations in SPECC1L have been identified in 
multiple patients with craniofacial malformations, including cleft palate [Saadi, 2011; Bhoj, 2015; 
Kruszka, 2015; Bhoj, 2018]. Mouse embryos homozygous for a null Specc1l gene trap allele die 
between E9.5-E10.5 with open neural folds and defects in CNCC delamination [Wilson, 2016]. 
Loss of SPECC1L also results in increased staining of adherens junction markers β-catenin and E-
cadherin, as well as defects in actin cytoskeleton organization [Saadi, 2011; Wilson, 2016]. In 
Chapter 2, we reported the generation of a truncation Specc1l allele (Specc1lΔC510) that causes 
perinatal lethality. Crossing this allele with a gene trap (Specc1lcGT) resulted in Specc1lcGT/ΔC510 
compound mutant embryos that exhibit a delay in palate elevation [Chapter 2]. These mutants also 
show transient oral adhesions and improper localization of adherens junction markers to the apical 
surface of periderm cells [Chapter 2]. We proposed that these adhesions were contributing to the 
delay in palate elevation by inhibiting the movement of the shelves [Chapter 2]. However, Specc1l 
is broadly expressed in both the palatal mesenchyme and epithelium, suggesting that it may also 
play a role during mesenchymal remodeling. Consistent with SPECC1L playing a role in cell 
migration, SPECC1L-kd U2OS cells close the wound more slowly than controls in wound-repair 
assays [Saadi, 2011; Wilson, 2016]. 
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In this study we report a quantitative analysis of wound closure in SPECC1L-kd U2OS 
cells to determine which aspect of cell behavior is responsible for these migration defects. We also 
perform random motility and wound-repair experiments using primary mouse embryonic palatal 
mesenchyme (MEPM) cells from wildtype and Specc1lcGT/ΔC510 mutant embryos, as they represent 
a more relevant model of palate development. Importantly, we find that MEPM cells exhibit stream 
formation, an attribute of collective migration, and show that this behavior is reduced in mutant 
MEPM cells. Lastly, we investigate whether pharmacological activation of the PI3K-AKT 
pathway, which is reduced in Specc1l mutants, is sufficient to rescue migration defects in these 
cells. Together, these data show a novel role for SPECC1L in cell migration through regulation of 
the PI3K-AKT signaling pathway, as well as establish MEPM cells as a proxy model for migration 
during palatogenesis. 
 
3.3 Materials and Methods 
3.3.1 U2OS and MEPM cell culture 
Control and SPECC1L-kd U2OS cells (ATCC HTB-96) were cultured in 10% DMEM as 
previously shown [Saadi, 2011; Wilson, 2016]. For MEPM isolation and culture, Specc1lΔC510/+ x 
Specc1lcGT/+ mouse mating pairs were placed together overnight, and the female was checked for 
plugs each morning. Upon identification of a plug, females were removed from the male into a 
separate cage until the desired stage. Gestational stage was defined as embryonic day 0.5 (E0.5) at 
noon of that day. Females were euthanized at E13.5 or E14.5 using a primary and a secondary 
method as approved by the institutional IACUC. Embryos were then harvested from euthanized 
dams under aseptic conditions and washed in sterile 1x PBS. Palatal shelf isolation was performed 
by first decapitating the embryos and removing the jaw. Next, a transverse slide was made above 
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the eyes to create a flat surface and the head was flipped to expose the palatal shelves. Using fine 
forceps and microdissection scissors, palatal shelves were cut away from the rest of the oral cavity, 
placed in a 1.5mL tube with 0.5mL of 0.25% Trypsin (ThermoFisher, 25200056), and incubated 
at 37°C for 10 minutes. Occasional pipetting up and down was performed to accelerate dissociation 
of the shelves by mechanically breaking apart the tissue. The resulting MEPM cells in the Trypsin 
solution were then mixed with 5mL of DMEM (HyClone, SH30243.01) containing 10% FBS 
(Corning, 35-010-CV) in a conical tube. The tube was then centrifuged at 200rcf for 10 minutes 
to pellet the cells. After removing the supernatant, the MEPM cells were resuspended in standard 
high glucose DMEM containing 10% FBS, plated on tissue culture treated plastic dishes, and 
incubated at 37°C for propagation of the cells. Cells were cryopreserved upon isolation, and only 
passaged up to 3 times for use in experiments. 
 
3.3.2 Time-lapse imaging assays 
For wound assays, control and SPECC1L-kd U2OS cells were seeded in silicone inserts 
(Ibidi, 81176) on tissue culture treated plastic dishes at a density of 2.3 x 103 cells/mm2. Specc1l+/+ 
and Specc1lcGT/ΔC510 MEPM cells were seeded at a density of 1.4 x 103 cells/mm2. All cells were 
allowed to continue growth for 48 hours post-confluence before the silicone insert was removed, 
leaving a cell-free gap of 500μm. For MEPM drug experiments, 100µg/mL 740 Y-P (ApexBio, 
B5246) was added 24 hours prior to imaging. The drug was added again at the start of imaging, 
and it remained throughout the duration of imaging. An equal proportion of water was added to 
vehicle control wells. For U2OS drug experiments, 100µg/mL 740 Y-P and 10-30µM wortmannin 
(ApexBio, A8544) were instead dissolved in DMSO. For stream formation analysis of Specc1l+/+ 
and Specc1lcGT/ΔC510, MEPM cells were seeded at low, medium, and high densities; 36 cells/mm2, 
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107 cells/mm2, and 321 cells/mm2 respectively. For these three density analyses, MEPM cultures 
were seeded onto tissue culture plastic dishes that contained 3D-printed rings with the same 
dimensions as one well of a standard 96 well plate. All live-imaging experiments were performed 
in normal culture conditions with phase contrast images collected every 10 minutes over a period 
of 48-72 hours at 10x magnification. Imaging was performed using the EVOS FL Auto Imaging 
System (ThermoFisher, AMAFD1000) with the EVOS Onstage Incubator (ThermoFisher, 
AMC1000). Cell cultures were kept in a humidified, 5% CO2 environment at 37°C during 
imaging. 
 
3.3.3 Time-lapse imaging analysis 
Analysis of the live imaging was performed using software developed at the University of 
Kansas Medical Center by Dr. András Czirók, Ph.D. Three primary types of analyses were 
performed. First, percentage coverage was performed by automated imaging analysis to generate 
confluence and front propagation graphs. Secondly, displacement, flow plots, co-movement, and 
correlation lengths were all quantified from particle image velocimetry (PIV) analysis [Czirok, 
2013]. In brief, the image field was divided into small grid segments and the pixel values were 
analyzed over time to generate a velocity vector field. For displacement, the average velocity of 
the field was calculated over time. For flow analysis, each vector was compared to their 
“neighbors” both parallel and perpendicular to their direction of movement and averaged across 
all vectors. The generated plots were then fitted to a curve from which the co-movement (average 
constant across larger distances) and correlation length (lower rate of drop-off proceeding from 
center results in larger values) were calculated. Co-movement speed is analogous to propagation 
speed of wound, while correlation length is an approximate measure of collective migration. 
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3.4 Results 
3.4.1 SPECC1L-kd U2OS cells show migration defects during wound closure 
To evaluate the effect of SPECC1L deficiency on migration, we performed wound-repair 
assays with control and SPECC1L-kd U2OS cells (Fig. 3.1A-F). Similar to previous findings 
[Saadi, 2011; Wilson, 2016], control cells closed the wound before SPECC1L-kd cells, signifying 
a defect in migration (Fig. 3.1C vs F). To quantify the wound closure, we measured the occupied 
wound area and calculated the percentage of confluency at each 10-minute interval (Fig. 3.1G). 
The rate of the control cell closure is much faster than the SPECC1L-kd cells, as shown by the 
higher slope of the control closure line, and reaches confluency at an earlier frame (Fig. 3.1G, 
green vs. red lines). Averaging of the slopes into a single value similarly shows a front 
propagation speed in the controls (Fig. 3.1H). We also performed automated PIV analysis to 
approximate the behavior of cells within the monolayers. To determine if the impaired wound 
closure was due to the decreased motility, we calculated the average PIV displacement within the 
fields over time (Fig. 3.1I). Indeed, the control fields show a spike in displacement during wound 
closure that is much less pronounced in the SPECC1L-kd (Fig. 3.1I). 
SPECC1L has been implicated in the regulation of the actin cytoskeleton and cell junctions, 
both of which are essential for the collective migration of cells. Therefore, we hypothesized that 
coordinated movement may also be affected in SPECC1L-kd cells. To do this, we first performed 
manual tracking on the cells during wound closure. Migration plots show that SPECC1L-kd cells 
exhibited an increased dispersion pattern during initial phase of wound closure (Fig. 3.1J). We 
also measured the flow by comparing each vector to their neighbors both perpendicular and parallel 
to the direction of movement (Fig. 3.1K-L). Compared to controls, SPECC1L-kd cells showed a 





Figure 3.1: SPECC1L-kd U2OS cells have migration defects. A-F) Images from wound-
repair assays using control (A-C) and SPECC1L-kd (D-F) U2OS cells. At the onset of wound 
closure (A, D; 0 hr) neither wound contains cells. A delay in knockdown cell wound closure 
can be appreciated by mid-closure at 6 hr (B,E) and upon control wound closure (C,F). G-H) 
Automated confluence analysis of wound-repair experiments showing the average percentage 
of wound closure over time (G) and the average speed of front propagation (H) is decreased in 
knockdown cultures (red) compared to control (green). I) Average displacement calculated 
from automated PIV analysis shows an initial spike in knockdown speed. Wildtype 
displacement overtakes mutant displacement during wound closure, but decreases after wound 
is closed at ~12.5hr. J) Manual cell tracking data show increased spread of SPECC1L-kd cells 
compared to wildtype. K-L) PIV flow plot shows average speed of movement surrounding a 
given point in both the parallel (K) and perpendicular (L) directions. Movement in the positive 
parallel direction (K; front) is higher compared to the negative direction (K; back). Knockdown 
cultures show decreased speed at all points (K,L red dots). M) Calculating the constant of the 
fitted curve shows reduced knockdown co-movement speed, analogous to front propagation. 
N) Slower drop-off of the fitted curves converted to correlation length showed an increase in 
correlation length in control cultures compared to knockdown. 
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decrease in knockdown cells, indicating that neighboring cells were migrating in a less coordinated 
fashion (Fig. 3.1M-N) Collectively, these results show that both decreased individual cell speed 
and poor directed motility may contribute to the wound closure delay seen in SPECC1L-kd U2OS 
cultures. 
 
3.4.2 Mouse embryonic palatal mesenchyme (MEPM) cells display attributes of collective 
movement 
To study SPECC1L deficiency in a model that was more relevant to the palate defects seen 
in human patients and our mouse models, we isolated mouse embryonic palatal mesenchyme cells 
(MEPM) from wildtype and Specc1lcGT/ΔC510 compound mutant embryos. We initially 
characterized the dynamics of MEPM growth and movement with time-lapse videos of cultures 
plated at different densities (Fig. 3.2 A-C). Confluency analysis showed that each plating density 
resembled different ranges within a typical S-shaped logistic growth curve, with lower densities 
just entering the rapid growth phase and higher densities reaching a plateau by the end of imaging 
(Fig. 3.2D). The slopes of Specc1lcGT/ΔC510 MEPM cells showed a slower rate of growth at the low 
and medium plating densities compared to wildtype (Fig. 3.2D). PIV analysis of the cultures 
showed that increasing cell density coincided with lower displacement likely due to a reduced 
freedom of movement (Fig. 3.2E). Mutant MEPM cells show reduced PIV displacement at the 
low and medium plating densities (Fig. 3.2E). 
Next, we asked if MEPM cells had any attributes of collective movement. Interestingly, 
cell tracking videos showed adjacent cells moving in similar directions (data not shown). This 
behavior appeared to be more robust at high density, suggesting that the proximity to neighboring 





Figure 3.2: Specc1lcGT/ΔC510 MEPM cells exhibit decreased correlation length in 2-D 
random motility assays. A-C) Representative images of wildtype MEPM random motility 
cultures at low, medium, and high plating densities. D) Confluency curves show an increased 
rate of growth in wildtype MEPM cultures (green shades) compared to mutant cultures (red 
shades). E) PIV displacement plots show higher speeds in wildtype cultures compared to 
mutant cultures at a given density. Displacement speed decreases at higher densities. F) 
Analysis of low density MEPMs (33 cells/mm2) PIV flow plots show decreased co-movement 
speed in mutant cultures compared to wildtype with less difference in correlation length. G) 
Analysis of high density MEPMs (330 cells/mm2) PIV flow plots show decreased co-movement 
speed and correlation length in the mutant cultures. 
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assessed by PIV flow analysis (Fig. 3.2F,G). Correlation between neighboring vectors was higher 
at close proximities and tapered off as distance increased across all conditions, but the low density 
showed a more immediate drop-off (Fig. 3.2F,G). At high density, mutant MEPM cells showed a 
lower co movement speed and correlation length than wildtype cells, suggesting that their ability 
to form streams is impaired (Fig. 3.2F,G). 
Lastly, we performed wound-repair assays to determine if these defects could impact the 
ability for mutant MEPM cells to close the gap. Mutant MEPM cells took longer to close the 
wound than wildtype cells (Fig. 3.3A-F), confirmed by the averaged confluency and front 
propagation (Fig. 3.3G-H). Importantly, this result validated our findings of poor cell migration 
with SPECC1L-deficient U2OS cells. Average displacement was also reduced in mutant wounds 
(Fig. 2.3I). However, contrary to the results from 2-D random motility assays, PIV analysis 
showed only minor reduction in co-movement speed and no significant changes in correlation 
length in mutant cultures (Fig. 3.3J-M). These results demonstrate that Specc1l deficiency can 
perturb MEPM cell growth and speed, as well as their ability to move collectively. However, the 
collective movement defect was only identified in the context of the random motility assay. 
 
3.4.3 Upregulation of PI3K-AKT signaling rescues SPECC1L-deficient migration defects 
We previously reported that loss of SPECC1L results in decreased PI3K-AKT signaling 
along with defects in cell adhesion and cell shape [Wilson, 2016]. Pharmacological activation and 
inhibition of the pathway was sufficient to rescue or exacerbate these phenotypes, respectively 
[Wilson, 2016]. To test if modulation could alter wound closure, we performed wound-repair 
assays with control and SPECC1L-kd U2OS cells and treated with either PI3K inhibitor 





Figure 3.3: Specc1lcGT/ΔC510 MEPM cells exhibit defects in wound closure, but not 
correlation length during wound-repair assays. A-F) Images from wound-repair assays 
show that wildtype (A-C) MEPM cells close wounds faster than Specc1lcGT/ΔC510 (D-F) MEPM 
cells, similar to U2OS experiments. G-H) Mutant MEPM cells (red) show reduced averaged 
confluency curves and front propagation compared to wildtype (green). I) Average 
displacement of wildtype MEPM cells is higher compared to mutant at all stages of wound 
closure. J-K) PIV flow plots show no differences between the four directions with slightly 
reduced speed in mutant MEPMs compared to wildtype. L) Co-movement speed of mutant 
wounds is reduced, but correlation lengths are unchanged compared to wildtype. 
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wortmannin treatment severely impaired the rate of U2OS cell wound closure (Fig. 3.4A-B). The 
speed of control wound front propagation was reduced to the speed of untreated knockdown cells, 
while wortmannin-treated knockdown cell propagation speed was even further reduced (Fig. 3.4A-
B). In contrast, treatment with 740 Y-P had little effect on control wound closure, but rescued the 
rate of knockdown wound closure to control levels (Fig. 3.4A,B). Next, we treated MEPM cell 
wounds with 740 Y-P to see if it would result in a similar effect. PI3K activation did indeed rescue 
the wound closure defect in Specc1lcGT/ΔC510 mutant MEPM cultures (Fig. 3.4C-D). However, 
unlike U2OS cells, 740 Y-P treatment of both wildtype and mutant MEPM cells increased the rate 
of wound closure beyond untreated wildtype levels, possibly owing to increased baseline levels of 
the pathway in U2OS cancer cells (Fig. 3.4C-D). 
To determine what aspect of cell behavior was improved by the rescue experiments, we 
compared cell tracking results from untreated U2OS and MEPM cells to those treated with 740 Y-
P (Fig. 3.5). A subtle decrease in dispersion was observed upon PI3K activation in SPECC1L-kd 
U2OS wounds, but this change was restricted to the early stages of closure (Fig. 3.5A-C). To 
evaluate movement speed, we calculated displacement over time from both the PIV and manual 
tracking data (Fig. 3.5D-E). PIV analysis shows a slight rescue at mid-closure upon 740 Y-P 
treatment (Fig. 3.5D). However manual tracking speed did not show a significant change apart 
from an initial spike in mutant cells (Fig 3.5G). To more easily visualize the differences in these 
data, we plotted both total displacement (Fig. 3.5F; thick lines) and x-axis displacement (Fig. 
3.5F thin lines) over time. We also divided x-axis displacement (movement into the wound) by 
total displacement (Fig. 3.5G). This value shows the proportion of total movement that can 
attributed to movement into the wound, thereby acting as a measure of directed movement. 





Figure 3.4: Activation of PI3K-AKT signaling rescues wound closure defects of 
SPECC1L-deficient cells. A-B) Confluency curves and front propagation of control (green, 
dark green, blue) and SPECC1L-kd (red, brown, pink) U2OS cell wound-repair assays treated 
with vehicle, 740 Y-P, and wortmannin. 740 Y-P treatment rescues knockdown closure 
(brown), and has no effect on control (dark green). Conversely, wortmannin treatment 
decreases closure speed in both control (blue) and knockdown wounds (pink). C-D) 
Confluency curves and front propagation of wildtype (green, dark green) and Specc1lcGT/ΔC510 
(red, dark red) MEPM cell wound-repair assays treated with vehicle and 740 Y-P. Treatment 
with 740 Y-P increases wound closure speed in mutant wounds (dark red), but also wildtype 





Figure 3.5: Activation of PI3K-AKT signaling increases cell movement into wound. A-C) 
Manual cell tracking plots of control (green), SPECC1L-kd (red), and 740 Y-P-treated (blue) 
SPECC1L-kd U2OS wound-repair assays. D-E) Displacement values from PIV (D) and manual 
tracking (E). An initial spike in knockdown movement speed is present in the manual tracking 
graph, but not PIV displacement. F) Average total displacement (F; thick lines) and movement 
directed into the wound (F, thin lines) overtime calculated from manual tracking data to show 
cell speed and directed movement. Knockdown cells show a reduction in both, but this is 
rescued upon 740 Y-P treatment. G) Ratio of these values shows directed movement into the 
wound normalized to total displacement. Knockdown cultures show reduced directed 
movement compared to wildtype, but directed movement is increased in knockdown cultures 
teated with 740 Y-P.  H-J) Manual cell tracking plots of Specc1l+/+ (H; green) Specc1lcGT/ΔC510 
(I; red), and 740 Y-P-treated Specc1lcGT/ΔC510 (J; blue) MEPM wound-repair assays. K-L) Total 
displacement (K; thick lines), wound-directed displacement (K; thin lines), and directionality 
(L) is reduced in mutant cultures, but rescued upon 740 Y-P treatment. 
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upon treatment with 740 Y-P. Contrary to the subtle change seen in the U2OS migration plots, cell 
tracking of MEPM cells showed a substantially reduced dispersion pattern in the rescue wounds 
(Fig. 3.5H-J). Furthermore, plotting total and x-axis displacement (Fig. 3.5K,L) showed the same 
pattern as the U2OS tracking data, where the displacement and directionality of mutant MEPM 
cells was reduced compared to wildtype cells. However, mutant cultures treated with 740 Y-P 
displayed a marked increase in directed movement into the wound that surpassed untreated 
wildtype cells. Taken together, these data show that PI3K activation rescues wound closure defects 
in SPECC1L-deficient cells through improvement of both cell speed and directed movement. 
 
3.5 Discussion 
Generation of mutant mouse models have been very helpful in characterizing the various 
cellular and molecular mechanisms underlying palatogenesis [Gritli-Linde, 2008]. Though palate 
outgrowth and fusion have been well-characterized, the mechanisms driving the elevation of the 
palatal shelves remain elusive. Much of what we know about palate development stems from 
analysis of fixed tissues, but the dynamic and rapid nature of palate elevation renders this process 
difficult to study using this method. Tissue culture of E13.5 embryo heads has been used to directly 
observe elevation, thereby circumventing some limitations of fixed tissue [Iseki, 2007; Okano, 
2012; Song, 2013; Lan, 2016; Lai, 2016]. For example, removal of the jaw can be used to 
determine whether an elevation defect is intrinsic to the shelves. This method also allows testing 
the effect of various inhibitory compounds, growth factors, and even gene expression plasmids on 
palate development [Brinkley, 1982; Shimizu, 2001; Kosazuma, 2004; Tang, 2015]. Isolation of 
primary MEPM cells has also been used for similar purposes [Liu, 2014; Fantauzzo, 2014; 
Vasudevan, 2014; Fantauzzo, 2016; Iyyanar, 2017; Jiang, 2017; Gao, 2019]. The uniform 
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monolayer facilitates the assessment of cellular and molecular processes in highly standardized 
manner, and so this technique has been popular in exploring the various pathways contributing to 
mesenchymal proliferation and differentiation. However, only a few studies have investigated the 
migration of MEPM cells [He, 2013; Fantauzzo, 2017; Gao, 2019], and none, to our knowledge, 
have examined if they can migrate collectively. We identify the presence of stream formation in 
MEPM cells, a behavior generally thought to be a feature of collective migration [Szabo, 2010; 
Czirok, 2013; Scarpa, 2016]. This process requires the active communication through cell 
adhesions, as well as the dynamic reorganization of the cytoskeleton to direct movement in 
response to signals from neighboring cells [Czirok, 2013; Theveneau, 2013; Tang, 2017]. The 
higher correlation lengths seen in the high-density MEPM cultures are consistent with this contact-
dependent mechanism. 
SPECC1L deficiency has been previously shown to result in defects in cell adhesion and 
cytoskeletal organization [Saadi, 2011; Wilson, 2016]. In this study we provide a detailed account 
of cell migration in SPECC1L-deficient MEPM cells. Importantly, we used these cells to 
successfully replicate the previously reported SPECC1L-kd wound closure defects, supporting a 
palate-specific role for SPECC1L in cell migration [Saadi, 2011; Wilson, 2016]. Our analyses offer 
three non-exclusive mechanisms that may contribute to these wound closure defects. First, the 
decreased displacement we assessed by PIV analysis suggest an overall reduction in movement 
speed of mutant cells. This mechanism is the easiest to explain, as slower-moving cells would 
predictably result in slower wound closure. Next, the increased dispersion pattern demonstrated 
by cell tracking shows that the cells do not move persistently to close the wound. If we assume 
that cell movement in any direction has a maximum speed, any movement not directly towards the 
wound would decrease the rate of closure. Finally, the reduced correlation lengths we measured 
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imply that mutant cells have a diminished capacity to respond to the movement of their neighbors, 
therefore resulting in cells that do not travel with the “flow” into the wound. The latter two findings 
are likely related, as poor collective movement of the culture may lead to poor directed movement 
of individual cells. However, we did not see a reduction in correlation length in mutant MEPM 
wound-repair assays. It is possible that the directionality of wound closure obscures the collective 
movement of MEPM cells. Each of these mechanisms together or alone could reduce the efficiency 
of wound closure. 
Studies of palatogenesis have demonstrated that remodeling is a primary feature of the 
elevation process [Yu, 2011; Chiquet, 2016; Li, 2017]. Initial examination of Specc1lcGT/ΔC510 
mutants suggested that their delay in palate elevation was due to transient epithelial adhesions 
[Chapter 2]. However, given the migration defects we identified in Specc1lcGT/ΔC510 mutant MEPM 
cells, it is likely that deficiencies in mesenchymal remodeling are also contributing to this delay. 
Moreover, there remain several mouse mutants with elevation defects for which the underlying 
pathogenic mechanisms have not been fully elucidated [Reviewed in Gritli-Linde, 2007; Gritli-
Linde, 2008; Bush, 2012; Funato, 2015; Li, 2017]. Future inquiries of these mutants may benefit 
from using MEPM cell migration as a proxy for mesenchymal remodeling during palatal shelf 
elevation. 
Our final analyses showed that activation of PI3K-AKT signaling rescued the wound 
closure defects in both SPECC1L-kd U2OS cells and Specc1lcGT/ΔC510 mutant MEPM cells. These 
results are in agreement with the rescue of cell shape and cell adhesion phenotypes in SPECC1L-
kd U2OS cells with PI3K-AKT activation that was previously shown [Wilson, 2016]. 
Interestingly, 740 Y-P treatment increased the front propagation speed of wildtype MEPM cells, 
but not control U2OS cells. Many cancers already have elevated PI3K-AKT signaling [Altomare, 
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2005; Testa, 2005], so it is possible that the pathway may have been at capacity before treatment 
with the activator. Furthermore, cell tracking revealed that increased cell speed and wound-
directed movement contributed to this rescue. Given that AKT is a pro-migratory factor [Xue, 
2013], the increase in cell speed can be easily explained. However, further studies will be required 
to determine if the increase in wound-directed movement is due to an improvement in the cells’ 
ability to maintain their direction, or simply an emergent effect of the increased cell speed into the 
wound. Nevertheless, these experiments collectively demonstrate that SPECC1L regulates cell 
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4.1 Abstract 
SPECC1L is a cytoskeletal protein implicated in the regulation of cell adhesions and 
migration. Heterozygous mutations in SPECC1L have been identified in patients with a spectrum 
of phenotypes overlapping Teebi Hypertelorism and Opitz G/BBB syndromes. These disorders 
consist of midline defects including hypertelorism, cleft lip and/or palate (CL/P), and ventral body 
wall anomalies. Previous mouse models with Specc1l truncation alleles have not recapitulated 
these malformations. Notably, all SPECC1L mutations identified thus far lie within the second 
coiled-coil domain (CCD2) or calponin homology domain (CHD). We therefore asked if these 
point mutations would result in palate-specific phenotypes compared to the other alleles. In this 
study, we generated a knock-in Specc1l allele with a mutation in CCD2, T397P, from a patient 
originally diagnosed with autosomal-dominant Opitz G/BBB syndrome. The resultant 
homozygous mutant embryos displayed omphaloceles and cleft palate. Cleft palate was also 
observed in some heterozygous mutants, aptly recapitulating the human condition. To understand 
the etiology of the cleft palate, we assessed both palate epithelium and mesenchyme, defects in 
which were also identified in truncation mutants. We found that mutant epithelium showed 
increased staining of filamentous actin (F-actin), and that mutant protein strongly colocalized with 
F-actin. Our analysis of mutant mouse embryonic palate mesenchyme (MEPM) cells showed poor 
migration in wound repair assays. Thus, our findings show that a SPECC1L human point mutation 
in CCD2 is dominant negative. T397P appears to have a more severe effect on both palatogenesis 
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than Specc1l truncation alleles, indicating that the mutation is gain-of-function. In addition, the 
T397P mutation also recapitulated the ventral body wall closure defect (omphalocele) that is found 
in 32% of patients with SPECC1L mutations. 
 
4.2 Introduction 
Clefts of the lip and/or palate (CL/P) are one the most common craniofacial defects, 
occurring in approximately 1 in 800 live births [Rahimov, 2012; Mossey, 2012]. In most cases, 
cleft palate occurs in conjunction with other malformations as part of a clinical syndrome, while 
the remainder are isolated, non-syndromic clefts. Opitz G/BBB syndrome, one such craniofacial 
disorder, presents with anomalies including hypertelorism, laryngeal defects, and CL/P, as well as 
urogenital and heart defects [Cappa, 1987]. Opitz syndrome cases have been reported to have both 
an autosomal dominant and X-linked inheritance pattern and have been associated with mutations 
in cytoskeletal genes SPECC1L and MID1 (midline-1), respectively. [Taylor, 2010; Bhoj, 2015; 
Kruszka, 2015; Bhoj, 2018]. SPECC1L mutations have also been identified in patients with Teebi 
hypertelorism syndrome, another autosomal dominant disorder that presents with similar facial 
features [Bhoj, 2015]. MID1 is responsible for assembling a microtubule-associated complex 
[Taylor, 2010; Winter, 2016], whereas SPECC1L plays a role in both microtubule stability and F-
actin organization [Saadi, 2011; Wilson, 2016; Chapter 2]. Recently, a comprehensive analysis of 
SPECC1L and MID1 mutations identified a partially overlapping, but distinct spectrum of 
anomalies between the two groups, and suggested delineation between MID1 and SPECC1L-
related syndromes [Bhoj, 2018]. 
Characterizing the cellular and developmental function of these proteins is imperative to 
understanding how they contribute to these disorders. Additionally, not all polymorphisms are 
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deleterious to gene function [Janssen, 2012; Leslie, 2012; Charzewska, 2015]. Therefore, model 
systems must be utilized to validate the developmental consequences of candidate gene deficiency. 
Gene trap (RRH, DTM, and cGT) and truncation (ΔC510) mutant Specc1l mouse alleles were 
previously generated to investigate the role of SPECC1L in craniofacial development [Wilson, 
2016; Chapter 2]. Embryos homozygous for the gene trap alleles undergo embryonic lethality at 
embryonic day 9.5 (E9.5) along with defects in cranial neural crest cell (CNCC) delamination 
[Wilson, 2016]. In contrast, Specc1lcGT/ΔC510 compound heterozygotes die perinatally and exhibit 
a delay in palatal shelf elevation with over 60% penetrance [Chapter 2]. This delay is only 
temporary, as the palates of most compound heterozygotes elevate by E15.5 [Chapter 2]. These 
mutants also show transient oral adhesions and ectopic apical expression of adherens junction 
markers at the apical surface of periderm cells, representing a potential mechanism for the 
elevation delay [Chapter 2]. Furthermore, live-imaging analysis showed migration defects in 
Specc1lcGT/ΔC510 mouse embryonic palatal mesenchyme (MEPM) cells [Chapter 3]. These results 
are consistent with a role for SPECC1L in palatogenesis in both the palate epithelium and 
mesenchyme. 
SPECC1L contains 8 coiled-coil domains (CCD) and a C-terminal calponin homology 
domain (CHD). CHDs are known for their affinity for F-actin [Gimona, 2002; Korenbaum, 2002]. 
In agreement with this cytoskeletal role, examination of SPECC1L cellular expression shows 
association with both the F-actin and microtubule components of the cytoskeleton [Saadi, 2011; 
Wilson, 2016]. Syndromic SPECC1L variants cluster within, or immediately adjacent to, the 
second CCD (CCD2) and the CHD [Saadi, 2011; Kruszka, 2015; Bhoj, 2015; Bhoj, 2018]. The 
addition of mutations from either region disrupts SPECC1L association with microtubules, 
suggesting that both regions are critical for SPECC1L function [Saadi, 2011; Kruszka, 2015]. 
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The ΔC510 truncation allele removes most of the C-terminal half of the protein, including 
the CHD [Chapter 2]. However, this model does not recapitulate the orofacial clefting seen in 
patients with SPECC1L mutations. Thus, we hypothesized that the human mutations may have a 
gain-of-function effect on SPECC1L function. In this study we report the generation of a knock-
in mouse line containing a CCD2 mutation from an Opitz Syndrome family [Kruszka, 2015]. 
Mutant embryos from this line display a high penetrance of cleft palate. We also show that the 
mutation results in palatal mesenchyme migration defects and alters SPECC1L localization. In 
sum, these results show that SPECC1L mutations within CCD2 have a qualitatively different 
impact on SPECC1L function compared to the truncation. 
 
4.3 Materials and Methods 
4.3.1 Allele generation, mouse crosses and embryo processing 
T397P allele was made with CRISPR/Cas9 with guide RNA 
(TCTGGTGAATCCGTTCTGTCNGG) targeting the CCD2 region. Heterozygous matings 
(Specc1lT397P/+ x Specc1lT397P/+) were used to generate all analyses, apart from the lineage tracing 
experiments. To generate mice for those experiments, the T397P allele was separately crossed with 
the ROSAmTmG (Jax #007576) and Sox10-Cre (Jax # 025807) lines. The ROSAmTmG line was then 
bred one additional time to generate Specc1lT397P/+; ROSAmTmG/mTmG mice. Lastly, Specc1lT397P/+; 
Sox10-Cre and Specc1lT397P/+; ROSAmTmG/mTmG mice were crossed together. Embryo harvest and 
histology processing was performed as previous stated [Chapter 2]. All euthanasia was performed 




4.3.2 Whole mount imaging 
Method for DAPI-stained embryos was adapted from published methods [Sandell, 2012]. 
Briefly, harvested embryos were fixed and permeabilized in 4% PFA at 4°C (overnight for E14.5; 
8 hours for E9.5). Next, embryos were washed three times in 1x PBS and then stained in 500nM 
DAPI dilactate overnight at 4°C. Embryos were submerged in 1x PBS for all imaging. Fluorescent 
images of lineage tracing at E9.5 were captured on a Nikon Eclipse 80i upright microscope, while 
all other brightfield and E14.5 DAPI palate images were captured on a Nikon SMZ 1500 
stereomicroscope. 
 
4.3.3 Skeletal Preparations 
Skeletal stains were performed as dictated by published methods [Rigueur, 2014]. Briefly, 
E19.5 embryos were harvested, washed in 1x PBS, skinned and eviscerated, and then fixed in 95% 
ethanol overnight. Embryos were then placed in acetone overnight for additional fixation and 
permeabilization followed by staining with Alcian blue overnight (product#). After staining, 
embryos were washed in several ethanol solutions and then cleared in 1% potassium hydroxide 
(KOH). Next, bones were stained in a 1% KOH/Alizarin red solution. Lastly, stained embryos 
were acclimated and washed in a 50% glycerol:50% 1% KOH solution for several days, followed 
by long term storage in 100% glycerol. Images were taken on a Nikon SMZ 1500 
stereomicroscope. 
 
4.3.4 MEPM wound-repair assays 
MEPM isolation, culture, and wound-repair assays were performed as previously described 
[Chapter 3]. Briefly, embryos from heterozygous T397P matings were harvested at E13.5. Palatal 
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shelves were removed from the embryos and dissociated in trypsin before culture in 10% DMEM. 
For wound-repair assays, MEPM cells were seeded in silicone inserts (Ibidi, 81176) on tissue 
culture treated plastic dishes at a density of 1.4 x 103 cells/mm2 and cultured for 48 hours. After 
insert removal to create the wound, imaging was performed using the EVOS FL Auto Imaging 
System (ThermoFisher, AMAFD1000) with the EVOS Onstage Incubator (ThermoFisher, 
AMC1000). Cell cultures were kept in a humidified, 5% CO2 environment at 37°C during 
imaging. Analysis of the live imaging was performed using software developed at the University 
of Kansas Medical Center by Dr. András Czirók, Ph.D. 
 
4.3.5 Immunofluorescence analysis 
For cryosections, samples were permeabilized with 0.5% Triton X-100 in 1x PBS for 30 
minutes, washed in PBS, then blocked in 10% NGS (ThermoFisher, #50062Z). Mouse IgG’s were 
blocked with goat anti-mouse antigen-binding fragments (Jackson Immunoresearch, #115-007-
003). Primary Rabbit anti-SPECC1L antibody (Proteintech, #25390-1-AP) was incubated 
overnight at 4°C. Secondary Alexa 488 Goat anti-Rabbit antibody (Invitrogen, A-11008) and Acti-
stain 555 phalloidin (Cytoskeleton, #PHDH1-A) incubated for 1 hour at room temperature. Slides 
were mounted with Prolong Gold with DAPI (Invitrogen, #P36931). Confocal images were 
captured on a Nikon A1R confocal laser microscope. 
 
4.4 Results 
4.4.1 Generation of knock-in T397P Specc1l mouse allele 
We utilized CRISPR-Cas9 technology to generate a mouse line containing the p.Thr397Pro 
(NP_056145) SPECC1L mutation that was previously identified in a multigenerational family with 
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autosomal dominant Opitz G/BBB Syndrome [Kruszka, 2015; Qin, 2016]. Affected members of 
this family exhibited several malformations including ocular hypertelorism, CL/P, and 
micrognathia. [Kruszka, 2015]. They also presented with diaphragmatic, inguinal, and umbilical 
hernias [Kruszka, 2015]. This mutation was chosen for the high proportion of orofacial clefting 
among the affected members relative to those with other SPECC1L variants, as well as for its 
proximity to CCD2 [Kruszka, 2015; Bhoj, 2018]. To create this mutation, we created a CRISPR 
targeting oligo that contains two alterations from the original sequence (Fig. 4.1). The first is a 
synonymous substitution (NM_153406.3:c.1372C>T) that eliminates a Cac8I restriction site (Fig. 
4.1A; green text), while the second (NM_153406.3:c.1376A>C) results in the threonine to proline 
change (NP_700455.3:p.Thr398Pro) (Fig. 4.1A; red text). Note that compared to human 
SPECC1L, the murine protein contains an additional valine at amino acid position 228 that shifts 
the amino acid number forward by one. However, for consistency we still refer to the allele as 
Specc1lT397P. We designed forward primers that mapped to the region of either the WT or mutant 
sequence with one added mismatch, allowing us to genotype each allele without needing to use 
restriction enzymes or sequencing (Fig. 4.1B). 
 
4.4.2 T397P homozygote embryos show highly penetrant cleft palate 
To evaluate the developmental impact of the T397P mutation, we set up heterozygous 
matings and harvested embryos at mid-gestational (Fig. 4.2A,B,C,E,F,G) and perinatal stages 
(Fig. 4.2D,H). We identified omphaloceles, characterized by improperly externalized gut and liver 
[Weber, 2002; Torres, 2015], in ~87% of Specc1lT397P/T397P embryos (Fig. 4.2E-H; arrows). 
Homozygotes also displayed occasional edema (Fig. 4.2I,J; arrowheads), exencephaly (Fig. 4.2I; 
arrow), and vascular defects (Fig. 4.2J; arrow). Examination of the palate showed clefts of the  
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Figure 4.1: Generation of T397P Specc1l allele with CRISPR/Cas9. A) Schematic of 
Specc1l depicting the location of the T397P knock-in changes. Gray boxes represent exons. 
The silent and missense changes are shown in green and red, respectively. The boxes around 
each DNA sequence are matched with the adjacent sanger chromatogram. B) Representative 
images of wildtype and mutant allele PCRs with wildtype, heterozygote, and mutant samples. 





Figure 4.2: T397P mutation causes cleft palate and ventral body wall defects. A-H) 
Representative images of wildtype (A-D) and T397P homozygote (E-H) embryos at E13.5, 
E14.5, E15.5, and E18.5. Homozygotes exhibit omphaloceles that contain gut and liver (E-H; 
arrows). I-J) Representative images of the exencephaly (I; arrow), vasculature defects (J; 
arrow), and edema (I,J; arrowheads) identified in some T397P homozygotes. K-N) Oral view 
of wildtype (K,M) and T397P homozygote (L,N) palates at E14.5 and E15.5. At E14.5, palates 
of homozygotes are not elevated (L; arrow) compared to controls (K). At E15.5, the shelves are 
elevated but still do not make contact (N; arrow). E14.5 palates are stained with DAPI, while 
E15.5 images are brightfield. Bottom-left graph displays compilation of omphalocele and cleft 
palate phenotypes. 
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secondary palate in 100% of homozygotes (Fig. 4.2L,N; arrows) compared to wildtypes, which 
showed no palate defects (Fig. 4.2K,M). Omphaloceles and cleft palate were found in 22% and 
27% of heterozygotes, respectively (Fig. 4.2 Table). Late-stage mutants would also occasionally 
show eye-closure defects (data not shown). To determine if the mutation affected bone and 
cartilage development, we made skeletal preparations of E19.5 embryos. WT (Fig. 4.3A,C,E) and 
heterozygote (Fig. 4.3B,D,F) littermates were comparable in size with no obvious changes in 
staining intensity. However, examination of a heterozygote palate showed defects of the palatine 
processes of the palatine bone (Fig. 4.3F; dotted lines) and palatine processes of the maxilla (Fig. 
4.3F; arrowheads) compared to wildtype control (Fig. 4.3E), consistent with the cleft palate 
phenotype. Additionally, one heterozygote (1/4; n=4) had a partial cleft sternum with malformed 
ribs (Fig. 4.3D; arrows). This defect may have been caused by the severe omphalocele, wherein 
midline fusion was physically obstructed by the herniated viscera during ribcage development. 
 
4.4.3 T397P homozygote embryos have normal CNCC contribution to craniofacial primordia 
Homozygous Specc1lgenetrap/genetrap embryos exhibit defects in CNCC delamination 
[Wilson, 2016]. Given that defects in CNCC function can lead to craniofacial malformations, 
including orofacial clefts [Etchevers, 2006; Achilleos, 2015], we asked if this was the case in 
Specc1lT397P/T397P homozygotes. To achieve this, we performed lineage tracing by crossing the 
T397P allele with the ROSAmT/mG two-color Cre-reporter [Muzumdar, 2007] and Sox10-Cre allele 
[Matsuoka, 2005]. ROSAmT/mG ubiquitously expresses membrane-localized tdTomato until Cre 
recombination, after which it expresses membrane-localized EGFP. Sox10-Cre is expressed in the 
migratory neural crest, allowing the visualization of this population in embryos [Matsuoka, 2005]. 





Figure 4.3: Identification of sternal cleft in T397P heterozygote. Skeletal preparations of 
E19.5 embryos stained with Alcian blue for cartilage and Alizarin red for bone. A-B) Side view 
shows that ribcage of T397P heterozygous embryo (B) is slightly smaller compared to the 
wildtype (A). C-D) Front view shows that the inferior sternum is not fused in the heterozygote 
(D; arrows) with malformed ribs (C vs. D; arrowheads and dotted line) compared to wildtype 
(C; arrow). E-F) Oral view reveals palatine processes of the palatine bone (pp; dotted lines) 
and palatine processes of the maxilla (pm; arrowheads) are much smaller in the heterozygote 
with cleft palate (F) compared to wildtype (E). 
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morphology [Sandell, 2012] (Fig. 4.4). There were no gross differences in size between WT (Fig. 
4.4A-C) and Specc1lT397P/T397P homozygous (Fig. 4.4D-F) embryos, but a lack of lateral turning 
was observed in both heterozygotes (not shown) and homozygotes (Fig. 4.4A,B vs. D,E; 
arrowheads). GFP expression in homozygotes (Fig. 4.4D,F; arrows) was similarly distributed in 
the frontonasal process and first pharyngeal arch compared to WT (Fig. 4.4A,C; arrows), 
suggesting that CNCC migration to the craniofacial regions is not impaired in T397P mutants. 
 
4.4.4 T397P mutant MEPM cells show defects in migration 
Previously, we showed that SPECC1L deficiency can lead to migration defects in cultured 
primary mouse embryonic palate mesenchyme (MEPM) cells [Saadi, 2011; Chapter 3]. Since 
CNCC migration was largely unchanged, we asked if the T397P mutation would affect the 
migration of CNCC-derived palatal mesenchyme. To test this, we harvested MEPM cells from 
E13.5 embryos and performed wound-repair assays as previously described [Chapter 3]. Both 
Specc1lT397P/+ and Specc1lT397P/T397P MEPM cells closed the wound more slowly compared to WT 
(Fig. 4.5A,B), consistent with the migration defects seen in Specc1lcGT/ΔC510 compound 
heterozygote MEPMs [Chapter 3]. Together with the linage tracing, these data suggest that while 
CNCCs populate the craniofacial structures normally, defects in palatal mesenchyme remodeling 
may be contributing to the palate defects in T397P mutants. 
 
4.4.5 Palates of T397P homozygotes show aberrant SPECC1L and F-actin staining 
Lastly, we wanted to examine if the palate Specc1lT397P/T397P embryos showed similar 
molecular changes to those seen in Specc1lcGT/ΔC510 compound heterozygotes [Chapter 2]. We 
examined SPECC1L expression and co-stained with phalloidin to assess F-actin staining (Fig.  
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Figure 4.4: Neural crest cell lineage tracing with Sox10-Cre shows no changes in T397P 
homozygotes. Whole mount epifluorescent images of DAPI-stained E9.5 embryos with GFP-
labeled migratory neural crest cells. A-C) Wildtype embryos are turned (arrowheads) with GFP 
expression in FNP, PA1, and PA2 (arrows). D-F) GFP distribution is similar in T397P 
homozygote (arrows) but turning is less robust (arrowheads). FNP=frontonasal prominence; 
PA=Pharyngeal arch. Scale bar is 500µm. 
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Figure 4.5: Primary mouse palatal mesenchyme cells from T397P mutants have impaired 
migration. A-B) Graphs depicting average percentage closure (A) and average front 
propagation (B) of MEPM cell wound-repair assays. MEPM cells from homozygous (red) and 






Figure 4.6: Oral epithelium of T397P homozygotes show altered SPECC1L localization. 
A-B) Confocal images E13.5 wildtype (A) and Specc1lT397P/T397P (B) coronal sections stained 
for SPECC1L (green) and F-actin (red). C-J) Zoomed in regions of A and B. Wildtype 
SPECC1L expression is punctate in the wildtype with little apical expression (D; arrow). In 
contrast, staining in T397P homozygotes show increased localization of SPECC1L to the cell 
membrane (H; arrow). This change in localization coincides with increased F-actin staining (E 
vs. I; arrows). PS=palatal shelf; T=tongue. 
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4.6). SPECC1L staining in the wildtype embryo exhibited a punctate pattern that was distributed 
throughout the cells with some concentrations along F-actin and cell-cell contacts (Fig. 4.6A) 
[Saadi, 2011; Wilson, 2016]. In contrast, Specc1lT397P/T397P palates showed an increased staining 
intensity of both SPECC1L and F-actin, particularly at the cell border. (Fig. 4.6B). This increased 
staining intensity was also present at the apical surface of flattened periderm cells (Fig. 4.6G-J vs 
C-F; arrows). These results partially reproduce the changes in Specc1lcGT/ΔC510. Additionally, 




This study presents the first example of a human SPECC1L mutation in a mouse model. 
The cleft palate and omphaloceles identified in these embryos (Fig. 4.2) recapitulate congenital 
anomalies seen in patients with SPECC1L mutations, further solidifying a causal role for 
SPECC1L disruption in these disorders [Kruszka, 2015; Bhoj, 2015; Bhoj, 2018]. 
The edema and palate elevation delay in Specc1lcGT/ΔC510 compound heterozygotes shows 
that loss of SPECC1L function can lead to developmental defects [Chapter 2]. While we did 
identify edema in some Specc1lT397P/T397P mutants, the other malformations seen in these embryos 
indicate that the impact of this mutation on SPECC1L function is different from the loss of function 
models [Wilson, 2016; Chapter 2]. Haploinsufficiency of Specc1l is tolerated in mice as indicated 
by the very rare incidence of malformations in Specc1l gene trap heterozygotes [Wilson, 2016]. In 
contrast, embryos with only one T397P allele often exhibited malformations, consistent with a 
gain-of-function mutation. This also reproduces the autosomal dominant inheritance pattern of the 
family in which the mutation was identified [Kruszka, 2015]. 
122 
We showed that the palatal shelves of Specc1lT397P/T397P embryos are unelevated at E14.5 
compared to wildtype littermates (Fig. 4.2K,L). This is similar to the elevation delay present in 
the majority of Specc1lcGT/ΔC510 embryos [Chapter 2]. However, unlike the compound heterozygote 
model, the palates of Specc1lT397P/T397P embryos do not make contact after elevation at E15.5 (Fig. 
4.2M,N), resulting in cleft palate in all the embryos we evaluated. Palatogenesis requires the 
outgrowth, elevation, and fusion of the secondary palatal shelves, and disruption to any of these 
steps can lead to cleft palate [Bush, 2012]. For instance, analyses of cleft palate in other mouse 
models show that reduced proliferation can lead to smaller palatal shelves that fail to make contact 
[Liu, 2008]. Reduced CNCC contribution to the craniofacial structures can lead to similar 
outcomes, but lineage tracing with Sox10-Cre in our mutants suggests that this is not the case (Fig. 
4.4) [Dixon, 2006]. Additionally, the middle and posterior palate has been shown to undergo 
extensive remodeling, and deficiencies in this process, especially during elevation, may lead to 
palate defects [Yu, 2011]. Indeed, Zfhx1a null mice exhibit delays in palate elevation and cleft 
palate without obvious changes to palatal shelf growth [Jin, 2008]. The migration defect in MEPM 
cells from Specc1lT397P/T397P embryos suggests that deficient remodeling may also be a contributing 
factor in our model (Fig. 4.5). Furthermore, increased SPECC1L staining at the membrane in 
Specc1lT397P/T397P embryos (Fig. 4.6) is reminiscent of the pattern seen in high density cultures 
[Wilson, 2016]. This pattern has been shown to overlap with adherens junction markers [Wilson, 
2016]. Considering that improper adhesions and abnormal cell junction staining were shown in 
Specc1lcGT/ΔC510 mutants, it follows that they may also occur in Specc1lT397P/T397P mutants [Chapter 
2]. Lastly, it is possible that the cleft palate in these embryos is not solely intrinsic to the palatal 
shelves. Roughly a third of patients with SPECC1L mutations were noted to have micrognathia, a 
condition characterized by an undersized jaw [Bhoj, 2018]. It has been demonstrated in mouse 
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models with this malformation that obstruction by the tongue is sufficient to cause palate defects 
[Song, 2013; Reviewed in Okano, 2014]. However, we have no consistent evidence for this 
phenotype in our mutants. The mechanisms suggested here are not mutually exclusive. Further 
studies into the morphological and molecular changes in T397P mutant embryos must be 
performed to determine which are contributing to these palate defects. 
Ventral body wall defects, including omphaloceles, comprise a group of rare congenital 
anomalies characterized by the herniation of viscera through an opening in the anterior body wall 
[Weber, 2002; Torres, 2015]. In humans, omphaloceles occur as isolated cases or as part of a 
syndrome with a prevalence of approximately 1 per 5000 pregnancies [Stoll, 2001; Benjamin, 
2014]. The omphaloceles in our T397P mouse model faithfully reproduce those reported in 32% 
(10 out of 31) of patients with SPECC1L mutations [Bhoj, 2018]. Many mouse models with defects 
of the ventral body wall have been analyzed [Reviewed in Brewer, 2004; Williams, 2008; 
Takahashi; 2018]. However, mutants for proteins involved in cell migration and adhesion, 
particularly through regulation of cytoskeletal dynamics, display phenotypes that match closely 
with our model. Loss of Rho-associated kinase I/II (ROCK-I/II) results in impaired eyelid closure 
and omphaloceles stemming from defects in actomyosin cable formation [Shimizu, 2005; 
Thumkeo, 2005]. A similar example can be seen in mice with a point mutation in non-muscle 
Myosin II-B (NMII-B), which exhibit cleft palate, omphalocele, edema, and inferior sternal cleft 
[Ma, 2014]. Umbilical ring closure requires the contractility of actomyosin structures, and it has 
been proposed that the ventral body wall defects in ROCK-I/II KO mice are due to deficiencies in 
this process [Shimizu, 2005; Thumkeo, 2005]. SPECC1L deficiency has been shown to result in 
defects in actin reorganization [Saadi, 2011; Wilson, 2016; Chapter 2]. This is consistent with our 
immunostaining of palatal epithelium showing that the T397P mutation changes SPECC1L 
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localization and F-actin association (Fig. 4.6). Thus, it is reasonable to hypothesize that several 
malformations in T397P mutant mice are due to impairment of the actomyosin structures, 
especially with respect to umbilical ring closure. 
Taken together, we can conclude that the T397P mutation is indeed gain-of-function in 
nature. The high penetrance of cleft palate in Specc1lT397P/T397P embryos solidly established a role 
for SPECC1L in palatogenesis. Future analyses into the functional consequences of CCD2 
disruption will shed light onto the pathogenetic mechanisms of the craniofacial disorders in 
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5.1 Discussion 
5.1.1 A validated role for SPECC1L in palatogenesis 
Genetic analysis of patients with orofacial clefts provides an ever-growing list of associated 
genes. However, association alone is not enough – a causal link in a model system is critical for 
understanding the underlying mechanisms of these defects. After the two initial patients with 
oblique facial clefts, SPECC1L variants were identified in 31 other individuals diagnosed with 
either Opitz G/BBB or Teebi hypertelorism syndrome [Saadi, 2011; Kruszka, 2015; Bhoj, 2015; 
Bhoj, 2018]. While many models of SPECC1L-deficiency have been studied, the palate defects in 
these patients have yet to be recapitulated in a mammalian system [Saadi, 2011; Gfrerer, 2014; 
Wilson, 2016]. Utilizing three novel Specc1l mutant mouse alleles, we were able to generate 
embryos with impaired palate development. Our analyses suggest defects in palatal epithelium and 
mesenchyme are at play in these mutants [Chapter 2; Chapter 3]. We also extend the SPECC1L-
deficient phenotype to ventral body wall defects seen in patients with SPECC1L patients [Chapter 
4]. These studies are the first to establish a direct role for SPECC1L in the development of the 
mammalian palate. 
 
5.1.2 Palate elevation delay as a model of cleft palate predisposition 
Histological analysis of E14.5 embryos showed that ~66% of Specc1lcGT/Δ510 mutant palates 
had not elevated compared to littermate controls [Chapter 2]. Numerous mouse mutants with palate 
elevation defects have been described [Reviewed in Gritli-Linde, 2007; Gritli-Linde, 2008; Bush, 
2012; Funato, 2015; Li, 2017]. In some mutants, the shelves completely fail to reorient and remain 
in a horizontal position, as in seen in Golgb1 deficient mice [Lan, 2016]. However, cleft palate 
due to incomplete or delayed elevation is more commonly observed [Chapter 1.2.3; Reviewed in 
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Gritli-Linde, 2008]. In contrast with these other mouse mutants, we found that most Specc1lcGT/Δ510 
embryos do not exhibit cleft palate. This phenomenon – a delay in elevation with rare or absent 
cleft palate phenotypes – has only a few examples in the literature. For instance, Arhgap29 
heterozygotes showed no evidence of cleft palate, but elevation delay was found in 28% of 
embryos [Paul, 2017]. Another example can be seen in embryos heterozygous for a gain-of-
function Fgfr2 allele, which show delayed elevation and cleft palate with 49% and 4% penetrance, 
respectively [Snyder-Warwick, 2010]. It is likely that delays in other mouse mutants remain 
unreported due to the transient nature of the phenotype, especially if they do not result in cleft 
palate. 
Delays in palate elevation have also been identified in the A/J inbred mouse strain, which 
naturally shows a low incidence of CL/P [Walker, 1956; Reviewed in Juriloff, 2008]. A 
comparison analysis found that A/J embryos closed palates approximately 10-12 hours after 
C57BL/Fr embryos of the same developmental stage [Walker, 1956]. Previous studies also found 
that A/J mice are more likely than other strains to develop CL/P upon exposure to teratogens 
[Vekemans, 1979; Sonawane, 1981; Gasser, 1992; Yamada, 2006; Juriloff, 2008]. 
Together, these models demonstrate that even if an elevation delay is not sufficient to cause 
cleft palate, it can render palatogenesis more susceptible to other insults. Consistent with this, 
numerous genetic and environmental factors have been shown to confer an increased risk of CL/P 
[Leslie, 2013]. Thus, we posit that a palate elevation delay might serve as a predisposing factor to 
orofacial clefting, only resulting in cleft palate upon further perturbation. This is especially 
applicable to the incomplete penetrance of nonsyndromic CL/P [Jugessur, 2009; Pengelly, 2016]. 
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5.1.3 Abnormalities in both the palatal epithelium and mesenchyme of Specc1l mutants contribute 
to elevation delay 
In Chapter 2, analysis of Specc1lcGT/Δ510 mutants revealed an abnormal oral epithelium with 
transient adhesions and ectopic localization of adherens junction proteins. We also showed that 
SPECC1L lies downstream of IRF6. Similar epithelial and elevation defects are seen in mouse 
mutants for Irf6 and Arhgap29 [Ingraham, 2006; Richardson, 2006; Paul, 2017]. If the palatal 
shelves are impeded with sufficient force during elevation, it is likely to delay this process. Next, 
Chapter 3 showed reduced speed and correlation length in wound repair assays and in an open 
field of Specc1l mutant MEPM cells. Previous studies have shown that the middle and posterior 
sections of the palate undergo remodeling during elevation [Yu, 2011]. Furthermore, ex vivo 
experiments have shown that palatal mesenchyme can migrate in the context of the shelves [He, 
2008]. If the movement of the palatal mesenchyme is disrupted, it may also result in decreased 
elevation efficiency. Together, our analysis of Specc1lcGT/ΔC510 mutant embryos offers two 
probable roles for SPECC1L in palatogenesis: prevention of epithelial cell adhesion and regulation 
of mesenchymal remodeling. 
 
5.1.4 Specc1l mouse mutants exhibit a broad spectrum of phenotypes 
5.1.4.1 Evaluating the phenotypes of the Specc1l allelic series 
Three kinds of novel Specc1l mutant alleles have been presented in this work: gene trap 
(cGT), truncation (ΔC510), and CCD2 point mutation (T397P). During the process of generating 
the T397P allele, we also created a series of in-frame deletion alleles (data not shown). One results 
in the deletion of just the 397th threonine (ΔT397), while the other deletes the entire CCD2 
(ΔCCD2). Phenotypic analysis thus far indicates these mutants show similar phenotypes to T397P 
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mutants. A third allele deletes exon 4 and introduces a stop codon that truncates the majority of 
SPECC1L (ΔC1016) including CCD2, and initial matings suggest it results in similar phenotypes 
to the ΔC510 truncation mutant, i.e. no permanent cleft palate. Despite some overlap, each 
“category” of allele resulted in some unique phenotypes not seen in the others. Comparing these 
phenotypes across mutants should provide clues as to the specific processes disrupted by each 
allele. 
 
5.1.4.2 Explaining the embryonic lethality in Specc1l gene trap homozygotes 
The DTM, cGT, and RRH gene trap constructs reside within Specc1l introns 1, 2, and 15, 
respectively [Wilson, 2016]. In Chapter 2, we showed that Specc1lcGT/cGT homozygotes undergo 
embryonic lethality with open neural folds, consistent with other gene trap mutants [Wilson, 2016]. 
In contrast, homozygotes (and compound heterozygotes in the case of Specc1lcGT/ΔC510 embryos) 
with truncation or CCD2 disruption alleles die perinatally [Chapter 2; Chapter 4]. This difference 
is even more surprising given that the ΔC1016 deletion removes all but the first ~100 amino acids 
of SPECC1L, while the RRH allele only removes the CHD with a β-galactosidase tag. There are 
several possible reasons for the discrepancy in lethality phenotypes between truncation and gene 
trap.  
The truncated alleles of SPECC1L (ΔC510; ΔC1016) may have some residual function that 
is lost upon fusion with β-galactosidase by the gene traps. We have shown in Western blots that 
ΔC510 is indeed expressed [Chapter 2]. Another important factor is the strain background of the 
alleles. The genetrap alleles were generated on a mixed 129 and C57BL/6J background and 
backcrossed onto the C57BL/6J. The ΔC510 and ΔC1016 were created on a mixed FVB and 
C57BL/6J background. As we backcross these alleles onto the C57BL/6J background, the 
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homozygous phenotype has become more severe. It is also feasible that an additional cryptic splice 
site bypasses the stop codons we identified in these alleles. Our RT-PCR and western blot data on 
the ΔC510 allele show no evidence for this, but the ΔC1016 allele requires additional investigation. 
Alternatively, molecular consequences of the gene trap construct insertion and function may be 
important to explain why the gene traps have a more detrimental effect on embryonic development. 
The perinatal phenotypes in truncation mutants could represent the true Specc1l null phenotype, 
while the gene traps confer a dominant-negative effect during embryonic development. There may 
also be a chance that the insertion of these gene traps not only disrupts Specc1l, but also 
neighboring genes. Adora2a (NM_009630) encodes a G protein-coupled receptor and is located 
just downstream of Specc1l in the mouse genome. Screens of human transcripts have identified a 
SPECC1L-ADORA2A fusion transcript (NR_103546). Though this transcript has been 
categorized for nonsense mediated decay, a gene trap in Specc1l could also disrupt an equivalent 
transcript in the mouse. However, Adora2a knockout mouse models do not exhibit embryonic 
lethality, reducing the likelihood of this supposition [Ledent, 1997; Chen, 1999]. Lastly, Specc1l 
introns may contain regulatory elements for other genes that are disrupted upon gene trap insertion. 
 
5.1.4.3 Mutation of CCD2 may disrupt actomyosin networks 
Perhaps the most intriguing comparison is between the truncation and CCD2 disruption 
alleles. In Chapter 2, we identified a palate elevation delay phenotype in Specc1lcGT/ΔC510 mutant 
embryos. In contrast, Specc1lT397P/T397P mutant mice show cleft palate with ~100% penetrance 
[Chapter 4]. Disruption of CCD2 also results in other defects not seen in truncation mutants, 
including omphaloceles, eye closure defects, and exencephaly. Together, these phenotypes 
represent deficiencies in tissue fusion or closure. 
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It is established that changes in cellular organization during development are largely driven 
by actomyosin networks [Munjal, 2014; Heer, 2017]. Through adhesions with neighboring cells, 
these networks utilize myosin motors and crosslinking proteins to generate contractile forces 
across multiple cells [Munjal, 2014; Heer, 2017]. These cumulative forces direct tissue stiffness 
and contractility, thus giving rise to the phenomenon of tissue morphogenesis [Heer, 2017]. Given 
its association with cell junctions and cytoskeletal components, SPECC1L would likely be in close 
vicinity with this molecular machinery [Saadi, 2011; Mattison, 2011; Wilson, 2016]. Indeed, the 
fusion defects we observed in T397P mutants have all been linked to cytoskeleton-related genes 
[Ma, 2014; Reviewed in Brewer, 2004; Harris, 2007; Copp, 2010; Funato, 2015]. As discussed in 
Chapter 4, ROCK-I and ROCK-II knockout mice show impaired umbilical ring closure and eye 
closure defects with defects in actin cable formation [Shimizu, 2005; Thumkeo, 2005]. The 
“zippering” process by which the neural folds come together during neurulation has also been 
shown to rely on actomyosin networks [Galea, 2017]. Finally, analyses of F-actin patterning during 
palate elevation are beginning to implicate these networks in palate elevation, and there is no 
shortage of cleft palate models with mutations in actin regulators [Chiquet, 2016, Reviewed in 
Funato, 2015]. While the exact mechanisms are unclear, changes in tissue contractility or stiffness 
are probable explanations for the defects in CCD2 mutants. 
 
5.1.4.4 IRF6 may regulate SPECC1L in both the neural tube and palatal shelves 
There are several examples of mouse mutants that present with both cleft palate and neural 
tube defects, suggesting similar etiologies [Reviewed in Harris, 2007]. A recent review of the 
implicated genes and subsequent bioinformatic analysis found several common gene networks 
between the two processes [Kousa, 2017]. This overlap was then demonstrated in a follow-up 
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study that crossed together Tfap2a (Transcription Factor Activation Protein 2A), Irf6, and Grhl3 
mutant mouse alleles – all transcription factors implicated in human orofacial clefting syndromes 
– to evaluate genetic interactions [Kousa, 2019]. The resultant embryos showed neural tube defects 
of variable severity depending on the allelic combination, ranging from a mild curly tail phenotype 
to complete neural tube closure failure [Kousa, 2019]. In addition, the study also showed that IRF6 
is expressed in the neural folds and early migrating neural crest cells [Kousa, 2019]. This is 
consistent with SPECC1L expression in early embryogenesis [Wilson, 2016], as well as our 
finding that SPECC1L requires IRF6 in the palate [Chapter 2]. Together, these results further 
support a connection between SPECC1L and IRF6 during both neurulation and palate 
development. However, determining if CCD2 mutants develop neural tube defects through the 
same mechanisms as gene trap homozygotes will require further investigation. 
 
5.1.4.5 Sternal cleft in T397P heterozygote is consistent with midline syndromes 
In Chapter 4, we showed an inferior sternal cleft in a T397P heterozygote. In humans, this 
extremely rare defect can occur alone or with other anomalies with an incidence of approximately 
1 per 100,000 births [Alshomer, 2017]. Though no sternal clefts have been identified in patients 
with SPECC1L mutations, this is not unexpected due to the rarity of the malformation [Saadi, 
2011; Kruszka, 2015; Bhoj, 2015; Bhoj, 2018]. Examination of the sternum was not routine prior 
to the identification of this defect in our mice, so the penetrance of the phenotype in T397P mutants 
is currently unknown. 
Omphaloceles and inferior sternal clefts can be found together in patients with Cantrell 
syndrome [Marginean, 2018]. Also called pentalogy of Cantrell, this very rare disorder (1 per 
65,000-200,000 births) presents with five primary features: defects of the inferior sternum, anterior 
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diaphragm, apical pericardium, anterior abdominal wall, and intracardial regions [Marginean, 
2018]. While these malformations are more severe than Opitz G/BBB and Teebi hypertelorism 
syndrome, all three disorders are characterized by anomalies of midline structures, implying a 
similar etiology [Kruszka, 2015; Bhoj, 2015; Bhoj, 2018; Marginean; 2018]. Furthermore, mouse 
mutants with a mutation in the motor domain of non-muscle Myosin-IIB (NMII-B) phenocopy the 
defects of Cantrell syndrome, including omphalocele and sternal cleft [Ma, 2014]. These mice also 
exhibited cleft palate, consistent with a role for actomyosin activity in palatogenesis [Ma, 2014]. 
Interestingly, the study also examined the phenotypes of null NM-IIB embryos and found 
that they did not exhibit the palate, sternum, omphalocele, or diaphragm defects that were seen in 
the motor domain mutants [Ma, 2014]. Drawing from their previous in vitro studies [Kim, 2005], 
they hypothesized that the mutant NM-IIB protein had prolonged binding to actin filaments, 
thereby hindering any compensatory functionality of NM-IIA [Ma, 2014]. This is curiously 
analogous to the appearance of fusion defects and increased actin-associated staining in 
Specc1lT397P/T397P mutants when compared to Specc1lcGT/ΔC510 mutant phenotypes. 
 
5.1.4.6 Effects of genetic background on Specc1l mutant phenotypes 
As standard practice in our lab, newly generated Specc1l mutant mice are crossed onto a 
C57BL/6 background. This has two main benefits. First, mice of a consistent background should 
have more consistent phenotypes [Doetschman, 2009]. Second, outcrossing from the original 
founders is important for minimizing off-target effects, especially with mutants generated with 
CRISPR/Cas9 [Aryal, 2018]. Upon backcrossing the T397P allele, however, we began to see a 
much lower survival rate of heterozygote pups (data not shown). Previous studies have shown that 
genetic strain can have a considerable effect on mutant phenotypes, including lethality [Reviewed 
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in Doetschman, 2009]. One instance of this was found in ROCK-II mutant mice, wherein 
backcrossing to a C57BL/6N background from a 129/SvJ and C57BL/6N mixed background 
resulted in omphaloceles, eye closure defects, and increased perinatal lethality [Thumkeo, 2005]. 
Background strain has also been shown to impact the penetrance of craniofacial defects [Proetzel, 
1995; Dixon, 2004]. The possibility that the phenotypes in our Specc1l mutant mice may also be 
influenced by genetic background raises several questions. Could backcrossing our truncation 
alleles onto a different strain result in palate phenotypes, rather than just a delay in elevation? 
Additionally, genetic background may explain why homozygotes for the ΔC1016 truncation allele 
do not show embryonic lethality. Future studies using these mice will need to consider these 
factors. 
 
5.1.5 Molecular consequences of SPECC1L truncation and CCD2 disruption 
5.1.5.1 Technical classification of SPECC1L coiled-coil domains 
The structural architecture of coiled-coil domains is highly standardized, allowing 
moderately accurate predictions from amino acid sequence [Lupas, 1991; Gruber, 2006; 
Truebestein, 2016]. We derive our current figure of the SPECC1L CCD prediction (Fig. 5.1A) 
from the COILS program (https://embnet.vital-it.ch/software/COILS_form.html) using the 
following settings: unweighted MTIDK matrix with a scanning window size of 21 and prediction 
threshold of 50% [Lupas, 1991]. COILS analysis of human and mouse SPECC1L with these 
settings show identical number, length, and locations of the domains, excluding the additional 
valine in mouse SPECC1L (Fig. 5.1B). However, the number and sizes of the CCDs may change 






Figure 5.1: Prediction of SPECC1L CCD with in silico COILS analyses. A) Line plot 
showing probability of CCD formation in mouse SPECC1L generated with COILS. Below, 
SPECC1L diagram lined up with the plot to illustrate the domains. B) Chart depicting the amino 
acid residues of each CCD in human and mouse SPECC1L. C) Line plot showing the 
probability of CCD formation at the beginning of CCD2 in mouse SPECC1L (aa 385-425) with 
wildtype (green), T397P (red), Q415P (purple), I400-H401 (blue), or ΔT397 (yellow) 
mutations. Circles and triangles on lines represent location of mutations and deletions, 
respectively. 
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Mattison, 2011; Gfrerer, 2014; Bhoj, 2015; Kruszka, 2015]. For the purposes of this discussion, 
we will use our classification of eight CCDs when mentioning previous work. 
 
5.1.5.2 Point mutations may disrupt CCD2 structure 
To predict the impact of various mutations on CCD2 structure, we input mouse SPECC1L 
sequences (NP_700455) into PCOILS, an updated version of COILS, using the default MTIDK 
weighted settings [Gruber, 2006]. Included in the analysis were the T397P, Q415P, and I400-
H401del variants from the patients with SPECC1L mutations [Saadi, 2011; Kruszka, 2015; Bhoj, 
2015], as well as the ΔT397 deletion. Results from the wildtype CCD2 predict the beginning of 
CCD2 at amino acid 397 (Fig. 5.1C; green line), compared to 401 in the original COILS (Fig. 
5.1B). Addition of the T397P mutation drastically changes this prediction, not passing 50% 
probability until amino acid 412 (Fig. 5.1C; red line). Similar results are seen upon addition of 
the Q415P, I400-H401, and ΔT397 mutations with 50% probability at amino acids 418, 410, and 
411, respectively (Fig. 5.1C; purple, blue, and yellow lines). Stereotypical coiled-coil structure 
consists of heptad repeats formed into supercoiled α-helices, with hydrophobic residues typically 
at the points of contact between the coils [Truebestein, 2016]. Given that the T397P and Q415P 
mutations both convert a polar, non-charged amino acid into a hydrophilic proline, it is possible 
that this may compromise the integrity of the domain. Similarly, the two deletions may disrupt the 
structure by forcing a “shift” in the heptad sequence that does not recover until the next intact 
heptad. In addition, the Q415P mutation is predicted to disrupt a larger portion of the domain 
compared to the other mutations, consistent with the more severe atypical clefts identified in the 
patient with the Q415P mutation [Saadi, 2011]. This is possibly because it lies further into the 
domain, and the ~2 heptad repeats between the Q415P mutation and the others may not be able to 
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form a stable coil. Though these are just in silico results, they provide a basis for understanding 
the structural and functional impacts of mutations in CCD2. 
 
5.1.5.3 Disruption of SPECC1L association with microtubules, but not with the actin cytoskeleton, 
results in cleft palate phenotypes 
The differences in phenotypes between truncation and CCD2 disruption mutants most 
likely stem from how the alleles disrupt the function of SPECC1L domains. The ΔC510 truncation 
results in the loss of CCDs 6-8 and the C-terminal CHD. Previous studies have demonstrated that 
mutations in the CCD2 or the CHD can ablate the microtubule acetylation phenotype of full-length 
SPECC1L [Saadi, 2011; Kruszka, 2015]. Furthermore, a study of SPECC1L fragment expression 
showed that C-terminal third (aa 851-1117) of SPECC1L has an affinity for F-actin, consistent 
with the actin-binding role for CHDs [Korenbuam, 2002; Gimona, 2002; Mattison, 2011]. 
However, this study also found that the middle third (aa 351-851), containing CCDs 2-8, showed 
mild actin association [Mattison, 2011]. From these studies, one could hypothesize that the ΔC510 
truncation eliminates the ability for SPECC1L to stabilize microtubules or associate with the actin 
cytoskeleton. However, whether CCDs 2-5 retain the capacity to associate with the actin 
cytoskeleton is still unclear. 
This work has been expanded by a recent dissertation on the functions of Protein 
Phosphatase 1 (PP1), in which an interactome screen revealed an association between SPECC1L 
and PP1-interactor Myosin Phosphatase Targeting Protein (Mypt1) [Mehta, 2017]. This group 
performed SPECC1L-GFP fragment expression analyses like those seen in other studies, but with 
two additional refinements: improved partitioning of neighboring domains and examination of 
both tubulin and F-actin association [Mattison, 2011; Mehta, 2017]. These experiments verified 
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previous findings that the CCD3-7 (aa 462-890) and CHD (aa 891-1117) fragments associated 
with the actin cytoskeleton [Mehta, 2017]. More importantly, they showed that the N-terminal 
CCD1-2 fragment (aa 1-461) associates with tubulin and confirmed direct binding with a 
subsequent microtubule spin down assay. While the insertion of point mutations has suggested that 
the N-terminal region mediates microtubule binding, this analysis was the first to demonstrate it 
clearly [Saadi, 2011; Kruszka, 2015; Mehta, 2017]. 
Taken together, we can infer that the ΔC510 truncation and CCD2 disruption alleles would 
have fundamentally different impacts on SPECC1L function, resulting in loss of association with 
actin and microtubules, respectively. Truncation mutants may also be incapable of SPECC1L-
mediated microtubule acetylation. Furthermore, disruption of CCD2 by point mutation or deletion 
may cause ectopic binding to actin filaments. Indeed, this would be consistent with the increase in 
SPECC1L co-localization with F-actin in T397P mutant palates and may represent the gain-of-
function mechanism of the CCD2 mutations. 
 
5.2 Future directions 
5.2.1 Analysis of signaling pathways in wildtype and Specc1l mutant palates 
To better understand the molecular changes in our Specc1l mutants, we had an antibody 
microarray screen performed on wildtype and Specc1lcGT/ΔC510 palate lysates (Kinexus 
Bioinformatics Corporation). The resultant dataset provides a broad view on the signaling changes 
in our Specc1l mutants (Table X). This dataset will be useful for identifying new directions of 
research. For example, we can utilize Ingenuity Pathway Analysis (IPA) software to identify 
altered signaling networks. Manual scanning of top hits may also provide specific targets for 
investigation by western blot or immunofluorescence. Furthermore, these data can be used to 
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explain molecular changes we have already identified, such as changes in cell adhesion markers 
or increased F-actin staining [Chapter 2]. Indeed, an initial review shows a marked reduction in 
AKT2 in the mutant lysate, consistent with the reduction in AKT levels found previously [Wilson, 
2016]. 
 
5.2.2 Analysis of tissue fusion defects in embryos with CCD2 mutations 
In Chapter 4, we identified elevation delay and cleft palate in mice with the T397P allele. 
In order to determine the nature of this defect, future analyses should include paraffin histology 
and immunofluorescence. The former will allow the assessment of palatal shelf shape and size. If 
remodeling is affected in our mutants, for example, the palatal shelves may be of similar size, but 
not properly extended at E15.5. Alternatively, if proliferation defects are a major factor, then the 
palatal shelf size may be reduced. The palatal shelves by gross examination do not appear to be 
reduced in size, so we predict the shape will be the primary difference. Paraffin histology can also 
be used to look for oral adhesions, as we saw in Specc1lcGT/ΔC510 mutants [Chapter 2]. Furthermore, 
immunofluorescence can be used to evaluate adhesion and cytoskeleton components, especially 
those associated with the actomyosin networks. Proliferation and apoptosis levels should also be 
examined. Similar analyses can also be performed to investigate fusion defects of the ventral body 
wall, eye, and neural tube. We hypothesize that an increase in actin filament staining will be 
observed in these tissues. 
 
5.2.3 Specc1l in-frame deletions: utilizing an allelic series to dissect SPECC1L molecular function 
The allelic series we have generated not only allows evaluation of different SPECC1L 
disruptions on embryonic development, but also provides a unique tool to examine molecular 
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function of SPECC1L domains. After harvesting craniofacial tissue, we can combine an 
immunoprecipitation pulldown of SPECC1L with mass spectrometry to screen for differences in 
protein interactions between wildtype and mutant lysates. For example, comparing how protein 
interactions between ΔCCD2 and ΔC510 mutant SPECC1L will be informative to determine how 
each allele effects cellular function. 
Primary cells from these mutants can also be cultured to directly examine how each allele 
impacts cellular processes, such as cell division and migration. These analyses can be paired with 
treatment with pharmacological compounds, such as 740 Y-P to activate PI3K-AKT signaling. 
Follow-up immunostaining can be used to show how cytoskeletal and adhesion proteins are 
impacted. 
 
5.2.4 Investigating the function of SPECC1L in cell division 
SPECC1L associated with both the mitotic spindle and actomyosin ring during cell division 
(Fig. 5.2A,B; arrows). During our analysis of Specc1lcGT/ΔC510 MEPM cells, we noted that the 
cells will often fail to properly divide and try multiple times before succeeding (Fig 5.2C,D; 
arrows). Preliminary quantification showed that a greater proportion of mutant MEPM cell 
divisions are incomplete compared to wildtype cells (Fig. 5.2E,F; orange vs. blue bars). 
Furthermore, we also found a ~20% reduction in total division events in mutant cultures (Fig. 
5.2E). This is unexpected, given that we did not find any differences in Ki-67 staining between 
wildtype and mutant palates [Chapter 2]. However, Ki-67 is expressed during the G1, S, G2, and 
M phases, so it may only be showing us partial information. Moreover, failed cell divisions may 
not necessarily influence the rate of cell division itself. We also did not control for cell number in 





Figure 5.2: Cell division defects in Specc1lcGT/ΔC510 MEPM cells. A-B) Immunofluorescence 
images of SPECC1L (green) in control U2OS cells showing association with microtubules 
(A,B; arrows) and actomyosin ring (B; arrowhead) during mitosis. C-D) Representative frames 
from time-lapse videos showing normal cell divison in wildtype MEPM cells (C; arrows) and 
a failed division in Specc1lcGT/ΔC510 mutant MEPM cells (D; arrows). E-F) Graphs showing total 
division events (E) and percentage of failed division events (F) in wildtype and 
Specc1lcGT/ΔC510 mutant MEPM cells. 
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SPECC1L causes rocking of cell division [Mattison, 2011]. Taken together with the expression of 
SPECC1L in the mitotic spindle and peri-midbody region, this result strongly suggests a role in 
cytokinesis. We hypothesize that this increase in failed cell divisions is due to defects in 
cytokinesis, possibly resulting in impaired growth of the cell population and aneuploidy. Future 
analysis should include live imaging analyses to evaluate the division process in detail, as well as 
immunofluorescence to examine cytoskeletal components important for cell division. 
 
5.2.5 Rescue SPECC1L fusion defects with upregulation of PI3K-AKT pathway 
We showed that activation of the PI3K-AKT pathway can rescue the wound closure defects 
of Specc1l mutant MEPM cells [Chapter 3]. Previous studies show that the shape and adherens 
junction phenotypes of SPECC1L-kd U2OS cells can also be improved in a similar manner 
[Wilson, 2016]. Thus, we hypothesize that activation of this pathway in vivo may be able to rescue 
some of the developmental malformations seen in our Specc1l mutant embryos. This could be 
achieved in two ways. First, pregnant dams could be treated with 740 Y-P by intraperitoneal 
injection at specific developmental stages prior to the defect we wish to rescue. For neural tube 
closure defects, injections would be performed from E6.5–E8.5 with embryo harvest and 
evaluation at E9.5. Likewise, injections from E12.5-E14.5 and subsequent harvest at E15.5 can be 
used to evaluate rescue of the omphalocele and cleft palate defects. Next, a genetic rescue can also 
be performed by crossing our Specc1l mutants with mice heterozygous for tumor suppressor 
PTEN, a negative regulator of PI3K-AKT signaling [Majumder, 2005; Podsypanina, 2001; Di 
Cristofano, 1998]. This allele has already been generated in our colony by crossing a Ptenflox (Jax 
#004597) mouse with a CMV-Cre mouse (Jax #006054), resulting in a global knockout allele. 
Complete loss of PTEN results in embryonic lethality, so only one parent will contain this allele 
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in the crosses. Considering that mice deficient in the PI3K-AKT pathway have cleft palate and 
blebbing phenotypes similar to our Specc1l mutants, we would expect that these interventions 
would partially rescue some of these defects. 
 
5.2.6 Investigating differentiation and patterning in Specc1l mutant palates 
Proper ossification and patterning of the palate is critical for normal palatogenesis [Chapter 
1.2.5]. Though we did not examine differentiation directly, our skeletal stains of the T397P 
heterozygote embryo in Chapter 4 indicate that Specc1l may play roles in these processes (Fig. 
4.3). Inspection of the oral cavity revealed defects of the palatine processes when compared to a 
wildtype littermate. This finding is consistent with skeletal stains of other cleft palate mouse 
models [Baek, 2011; Lan, 2016; Strassman, 2017]. Future studies should investigate whether these 
staining differences are primary differentiation defects, or rather a consequence of the delay in 
palatal shelf elevation and insufficient horizontal growth. Palate morphology can be investigated 
by histology as described in 5.2.2, combined with Goldner’s trichrome [Wu, 2008] or Van Gieson 
(van Gieson's picrofuchsin and alcian blue) [Baek, 2011] stains to evaluate mineralization and 
connective tissue. Ossification can also be investigated by staining for osteogenesis markers, such 
as alkaline phosphatase [Sweney, 1971], Runx2 [Ducy, 1997], and Osterix [Nakashima, 2002]. 
Gross examination of wildtype and Specc1lΔC510/ΔC510 palates at E18.5 also reveal changes 
in rugae arrangement (Fig. 5.3) indicating that SPECC1L may also play a role in patterning. All 
rugae, apart from 7b, are visible in both palate images [Pantalacci, 2008]. In controls (Fig 5.3A), 
rugae 1-3 are straight, followed by slanted rugae until the eighth, which lies at the border between 
the hard and soft palate. In contrast, Specc1lΔC510/ΔC510 occasionally show abnormal morphology, 
such as the improperly slanted third ruga (Fig. 5.3B). Additionally, some rugae in the mutant also  
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Figure 5.3: Specc1l mutants show rugae defects. A-B) Oral view of wildtype (A) and 
Specc1lΔC510/ΔC510 mutant (B) palates at E18.5 with all rugae labeled except 7b. The mutant 
palate shows abnormal rugae morphology, including a slanted third rugae (B; #3) and 
discontinuous patterning (B; arrowheads) compared to wildtype control (A). Palate designation 
based on Pantalacci et al. 2008. 
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exhibit a discontinuous morphology (Fig 5.3B; arrowheads). There are several possible causes 
for these patterning defects. First, changes to the regional proliferation within and between rugae 
could result in altered morphology [Pantalacci, 2008]. Defects in rugae specification may also be 
responsible for the discontinuous patterning. Alternatively, it is possible that the defects are not 
due to a primary change in the rugae, but are instead caused by deficiencies in overall palatal shelf 
growth and elevation. Future analyses should include whole mount staining for SHH expression, 
an early marker of rugae formation, by in situ hybridization [Rice, 2006; Pantalacci, 2008]. Rugae 
proliferation and morphology can be visualized through whole mount immunofluorescence and 
DAPI staining, respectively [Pantalacci, 2008; Sandell, 2012]. 
 
5.3 Significance 
The consequences of orofacial clefts are multifold, posing not only a considerable financial 
burden on the family, but also a significant strain on the quality of life and social interactions of 
the affected patient [Reviewed in Wehby, 2010]. Thus, it is imperative that the various causes of 
these disorders are identified. The basic concept of an orofacial cleft is relatively straightforward: 
a gap resulting from the failed fusion between two craniofacial processes. However, even a cursory 
investigation into the basis of these congenital anomalies reveals that the underlying pathogenetic 
mechanisms are far from simple. Indeed, elucidating the etiology of orofacial clefts has remained 
an immense challenge due to the complex nature of craniofacial morphogenesis. 
These studies make multiple contributions to our understanding of orofacial clefting. First, 
we demonstrated that IRF6 is required for SPECC1L in the palate, thereby inserting SPECC1L 
into the well-characterized IRF6-GRHL3 craniofacial gene network. We also extend the known 
spectrum of SPECC1L-related phenotypes to patients with nonsyndromic clefts. Furthermore, our 
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analysis revealed oral adhesions and deficiencies of mesenchymal remodeling as two potential 
mechanisms for the palate elevation delay in Specc1l compound heterozygote mice. The former is 
consistent with previous studies on IRF6-related mouse mutants, while the latter attempts to 
answer a question that, despite old roots, has only begun to be investigated in recent studies. Lastly, 
perhaps the most impactful findings in this work come from our examination of T397P mutant 
mice. By recapitulating the cleft palate and omphalocele defects with a knock-in mutation identical 
to a human SPECC1L variant, we directly establish a causal role for SPECC1L in those human 
phenotypes. Our analyses of these mice also implicate actomyosin networks in palatogenesis, 
representing yet another mechanism that has been scarcely studied.  
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Construction of 5’ and 3’ homology arm and gene trap Entry plasmids 
This strategy for generating a multifunctional gene trap targeting construct for use in 
targeted trapping in embryonic stem (ES) cells has been described previously [Strassman, 2017]. 
In brief, 5’ and 3’ genomic homology regions (HR) from the second intron of Specc1l were PCR-
amplified from genomic DNA isolated from EDJ#22 (ATCC SCRC-1021) mouse 129S5/SvEvTac 
embryonic stem cells using the DNeasy Blood & Tissue Kit (Qiagen). PCR amplification was 
carried out using the HiFi PCR Kit (Kapa Biosystems) with oligonucleotide primers that contain 
specific GATEWAY att sites at their 5’ ends (5’ HR, oBB1686 -attB4 and oBB1687-attB1; 3’ HR, 
oBB1688-attB2 and oBB1689-attB3) (Table 2.2). Recombination of these amplified HRs into 
pDONR-P4-P1R and pDONR-P2R-P3, respectively, to generate pENTR-5’HR and pENTR-3’HR 
Entry clones was carried out via in vitro BP Clonase reactions. Reactions were transformed into 
chemically-competent Stbl3 cells (Invitrogen-Life Technologies) and grown on LB agar plates 
supplemented with Kanamycin. The prsFlipROSAβgeo*-TT0-ENTR11 Entry plasmid (TT+0 
refers to Targeted Trap +0 nt reading frame) was used to contribute an attL1-attL2-flanked gene 
trap cassette that maintains the Specc1l reading frame to the final targeted trapping construct 
[Strassman, 2017]. 
 
Construction of conditional gene trap targeted trapping vector 
The three Entry clones, pENTR-5’HR, pENTR-3’HR, and prsFlipROSAβgeo* TT0-
ENTR11, and the pPNT-DEST-R4-R3 Destination vector described previously [Strassman, 2017] 
were combined to create the final targeted trapping vector via the in vitro Multisite GATEWAY 
recombination system using LR Recombinase II Plus enzyme following manufacturer’s protocols 
(Thermo Fisher Scientific). The reaction was transformed into chemically-competent Stbl3 E. coli 
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cells after Proteinase K digestion and plated on LB agar plates supplemented with Ampicillin. 
Primers spanning 3 of 4 recombination junction sites were used to screen transformants 
(pUC_F/oBB 1712, oBB 1713/965 and oBB 1717/hsvtk_R) (Table 2.2), and positive clones were 
verified using restriction mapping after plasmid DNA was isolated using the QIAprep Spin 
Miniprep Kit (Qiagen). 
 
Gene trap insertion into mouse ES cells 
Plasmid DNA for the final ~20 kb targeted trapping vector, prsFlipROSAβgeo*-
Specc1lin2, was isolated using the Endo-free MaxiPrep Kit (Qiagen) and linearized via AscI 
digestion prior to electroporation into EDJ#22 ES cells. Neomycin-resistant ES cell colonies were 
grown in the G418 (250 μg/ml) for 10 days. G418-resistant colonies were picked and split into 
replicate plates for 1) frozen storage in 10% DMSO/DMEM; 2) genomic DNA isolation and 3) 
total RNA isolation. Genomic DNA was isolated using standard Proteinase K digestion protocols 
[Nagy, 2003] Total RNA was isolated using Trizol Reagent following manufacturer’s protocols 
(Invitrogen – Life Technologies). The promotorless gene trap depends upon endogenous Specc1l 
expression in ES cells to confer G418 resistance, so titrations of G418 concentrations were tested 
to determine optimal levels. For our experiment, 250 μg/ml G418 was sufficient to allow correctly 
targeted ES cells to survive, while still killing most incorrectly targeted ES cells.  
 
To identify correctly targeted ES cell colonies, total RNA was extracted using Trizol 
Reagent and used as template in One-Step Reverse transcriptase (RT)-PCR assays using primers 
oBB 1754 and oBB 1125 to amplify a predicted 250 bp product and identify the desired Specc1l-
βgeo* fusion gene trap transcript (Invitrogen - Life Technologies). Of the 48 ES cell lines resistant 
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to 125μg/μl G418, 24 were RT-PCR-positive. Genomic DNAs exacted from RT-PCR-positive ES 
clones were screened for desired recombination events using primers (oBB 1112/1753) designed 
near the 3’ end of the gene trap cassette and outside the 3’ homology arm sequence to generate a 
4.2 kb PCR product in correctly targeted clones (Gel image; Lane 2). Correct 5’ targeting was 
verified only in ES clones that were positive by RT-PCR and the 3’ targeting event. These primers 
(oBB 1752/1115) were designed near the 5’ end of the gene trap cassette and outside the 5’ 
genomic homology arm sequence and yielded an ~6 kb product (Gel image; Lane 1). 
 
Embryo Generation, Harvest, and Processing 
Correctly targeted ES cells containing the cGT cassette insertion into Specc1l intron 2 were 
microinjected into C57BL6/J blastocysts (KUMC Transgenic and Gene-Targeting Institutional 
Facility, Kansas City, KS). Chimeras were obtained and crossed to C57BL6/J mice to monitor 
germline transmission. Heterozygous progeny from the C57BL6/J outcross was confirmed by PCR 
genotyping to identify the Specc1lcGT allele. All animals were housed in accordance with 
University of Kansas Medical Center Laboratory Animal Resources facility regulations, and all 
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studies were performed consistent with protocols approved by the KUMC Institutional Animal 
Care and Use Committees. 
